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THE IMPORTANCE OF SKIN DISORDERS 
The skin is the largest organ of the body. It is the barrier that constitutes the body’s first line 
of defense against external environmental hazards [1], thus maintaining a safe internal 
environment conducive to normal physiological function [2].  
Skin disorders are common in all populations. The International Classification of Disease 10 
index lists over 1,000 skin or skin-associated ailments, yet skin disease continues to receive 
relatively little attention in national and global health [3]. Between 30% and 70% of people 
are reported to experience significant skin disease [3, 4] during their lifetimes. As with all 
diseases, accurate data on the distribution and prevalence of individual skin disorders will 
provide key information for the rational allocation of health resources within communities 
and will provide an evidence base for policy in a number of domains, including health, 
education and regulatory [3, 5].  
ETHNODERMATOLOGY 
Ethnodermatology is a rapidly growing subspecialty within dermatology, and concerns itself 
with the study and treatment of ‘ethnic’ skin, given that African ethnic groups share closely 
related skin features, share similar reaction patterns to certain cutaneous stimuli and develop 
specific cutaneous disorders [6].  
The terminology of race and ethnicity is contentious. For the purposes of this dissertation we 
have chosen to use the terms “white” to describe light-skin subject of European descent (a 
group frequently euphemistically termed “Caucasian” though the term is inexact and its use is 
currently questioned). We do not wish to characterise a large (indeed the predominant) 
proportion of the world’s population who are not of European extraction and have darker 
skins in terms of negatives such as “non-white” or “non-Caucasian”. Accordingly we refer to 
such populations as “ethnic”, and further use the term ethnic to qualify nouns such as skin 
and disease. Where necessary, we will specify a specific population as African (implying 
sub-Saharan African) or Indian (which in our context, means South African citizens of Indian 
descent). The term black is however reserved for instances where attention is drawn to 
specific contrasts between the skins of white populations and those of other ethnic 
populations. 
Ethnodermatoses are those skin conditions specific to people of different particular ethnicity, 
primarily black [7]. Recognition and diagnosis of ethnodermatoses necessitates a 
comprehensive understanding of the influence of ethnicity on the skin, of how it affects 
disease presentation and how therapy can be optimally adjusted for specific groups [7-9]. 
Yet, while the majority of the world’s population is predominantly not of European descent, 
with approximately 80% possessing pigmented skin [10], there are limited data on the 
epidemiology of skin diseases in these subjects. 
Conventional research and training in dermatology has rarely focused on ‘skin of colour’ or 
ethnic skin [11], leading to a lack of reliable data on the distribution of disease in ethnic 
populations, on aspects of pathophysiology peculiar to ethnic skin and its response to therapy. 
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However, recent years have seen a significant increase in research directed at the study of 
ethnic skin. This is in part, due to demographic changes in developed countries resulting from 
global migration as well as increasing affluence of people of colour, leading to an increased 
call on health-care resources [6, 12]. 
Whereas 32.8% of the United States population in 2006, it is projected that the sector will 
constitute the majority of the population by 2050 [13]. There is therefore an urgent 
imperative for substantial research in ethnodermatology, such that this large and overlooked 
population can receive the benefit of diagnosis, management and community interventions 
precisely targeted at the disease spectrum relevant to them [8, 10]. As part of this, it is 
essential that clinicians are familiar with the unique dermatoses most relevant to ethnic 
communities, as well as those differences in more widely spread disorders which are peculiar 
to ethnic skin.  
THE SKIN 
Fitzpatrick’s classification of skin types 
For the purposes of this thesis we define “ethnic skin” as the darker skin types found in ethnic 
populations, i.e. Fitzpatrick skin types IV, V, and VI [10]. Type IV is light brown in tone, 
burns minimally and tans well; type V is brown in skin tone, rarely burns and tans deeply; 
type V1 is dark brown in tone, never burns and tans deeply. Most Africans, African-
Americans, Asians, Hispanics, Native Americans, Native Australians and natives of the far 
south eastern, Caribbean, and Hawaiian Islands and their diaspora fall into one of these 
categories. The majority of the South African population can be categorised as having skin 
colour corresponding to Fitzpatrick skin type IV-VI. This population includes sub-groups of 
African ancestry, Indian and ‘coloured’ people of variably mixed European, African and 
Khoi ancestry. 
Physical characteristics of ethnic skin 
Studies in the literature comparing racial differences in skin structure, function and 
biochemistry are often confusing, or inconclusive due to lack of standardized study design, 
absence of objective methodology, small sample size, age and differences in age, anatomic 
site and climatic conditions [8]. 
There are however marked differences between ethnic and white skins. The epidermis in 
ethnic skin has more layers to the stratum corneum and an increased ceramide content in 
comparison with the skin of white subjects [8, 12]; these differences may result in varying 
responses to skin irritants. Differences are also seen in the dermis of Africans, which is 
slightly thicker and more compact compared to that of white skin (51 ± 2 and 57 ± 2 µm) 
respectively [14].  
Melanin is the major factor in the determination of skin colour. Ethnic skin has a higher 
eumelanin to pheomelanin ratio and melanin is effectively dispersed, providing increased 
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protection against ultraviolet radiation (UVR) [8, 15, 16]. The amount of epidermal melanin 
within melanosomes is significantly higher in darker compared to lighter skin types, [17] and 
is largely responsible for skin tone [18]. 
Although the number of melanocytes is similar in all races, there are differences in 
melanocyte activity and in the characteristics of the melanosomes [19]. In ethnic skin, 
melanosomes are distributed throughout the entire epidermis including the upper epidermal 
layers whereas in white skin, melanosomes are confined to the stratum basale and are absent 
in the upper epidermal layers. Fig 1.[20]. Ethnic skin patients have larger, more dispersed 
melanosomes compared to smaller and aggregated melanosomes in whites [8, 21]. The extent 
of these these differences correlates closely with skin colour. 
It has been shown that on average the epidermis in individuals of African origin provides a 
sun protection factor (SPF) of 13.4 [22]. Although the increased melanin provides protection 
against the harmful effects of UV radiation including photodamage and skin cancers, it also 
makes darkly pigmented skin more vulnerable to dyschromia as a result of trauma and 
inflammation [23]. 
 
Fig. 1 A, Facial skin of a 40-year old, fair skinned white woman. Melanosomes have 
sparse and patchy distribution and minimal extension through upper epidermal layers. 
B, facial skin of a 41-year old ethnic woman. Larger, denser population of 
melanosomes with greater distribution within upper epidermal layers. (Adapted from 
Montagna and Carlisle [20]. 
Collagen fibre bundles are larger in ethnic skin whereas they are smaller and closely stacked 
in white skin. There are fewer fibroblasts in whites compared to the numerous, larger, 
binucleated and multinucleated fibroblasts in their ethnic counterparts. Ethnic skin has an 
increased number of macrophages in the papillary dermis and a decreased amount of 
collagenase. This partly explains the high tendency to keloid formation among ethnic 
populations [12, 21]. Elastic fibres within white skin are more numerous and show features of 
elastosis compared to Ethnic skin, which has less fibres and less elastosis. Racial differences 
in sebaceous gland size have been suggested, though the evidence is as yet inconclusive [12]. 
Hair texture varies greatly even within the black groups, from the short, tightly curled hair of 
sub-Saharan Africans to the long straight hair of Asians [24]. 
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ETHNODERMATOSES 
The biological differences between white and ethnic skin have major clinical implications. 
Some of these are biological. For example, the increased melanin content in the epidermis 
leads to low rates of skin cancer and increased melanosome dispersion protects against 
cutaneous photo-aging effects; on the other hand ethnic skin is markedly prone to 
pigmentation disorders and dyschromia, whereas differences in hair structure may predispose 
to certain types of alopecias in ethnic populations [8, 25]. 
Biologically influenced skin conditions with a strong genetic association [26, 27] such as 
keloids, dermatitis papulosa nigra, pseudofolliculitis barbae and central centrifugal cicatricial 
alopecia (CCCA) are prevalent in people of African ancestry, while dysplastic naevi are 
common in those of European ancestry [9, 27, 28]. Inherited differences may also act 
indirectly for example by affecting an individual’s response to pharmacotherapy [8, 29]. 
Most ethnodermatoses are however, markedly influenced by cultural factors and cosmetic 
practices, which in turn are influenced by level of education, income and belief systems [8, 
30]. A number of ethnodermatoses are related to cosmetic practices, such as exogenous 
ochronosis which may be caused by unsupervised and prolonged use of high concentrations 
of hydroquinone to lighten the skin [31-34] as well as pomade acne, secondary to use of 
commedogenic hair pomades [35-37]. Cupping, coining and moxibustion are traditional 
practices which may result in cutaneous manifestations [10]. Furthermore the widespread use 
of traditional medicinal plants and herbal remedies, particularly prevalent among lower socio-
economic groups, may result in allergic or irritant contact dermatitis. Prolific use of chemical 
skin lightening preparations, which has been extensively reported in South Africa and other 
parts of Africa [38-40], commonly results in adverse effects such as dyschromia and steroid-
induced acne. Mechanical pulling of the hairline as practised for certain hair grooming 
hairstyles often result in traction alopecia. Both traction alopecia and CCCA are commonly 
seen in black and Hispanic patients [30, 41, 42].  
Ethnicity has been shown to have a significant impact on the clinical manifestations and 
severity of dermatoses [7, 8, 42, 43], and the presentation of dermatoses is often unique to 
ethnic populations. 
The spectrum of skin diseases seen most commonly among ethnic populations include 
eczemas, acne, pigmentary disorders, skin bleaching, skin infections, hair disorders, keloids 
and urticarias [44-46]. The 2003 Jamaican study performed by Dunwell and Rose found that 
acne vulgaris and seborrhoeic eczema occurred in 29 and 22% of the study cohort 
respectively. With pigmentary disorders, these were the three most common dermatoses 
encountered [47]. A study on black people living in South London (UK) found that acne 
(13.7%), acne keloidalis (13.7%) and eczema (9.6%) were the three most common skin 
diseases [48]. Nnoruka found eczema to be the most common diagnosis in a Nigerian study, 
accounting for 24.9% of dermatoses, followed by infections and parasitic infestations 
(19.1%) [49]. Dyschromia and skin infections are also significant causes of dermatologic 
disease in ethnic patients [50].  
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Acne and eczema have been reported to be the most common conditions seen within the 
South African black population [46]. We have found that this is followed by pigmentary 
disorders, as described in this dissertation. There are however few data on skin conditions 
such as abuse of skin lighteners, pigmentation disorders, albinism and skin cancer among the 
African population. The first of our studies set out to identify the ethnodermatological issues 
relevant to ethnic skin in South Africa.  
AIM OF THE STUDY 
The work summarised within this dissertation arises from a number of related studies 
focussing on 5 key areas, and provides a broad narrative on ethnodermatology in South 
Africa, with a specific focus on the ethnic population of the province of KwaZulu-Natal. 
These studies are: 
1. Delineation of the spectrum of skin diseases among the African population in a private 
dermatology clinics (Chapter 2). 
2. Skin-lightening practices among South African women of African and Indian ancestry 
(Chapter 3). 
3. Knowledge of and exposure to skin-lightening preparations among African and Indian 
women (Chapter 4). 
4. The chemical constituents of commonly used, self-prescribed skin-lightening 
preparations (Chapter 5). 
5. Knowledge regarding skin cancer risks and compliance with preventive measures among 
different ethnic groups (Chapter 6). 
6. Chemical and efficiency analysis of clays traditionally used as sunscreens by African 
women (Chapter 7). 
7. Analysis of indigenous plants used as traditional skin medicinals (Chapter 8). 
8. Inheritance of central centrifugal cicatricial alopecia (Chapter 9). 
9. A case series of central centrifugal cicatricial alopecia suggesting a familial aetiology 
(Chapter 10). 
10. Frontal fibrosing alopecia (Chapter 11). 
11. Frontal fibrosing alopecia; a possible link with lichen planus pigmentosus (Chapter 12). 
12. Familial frontal fibrosing alopecia (Chapter 13). 
13. Case report: frontal fibrosing alopecia in an African male (Chapter 14). 
14. Impact of alopecia on quality of life in African women: a pilot study (Chapter 15). 
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15. Discussion and Conclusions (Chapter 16). 
The introduction and background, details of subjects and methodology, results, discussion 
and conclusion are fully reported in the publications which constitute the major part of this 
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Abstract
Background Precise knowledge of the prevalence and spectrum of skin diseases in a
population allows for effective planning for provision of dermatology services and
distribution of resources. There are no published data on the epidemiology of skin
disorders in Durban, KwaZulu-Natal.
Objective We investigated the prevalence of skin diseases in black African patients
attending a predominantly black private healthcare facility and profiled the patients.
Methods Clinical charts of all black African patients seen between January 2003 and
December 2010 in a private practice in Durban were reviewed. The diseases seen were
described and the prevalence calculated.
Results A total of 6664 patient charts were reviewed. The five most common conditions
were acne, eczemas, dyschromias, infections, and hair disorders. These data agree with
reports from other parts of the world.
Limitations Selection bias was presented by a single private practice, thus data may not
be fully representative of our population.
Conclusion Acne, eczemas, dyschromias, infections, and hair disorders are, in that order,
the five most common disorders encountered.
Introduction
Knowledge of the incidence and spectrum of skin disease
in a population allows for effective planning to provide
appropriate dermatology services, distribute resources,
institutionalize appropriate preventative measures, and
target future research.1 Skin disease patterns have been
shown to be influenced by level of education, income,
belief systems, as well as cultural habits and customs.2
Skin diseases pose a significant public health problem in
Africa and the developing world in general, and are
mainly a result of common conditions that are due to pre-
ventable infections and infestations. Infectious dermatoses
account for up to 85% of skin conditions in Tanzania,
78% in Malawi, 71% in Ethiopia, and 40% in Uganda.3
The objective of the study was to determine the preva-
lence of skin diseases in black patients attending a pre-
dominantly black private healthcare facility, and to
investigate their distribution. For the purposes of this
study, black refers to patients of African ancestry.
Of the 50.6 million inhabitants of the Republic of
South Africa, KwaZulu-Natal (KZN) Province has the
second largest population with 10.8 million (21.4%) peo-
ple after Gauteng, with 11.3 million (22.4%) inhabit-
ants.4 Migration from rural to urban areas significantly
contributes to the growth of the urban population with
some living in informal settlements and the Durban
Metropolitan Area (DMA) is experiencing a rapid popu-
lation growth rate due to increasing urbanization, migra-
tion, and natural growth. Recent national surveys have
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indicated a decline in the rates of increase in natural
growth, attributable largely to a general decrease in fam-
ily size and the impact of AIDS.5 Urbanization levels for
KZN are expected to increase from 59% in 2010 to 62%
in 2020. This implies that in 10 years time, almost two-
thirds of the total provincial population will be living in
urban areas, of which the DMA is the largest5 and may
result in a changed profile of skin conditions in compari-
son with that reported by older studies.6–8
Previous epidemiological studies in South Africa have
reported eczema, infections, and acne as the three of the
most common dermatoses in black South Africans.6–8
These studies have provided valuable insights into the epi-
demiology and prevalence of skin diseases in this group;
however, they reported mainly on patients attending pub-
lic healthcare facilities in other provinces (Table 1). There
are no published data for KZN, nor indeed any recent
data on the epidemiology of skin diseases in South Africa.
The last study was undertaken 10 years ago by Hart-
shorne in Johannesburg.7
Materials and methods
This is a retrospective cross-sectional chart review targeted at
all patients presenting with skin conditions at a private
dermatology practice situated in central Durban. All records
were eligible for inclusion; where no clear diagnosis was
recorded, that patient was excluded from the analysis.
Ethical approval was obtained from the UKZN Biomedical
Research Institutional Review Board (BE 180/11). Charts of all
black patients seen between January 2003 and December 2010
(inclusive) were reviewed. All the patients were seen by three
registered dermatologists who are familiar with African skin. The
diagnosis was made on clinical grounds, supported by relevant
laboratory investigations or histopathology where necessary.
Only data relating to their first visits and main diagnosis were
recorded for each patient.
Skin diseases were divided into the following broad disease
categories using the International Classification of Diseases
(ICD 10)9: acne, eczemas, dyschromias, infections, hair
disorders, and skin neoplasms. Specific subtypes of these
categories were also documented. Dermatosis that did not
belong to the above broad disease categories were recorded
under “other.” The data were captured on a Microsoft Excel
spreadsheet and analyzed using SAS (v 9.1.3, SAS institute
Inc., Cary, NC, USA). Confidence intervals (CI 5%) were
calculated for all prevalences.
Results
A total of 7064 patient charts were reviewed between
January 2003 and December 2010, of which 6664 were
black. Adults accounted for 86.9% and were aged
between 19 and 86, with a mean age of 35.6 years, while
the children were aged between 1 and 18 years, with a
mean age of 11.3 years (74.1% of the patients were
female and 25.9% male).
Acne was the most frequent diagnosis, with a preva-
lence of 44.3% (CI: 42.3–45.5%) (Table 2), with a preva-
lence of 48.0% (CI 46.6–49.4%) in males and 33.6% (CI
31.4–35.9%) in females. It was most prevalent in the age
group 13–24 years (Table 4).
Eczemas were the second most common diagnosis, with
a prevalence of 15.9% (CI: 15.1–16.8%). Table 3 pro-
vides the prevalence of skin diseases by disease category.
The prevalence of eczema in females was 14.0% (CI
13.0–15.0%) and in males 21.5% (CI 19.6–23.6). The
third most prevalent skin disease was dyschromia (see
Table 3 where the diseases are listed by subtype). Infec-
tion was the fourth most frequent category: the common-
Table 1 Previous epidemiology of skin diseases studies conducted in South Africa
Year Authors
Number of persons and
population surveyed Top 5 conditions seen Reference
1957 Findlay 600 black: Pretoria Infections, eczemas, acne, pellagra Findlay28
1961 Schulz 2000 black: Pretoria
900 black: Pretoria
1000 black: Bloemfontein
Eczemas, infections, acne, pellagra Schulz et al.29
1966 Ross 2100 black: Sibasa, Northern
Transvaal
Infections, acne, eczemas, pellagra, papular urticaria Ross30
1968 Park 4544 black: Pretoria Infections, eczemas, acne, pellagra, porphyria (hepatic) Park31
1969 Findlay 3935 black: Pretoria Acne, eczema, infections, papular urticaria Findlay32
1970 Dogliotti 2000 black: Johannesburg Infections, eczemas, acne, pellagra, FDE Dogliotti33
1975 Dogliotti 9474 black: Johannesburg Infections, eczemas, acne, pellagra, psoriasis Dogliotti8
1982 Schulz 5000 black: Pretoria Eczemas, infections, acne, bleaching cream
dermatitis, pityriasis rosea
Schulz6
2003 Hartshorne 5355 black: Johannesburg Eczema, infections, acne, benign tumours, psoriasis Hartshorne7
2013 Dlova (current study) 6664 black: Durban Acne, eczema, dyschromia, infections, hair disorders
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est infections were tinea versicolor (2.8%), tinea capitis
(2.3%), molluscum contagiosum (1.6%), and human pap-
illomavirus infections (1.4%) (Table 4) .
Hair disorders were the fifth most common diagnosis,
and accounted for 4.7% of diagnoses, the most common
being acne keloidalis (1.3%), followed by pseudofolliculi-
tis barbae (1.2%), traction alopecia (0.7%), folliculitis de-
calvans (0.6%), lichenplanopilaris (0.5%), central
centrifugal cicatricial alopecia (0.4%), hirsuitism (0.3%),
and alopecia areata (0.2%). In sixth position were skin
neoplasms: Kaposis sarcoma (0.1%), solar keratosis
(0.1%), basal cell carcinoma (0.02%), and squamous cell
carcinoma (0.02%), the latter three presenting in albino
patients. Table 5 provides detail on those dermatoses listed
as other, which included eosinophilic folliculitis (3.0%),
pruritus (2.1%), papular urticaria (1.7%), xerosis (0.9%),
keloids (0.9%), psoriasis (0.7%), and sarcoidosis (0.2%).




n = 6664 Prevalence (%)
95% Confidence
interval
Acne 2953 44.3 42.3–45.5
Eczemas 1061 15.9 15.1–16.8
Dyschromia 775 11.6 10.9–12.4
Infections 668 10.3 9.6–11.1
Hair disorders 318 4.8 4.26–5.28
Skin neoplasms 14 0.2 0.1–0.4
Other 875 31.1
CI, confidence interval.









Unspecified 1935 29.0 28.0–30.2
Acne vulgaris 687 10.3 9.6–11.1
Acne excoriee 177 2.7 2.3–3.1
Steroid-induced acne 169 2.5 2.2–3.0
Middle age acne 125 1.9 1.6–2.2
Nodulocystic acne 2 0.03 0.01–0.12
Eczema type
Unspecified 519 7.8 7.1–8.5
Atopic dermatitis 482 7.2 6.6–7.9
Seborrheic dermatitis 159 2.4 2.0–2.8




Stasis eczema 1 0.02 0–0.1
Dyschromia
Unspecified 361 5.4 4.9–6.0








Ochronosis 3 0.05 0.01–0.14





<12 years 20/465 4.3 2.7–6.7
13–24 years 884/1348 65.6 63.0–68.1
>25 years 2011/4766 42.2 40.8–43.6
Eczema
<12 years 241/465 51.8 14.2–56.4
13–18 years 84/459 18.3 14.9–22.2
>25 years 605/4766 12.7 11.8–13.7
Table 5 Prevalence of other dermatoses
Skin condition
Number
n = 6664 Proportion (%)
95% Confidence
interval
Pruritus 141 2.12 1.79–2.5
Ochronosis 9 0.14 0.07–0.27








Keratosis pilaris 28 0.42 0.28–0.62
Pityriasis alba 32 0.48 0.33–0.69
Psoriasis 43 0.65 0.47–0.88
Drug eruption 32 0.48 0.33–0.69
Keloid 58 0.87 0.67–1.13




Granuloma annulare 1 0.02 0–0.1
Cellulitis 1 0.02 0–0.1
Sunburn 1 0.02 0–0.1




Hirsuitism 14 0.21 0.12–0.36




Papular urticarial 112 1.68 1.39–2.03
Syringoma 13 0.2 0.11–0.34
Sarcoid 13 0.2 0.11–0.34
Albinism 3 0.05 0.01–0.14
Pityriasis rubra pilaris 1 0.02 0–0.1
Nickel allergy 3 0.05 0.01–0.14
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Discussion
Most consultations were in adults (86.9%) with a female
preponderance (74.1%) suggesting that adults were more
likely to consult a dermatologist. The relatively low pre-
sentation in children can be attributed to the fact that
children tend to end up with specialist pediatricians and
general practitioners before consulting dermatologists for
their common skin conditions.
In a survey of 5000 black patients conducted in 1982
at Ga-Rankuwa Hospital in the Pretoria region of South
Africa, the prevalence of eczema was 22%, followed by
acne (11%) and skin damage resulting from the use of
bleaching creams (6%)6 (Table 1). The last study on the
spectrum of skin conditions in South Africa was con-
ducted in 2003 on 5355 black patients attending aca-
demic public hospitals in Johannesburg, in these patients,
the commonest skin diseases were eczema (32.7%), acne
(17.5%), and superficial fungal infections (5.7%).7
Our study has shown acne, eczemas, dyschromias,
infections, and hair disorders as the five most common
disorders. Our results demonstrate a changing trend on
the prevalence of skin diseases in Africans. Infections that
were previously ranked higher as common skin conditions
in previous local studies (Table 1) now rank fourth, with
acne, eczemas, and dyschromias as the leading disorders
in the population studied. This suggests improved living
conditions of the population studied. It is also possible
that the change results in part from changes in health-
seeking behavior, but this is not easy to determine in a
retrospective chart review.
The changing pattern we report is in agreement with
data from the USA, which indicate a changing trend in
black patients, with acne increasingly reported as the
commonest skin disorder.10–13 Similarities can be drawn
between our data and those encountered in North Ameri-
can black patients, although the order of conditions is dif-
ferent.10,11 Improved socio-economic circumstances have
allowed black patients in particular to seek skin care and
dermatological care from private practitioners under con-
ditions similar to those seen in the first world.10,11
Davis et al.,14 in a study from 1993 to 2009, reported,
acne, atopic dermatitis, unspecified dermatitis or eczema,
seborrheic dermatitis, and dyschromia as the five most
common diagnoses for African-American patients in der-
matology clinics. In another US study, the five most com-
mon diagnoses in black patients were acne, dyschromia,
contact dermatitis and other eczema, unspecified cause,
alopecia, and seborrheic dermatitis.10 A study by Halder
et al.11 between 1980 and 1982 among private black
patients in Washington DC reported acne vulgaris
(27.7%), followed by eczema (20.3%), pigmentary disor-
ders other than vitiligo (9.0%), seborrheic dermatitis
(6.5%), and alopecias (5.3%) as the most common der-
matoses. In an Afro-Caribbean population, acne vulgaris
(29.2%), seborrheic eczema (22.0%), pigmentary disor-
ders (16.6%), and atopic eczema (6.1%) were the most
common dermatoses.15 A study done in south-east Lon-
don reported acne (13.7%), acne keloidalis (13.7%), and
eczema (9.6%) as the three most common skin diseases in
black adults.16
In an African study, the five most common conditions
seen in Ghana were infections, dermatitis, pruritus, auto-
immune disease, and acne. This was compared with a
UK enquiry, where malignant and premalignant dermato-
ses, benign tumors, dermatitis, infections, and psoriasis
were listed as the five most prevalent conditions.17 The
high frequency of infections in Ghana, a developing
country, was attributed to the hot, humid climate, as
well as to adverse socio-economic conditions. The unreg-
ulated availability of depigmenting creams was impli-
cated as the cause of the high prevalence of dermatitis in
Ghana.17
In the present study, tinea versicolor was the most pre-
valent infection (2.8%). Tinea versicolor is a common
superficial fungal infection of the skin with a higher prev-
alence in hot tropical zones with humid climates, and
Durban is a coastal city with a humid climate.
The three most common conditions reported in our
study, acne, eczema, and dyschromia are discussed in
detail below.
Acne
The highest prevalence of acne (65.6%) was observed in
patients who were between the ages of 13 and 24 years,
with acne vulgaris being the most common diagnosis,
accounting for 10.3% of cases, followed by acne
excoriee. Notably, steroid-induced acne had a prevalence
of 2.5%, resulting from inappropriate use of steroid
creams to treat acne, post inflammatory hyper pigmenta-
tion, other dyschromias, and for skin bleaching. Unspeci-
fied acnes had a prevalence of 29.0%, which makes it
difficult to draw conclusions on the various types of acne
seen, as most could have been better classified had this
been a prospective study.
The prevalence of acne was higher in females (48.0%)
than in males (33.6%), suggesting that either acne is
more common in females or that they tend to seek medi-
cal attention more frequently than males. A descriptive
epidemiological study on acne in the USA reported that
nearly two-thirds of visits (65.2%) were made by
females.18 In a study aimed at defining the prevalence of
acne in women from different race groups, clinical acne
prevalence was 37% in African-American women and
23%, 24%, and 30% for Continental Indians, Cauca-
sians, and Asians (respectively women).19 Our findings
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are in line with the international literature with respect to
gender and skin conditions.
A recent systematic review on the epidemiology of
acne20 suggested that it is unclear if acne is truly associ-
ated with ethnicity, although black individuals are more
prone to post inflammatory hyper pigmentation and spe-
cific subtypes, such as pomade acne and steroid-induced
acne.20
Eczema
Eczema prevalence was 15.9%, with atopic dermatitis
being the most common type, with a prevalence of 7.2%.
It was more common in males, with a prevalence of
21.5%. The highest prevalence (51.8%) of eczema was
observed in children, suggesting that childhood eczemas
are more common in this population. Atopic dermatitis
has been shown in other studies to be the most common
skin disease in children, with data reflecting 51% of refer-
rals in black children and 39% in white children.16
Dyschromia
Dyschromias have been reported in several studies to be
common in black patients. Pigmentary disorders have a
significant psychological impact, as they tend to be more
obvious in darker skins.21,22 We have found dyschromias
to be the third most common skin condition seen, with a
prevalence of 11.6%. The commonest subtype was
unspecified hyper pigmentation (5.4%) followed by mel-
asma (4.0%) and post inflammatory hyper pigmentation
(2.2%). Schulz reported in 1982 that dermatitis resulting
from the use of bleaching creams was the third most com-
mon disorder in 324 black patients, nine (3%) had acute
contact dermatitis and 49 (15%) had leukomelanoderma
resulting from monobenzone containing creams, while
266 (82%) were found to have melanosis, ochronosis, or
colloid millium as a result of using hydroquinone-contain-
ing creams.6 A survey of 5355 black people in Johannes-
burg in 2003, where the first and largest number of
ochronosis cases were reported by Findlay et al. in
1975,23,24 found that only 27 (0.5%) had ochronosis.7
However, in the current study, ochronosis only accounted
for three (0.05%) of the patients seen, and they were all
in their early and late sixties, implying that they are pos-
sibly survivors of the skin bleaching scourge of the 1970s
and 1980s23 (Figs 1 and 2). A comparison of the preva-
lence data in five national surveys shows a dramatic
decline in ochronosis from 10% in 1978 to 0.05% in the
present study, confirming the success of the stricter South
African government regulations pertaining to the sale and
use of hydroquinone containing skin-lighteners.25 Thus,
dyschromias are a common indication for black patients
to consult a dermatologist; the psychological sequelae are
enormous and treatment remains a challenge.
Hair
Acne keloidalis nuchae (1.3%), pseudofolliculitis barbae
(1.2%), and traction alopecia (0.7%) were the most com-
mon hair disorders observed in our study. The low preva-
lence of traction alopecia could be explained by the fact
that many patients do not seek treatment for it, as they
regard it as a normal consequence of hair grooming.
Skin cancer
Very few patients presented with skin neoplasm, actinic
keratosis, and basal and squamous cell carcinomas, as
skin cancers are uncommonly seen in black patients.
These were observed in albino patients who are prone to
ultraviolet radiation-induced skin cancers.
HIV dermatoses
Eosinophilic folliculitis, an HIV-associated dermatosis,
had a prevalence of 3.0%. HIV has changed the topogra-
phy of skin diseases on the African continent, with
Kaposis sarcoma, papular pruritic eruption, and drug
reactions being the commonest dermatoses seen, followed
by herpes zoster, dermatophyte infections, and molluscum
contagiosum.26
Figure 1 Ochronosis. Severe involvement of the face and
neck in a black woman.
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Keloids, which are known to be common in black
patients,11 were noted in 0.9% of the cases (Table 5).
We observed sarcoidosis in 0.2% of our cases; similar
cases have previously been reported in Johannesburg.27
Nutritional disorders, such as pellagra, which used to be
among the common skin conditions seen previously
(Table 1), did not feature at all in this study, suggesting
an improvement in the socio-economic conditions of the
population studied.
Conclusion
In this retrospective study, we documented the spectrum
of skin diseases seen in a predominantly black private
practice in Durban, South Africa. Acne, eczemas, dys-
chromias, infections, and hair disorders were found to be
the five most common dermatoses presenting to dermatol-
ogists.
Our study limitations include the selection bias pre-
sented by a single practice, and the fact that only the pre-
senting diagnosis was considered thus preventing the
inclusion of secondary diagnoses. However, our study
provides a reasonable premise to plan future larger popu-
lation studies to map out accurately the epidemiology of
skin disease for the DMA, and ultimately establishing the
prevalence of skin diseases in KZN.
It is hoped that this new information on the spectrum
of skin diseases in KZN will add to the body of knowl-
edge, inform effective planning, and offer pertinent rec-
ommendations for the needs of the province as a whole.
As our patients were recruited from a private healthcare
facility, targeting a particular income group of the popu-
lation that is able to afford medical insurance, and is
therefore likely to be biased against those disorders asso-
ciated with poverty. Further studies in the public sector,
in rural communities and from other areas, as well as in
other racial groups, are needed to provide a valid cross-
sectional impression of the entire population. This will
allow clinicians and policy makers to plan effectively for
the provision of dermatology services, distribution of
resources, and implementation of relevant preventative
measures, including consumer and public education cam-
paigns against the dangers of inappropriate and pro-
longed use of topical steroids.
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Background Cutaneous adverse sequelae of skin lightening creams present with
myriad skin complications and affect dermatology practice, particularly in sub-
Saharan Africa where such products are widely used, with a prevalence of 25–
67%.
Objectives To examine the skin lightening practices of both African and Indian
women living in South Africa.
Methods A cross-sectional survey was undertaken in the general outpatient depart-
ments of two regional university hospitals in Durban, South Africa. All consent-
ing African and Indian women aged 18–70 years were recruited and asked to
complete a questionnaire.
Results Six hundred women completed the questionnaire, of whom 327%
reported using skin lightening products. The main reasons cited were treatment
of skin problems (667%) and skin lightening (333%). Products were purchased
from a variety of sources. Twenty-five per cent reported using sunscreen.
Conclusions The use of skin lightening cosmetics is common among darkly pig-
mented South African women, including those of both African and Indian ances-
tries. Despite more than 20 years of governmental regulations aimed at
prohibiting both the sale of cosmetics containing mercury, hydroquinone and
corticosteroids, and the advertising of any kind of skin lightener, they are far
from having disappeared. The main motivations for using these products are the
desire to treat skin disorders and to achieve a lighter skin colour. Television and
magazine advertisements seem to influence womens’ choice of these products
and, thus, would be efficient channels for raising public awareness about the
dangers of using uncontrolled skin lighteners.
The obsession with and wish for fair skin is a global phenom-
enon, particularly in dark-skinned cultures, not only restricted
to African countries. A prevalence of skin lightening of 25–
67% has been reported in African countries.1–8 It is well
known that South American, Asian and Middle Eastern cultures
also have their own beliefs about skin lightening.9
Studies have shown that women engage in skin lightening
practices more often than men, driven by a strong desire to
lighten their skin colour.6,7,10 Dadzie and Petit7 summarized
the studies conducted on the practice of skin bleaching, and
showed that skin lightening is a widespread phenomenon,
affecting diverse communities worldwide, including those in
Africa, North America, Europe, Asia and the Middle East. Skin
lightening agents have been used for decades, and the trend
appears to be increasing.9 However their use is associated with
adverse effects, resulting in tremendous challenges for derma-
tologists.2,8,11,12 Olumide et al.8 reported a case of squamous
cell carcinoma on an exogenous ochronotic area, raising con-
cerns about the use of skin lightening agents without the con-
comitant use of a broad-spectrum sunscreen, as secondary
longstanding sun damage may result in skin cancer on suscep-
tible depigmented skin.
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In South Africa, various ethnic languages specifically
describe the practice of skin lightening: ‘ukutsheyisa’ in isiXh-
osa (‘to chase beauty’), ‘ukucreamer’ in isiZulu (‘applying
creams on the skin’) and ‘hokgantsa sefatlhego’ in Setswana
(‘to lighten the face’). Indians tend to refer to the practice as
‘using fairness creams’. According to the literature, 75% of
the population in Nigeria,3 52–67% of the Senegalese popula-
tion and 35% of the population in Pretoria, South Africa,3,4,13
use skin lightening products. One of the reasons cited for
using skin lighteners is the belief that a lighter skin tone is
more attractive. In certain Indian and Asian communities, it is
believed that the prospects of marrying and belonging to a
higher caste, with the attendant social economic benefits, are
enhanced by fair skin.9,14,15 Skin lightening creams account
for 40% of all beauty products sold in India.9,15 Cosmetic
advertisements on television and in fashion magazines contrib-
ute to the magnification of light-coloured skin by featuring
fair-skinned models as attractive and desirable symbols.8,15,16
The desire for fair skin plays out among the Asian and black
communities in the form of a colour bias, which privileges
lighter over darker skin.8,9,15
South Africa possesses a unique history of skin lighteners.
During the 1960s and 1970s – at the height of apartheid rule
– the country’s skin lightener market was robust and highly
profitable. From the mid-1970s, the government began to
regulate the active ingredients found in these products, first
prohibiting ammoniated mercury and, later, limiting the level
of hydroquinone permitted to 2%. In the 1980s, opposition
to skin lighteners became a corollary of the antiapartheid
movement as medical professionals and Black Consciousness
activists called for their complete ban on both health and
political grounds. In 1990, South African regulation prohibited
the use of hydroquinone in cosmetics. Moreover, South Africa
became the first – and is still the only – country in the world
that prohibits advertisement of lighteners and adverts contain-
ing words such as ‘bleach’, ‘lighten’ or ‘whiten’.17,18
In a study carried out in the U.S.A. in early 1980s, Findlay
alluded to the notion that many black people dislike skin that
has a dull, drab, dusty or scaly surface, and prefer brightness.19
A recent paper investigating the contents of the top 10 bestsell-
ing skin lightening creams on the market in Durban, South
Africa, showed that nearly half of the analysed products con-
tained mercury as an active ingredient (banned for use in cos-
metics), although this was neither declared on the ingredient
listing nor the packaging label.20,21 Four (40%) of the products
analysed contained mercury as an active ingredient [Lemon Lite
Vanishing Cream (Tiger Brands, Byranston, South Africa);
Shirley Cream (Shirley Woking, U.K.); Rico Complexion Cream
(General Healthcare, Hayes, U.K.); and Cuticura (Godrej Con-
sumer Products, Hounslow, U.K.)], two (20%) contained corti-
costeroids [Movate cream (Movate, Milan, Italy); Persivate
cream (Pharmacare, Port Elizabeth, South Africa)], two (20%)
resorcinol [Bee-co Cream (Pride of Africa, Durban, South
Africa); Eskamel (Mentholatum, Tokai, South Africa)], and
one (10%) a hydroquinone derivative (Gentle Magic skincare
cream; Durmac, Durban, South Africa).20
The prevalence of and factors underlying the use and abuse
of skin lightening creams among Indian women living in
South Africa have never been investigated. Yet, in clinical
practice, dermatologists witness the devastating effects of skin
lighteners. Moreover, an in-depth and large-scale investigation
of the reasons why African women use skin lighteners has
never been undertaken. Clinical experience suggests that such
women use skin lighteners for a variety of reasons, including,
but not limited to, the pursuit of a lighter complexion. Many
black South African women are frustrated by the challenges of
postinflammatory hyperpigmentation, which is a characteristic
feature of black skin,22 and may use skin lightening creams as
self-medication in an effort to get rid of this and other
common dermatological conditions such as acne and
melasma.23–25
Evaluating the extent of and motivations behind use of skin
lighteners by African and Indian women should lead to the
development of targeted interventions aimed at changing per-
ceptions and educating consumers of the potential conse-
quences of their use. Therefore, the objective of this study
was to investigate the prevalence and misuse of skin lighten-
ing products, and the reasons and factors that encourage this
practice among African and Indian women.
Materials and methods
A cross-sectional survey was conducted at the general outpa-
tient departments (excluding skin clinics) of two regional
teaching hospitals of the Nelson R. Mandela School of Medi-
cine [R.K. Khan (RKK) and Prince Mshiyeni Memorial (PMM)
hospitals]. RKK mainly treats an Indian urban population,
while PMM hospital predominantly treats Africans. The study
received ethical approval from the University of KwaZulu-
Natal’s biomedical research institutional review board (BE
180/11). South African Indian and African women aged
between 18 and 70 years, with a Fitzpatrick’s skin type rang-
ing from 4 to 7, were enrolled in the study after providing
written informed consent. Six hundred women (300 South
African Indian and 300 African), were recruited to provide
statistically significant results. Data were collected by a trained
assistant who was proficient in both English and isiZulu. All
women were invited to participate over a period of 4 months
(1 September–31 December 2012). They were asked to com-
plete a structured questionnaire, adapted from Hamed et al.14
and listing well-known skin lightening creams. None of
participants was examined during the survey. The question-
naire focused on the following items: sociodemographic char-
acteristics (level of education, social class, marital status and
employment status); cosmetic habits and skin lightening prac-
tices (therapeutic, cosmetic); and factors associated with the
use of skin lighteners (therapeutic, cosmetic).
Data analysis
Data were entered into EXCEL (Microsoft, Redmond, WA,
U.S.A.) and analysed using SAS version 9.3 (SAS Institute Inc.,
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Cary, NC, U.S.A.). Data were summarized in contingency
tables. Logistic regression models were fitted to calculate the
odds ratios (ORs) with 95% confidence intervals (CIs).
Results
Sociodemographic characteristics of the study
participants
Almost half of the women (470%) were married, 585% had
received more than 10 years of education and 110% had a
tertiary education qualification. Approximately 900% of the
participants resided in either urban or suburban areas, with
two-thirds reporting that they were unemployed. About
700% had a light or light brown skin tone, while the remain-
der reported a dark (black) or dark brown skin tone. Approxi-
mately 850% stated that they were satisfied with their skin
tone (Table 1).
Cosmetic habits and skin lightening practices amongst
black South African women
Five hundred and seventy-one women answered the question
of whether they used skin lightening products. The overall
prevalence of use was 187/571 (327%; 95% CI 289–368):
75/277 (271%) Indian women and 112/294 (381%) Afri-
can women. The main reasons cited for use were treatment of
facial pigmentation (353%), skin lightening (262%) and the
Table 1 Sociodemographic characteristics of the study participants
Variable African (n = 300) Indian (n = 300) Total (n = 600)
Race 292 (973) 286 (953) 578 (963)
Unknown 8 (27) 14 (47) 22 (37)
Residence
Urban 31 (103) 155 (517) 186 (310)
Suburban 215 (717) 131 (437) 346 (577)
Rural 22 (73) 1 (03) 23 (38)
Semirural 26 (87) 2 (07) 28 (47)
Unknown 6 (20) 11 (36) 17 (28)
Age (years)
< 20 27 (90) 6 (20) 33 (55)
20–30 102 (340) 41 (137) 143 (238)
31–40 80 (267) 48 (160) 128 (213)
41–50 43 (143) 77 (257) 120 (200)
> 50 45 (150) 118 (393) 163 (272)
Unknown 3 (10) 10 (33) 13 (22)
Marital status
Married 85 (283) 197 (657) 282 (470)
Single 191 (637) 48 (160) 239 (399)
Divorced 7 (23) 22 (73) 29 (48)
Widowed 13 (43) 23 (77) 36 (60)
Unknown 4 (13) 10 (33) 14 (23)
Level of education (years)
None 11 (37) 13 (43) 24 (40)
1–5 16 (53) 11 (37) 27 (45)
> 5–10 55 (183) 127 (423) 182 (303)
> 10–12 163 (543) 123 (410) 286 (477)
Postgraduate 50 (167) 15 (50) 65 (108)
Unknown 5 (17) 11 (37) 16 (27)
Skin tone (subjective)
Light 94 (313) 97 (323) 191 (318)
Light brown 93 (310) 126 (420) 219 (365)
Dark brown 87 (290) 55 (183) 142 (237)
Black 21 (70) 11 (37) 32 (53)
Unknown 5 (17) 11 (37) 16 (27)
Monthly income
Unemployed 182 (606) 211 (703) 393 (655)
< R200 2 (06) 0 (0) 2 (03)
R200–400 8 (27) 2 (07) 10 (17)
> R400–600 5 (17) 1 (03) 6 (10)
> R600 98 (327) 75 (250) 173 (288)
Unknown 5 (17) 11 (37) 16 (27)
Data are presented as n (%).
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treatment of acne (235%) (Table 2). Twenty-five per cent of
women reported using lightening cream for more than 6 or
12 months, and the majority (660%) had used skin lighteners
for years. The products were purchased from a variety of
sources, including small cosmetics stores (588%) pharmacies
(299%), street vendors (43%) general practitioners (27%)
and beauticians (09%). The data showed that most women
used the products following advice from friends (600%) or
Table 2 Practice of skin lightening
Variable African (n = 112) Indian (n = 75) Total (n = 187)
Prevalence of skin lightening 112/294 (381) 75/277 (271) 187/571 (327)
Reasons for use
Pigmentation 33 (295) 33 (440) 66 (353)
Pimples 36 (321) 8 (107) 44 (235)
Dark skin 34 (304) 15 (200) 49 (262)
Unknown 9 (80) 19 (253) 28 (150)
Duration of use
3 months 10 (89) 9 (120) 19 (102)
> 6 months 7 (62) 10 (133) 17 (91)
> 12 months 19 (170) 9 (120) 28 (150)
Many years 73 (652) 43 (573) 116 (620)
Unknown 3 (27) 4 (53) 7 (37)
Time of application
Morning 50 (446) 25 (333) 75 (401)
Evening 7 (63) 2 (27) 9 (48)
Morning + evening 55 (491) 48 (640) 103 (551)
Site of application
Face 101 (901) 72 (960) 173 (925)
Marks 3 (27) 0 (0) 3 (16)
Pimples 3 (27) 0 (0) 3 (16)
Body 5 (45) 0 (0) 5 (27)
Unknown 0 (0) 3 (40) 3 (16)
Where products are bought
Pharmacy 46 (411) 10 (134) 56 (300)
Private doctor 4 (36) 1 (13) 5 (27)
Small stores 53 (473) 57 (760) 110 (588)
Street 8 (71) 0 (0) 8 (43)
Beautician 1 (09) 3 (40) 4 (21)
Unknown 0 (0) 4 (53) 4 (21)
Monthly cost of products (Rand)
< 10 12 (107) 1 (13) 13 (70)
10–20 45 (402) 15 (200) 60 (321)
> 20–50 38 (339) 22 (293) 60 (321)
> 50–100 11 (98) 14 (187) 25 (134)
> 100–200 1 (09) 13 (173) 14 (75)
> 200–1000 1 (09) 9 (120) 10 (53)
> 1000–2000 3 (27) 1 (13) 4 (21)
Unknown 1 (09) 0 (0) 1 (05)
Who advised on product
Doctor 4 (35) 2 (27) 6 (32)
Pharmacist 2 (18) 1 (13) 3 (16)
Friend 66 (589) 31 (413) 97 (519)
Television advert 4 (36) 0 (0) 4 (21)
Magazine or newspaper 18 (161) 12 (160) 30 (160)
In-store seller 3 (27) 3 (40) 6 (32)
On the street 3 (27) 2 (27) 5 (27)
Other 11 (98) 0 (0) 11 (59)
Unknown 1 (09) 24 (320) 25 (134)
Use of traditional plants 11 (98) 4 (53) 15 (80)
Use of ibomvu clay for sun protection 48 (429) 1 (13) 49 (262)
Use of sunscreen 13 (116) 27 (360) 40 (214)
Data are presented as n (%).
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from seeing adverts in magazines (160%) (Table 2). For most
women, monthly expenditure on skin lighteners ranged from
R10 (US$1) to R200 (US$20). Three African women (27%)
reported spending more than R1000 (US$100) a month on
lightening creams. While a small proportion (80%) reported
using traditional plants (‘ummemezi’ and ‘umqonga’) for skin
lightening, more than a quarter reported using traditional sun-
screen in the form of red clay (‘ibomvu’).26 The latter was
almost exclusively used by African women (only one Indian
woman reported using clay as sunscreen). About a fifth of the
women declared using commercial sunscreens (Table 2). More
Indian women (360%) used sunscreens on their face than
African women (116%; Table 3).
Factors associated with the use of skin lighteners
Ethnic background, education, age and residence were associ-
ated with the use of skin lightening products. African women
were 171 times more likely to use skin lighteners than Indian
women (95% CI 11–244; P < 001). Women aged 30 years
or younger used less skin lightener than older women (OR
056, 95% CI 036–088; P < 001). Women who had
received more than 10 years of education were also less likely
to use skin lightening products, and urban women were more
likely to engage in skin lightening practices than rural women
(Table 4).
Factors associated with the use of sunscreen
Of the 187 women who said they engaged in skin lightening,
only 214% declared using sunscreen. Ethnic background, age
and employment were associated with the use of sunscreen.
The frequency of sunscreen use by African women was three
times less than that of Indian women (OR 026, 95% CI
016–044; P < 001). Women aged 30 years or younger used
less sunscreen than older women (OR 050, 95% CI 027–
093; P < 003). Employed women were 175 times more
likely to use sunscreen than unemployed women (OR 175,
95% CI 111–276) (Table 3).
Discussion
Skin lightening was performed by 327% of the black African
women included in this study, almost 500% lower than that
reported in Senegal (672%), Nigeria (Lagos; 724%) and
other African countries.3,6,13
The main reason for using skin lighteners by women
included in this study was for the treatment of skin problems,
including postinflammatory hyperpigmentation, melasma and
acne (670%), followed by skin lightening (330%).
Twenty-five years ago, Hardwick et al.10 conducted an
epidemiological study of 195 patients with exogenous ochro-
nosis attending the outpatient department of Kalafong and
Table 3 Factors associated with use of sunscreen
Variable n/N (%)
Univariate Multivariate
OR 95% CI P-value OR 95% CI P-value
Ethnicity
African 21/192 (109) 026 016–044 < 001 017 009–034 < 001
Indian 89/280 (318)
Age (years)
< 30 19/124 (153) 050 027–093 003 052 024–114 010
31–50 53/209 (254) 095 058–154 083 098 056–172 096
> 50 38/144 (264)
Employment status
Employed 40/131 (305) 175 (111–276) 002 157 094–261 008
Unemployed 69/344 (201)
Marital status
Married 62/240 (258) 137 089–211 015 084 050–141 051
Not married 48/237 (203)
Education
< Grade 10 47/217 (217) 053 025–112 010 027 011–067 < 001
Grades 10–12 50/222 (225) 056 027–117 012 037 016–085 002
Graduate 13/37 (351)
Skin colour (subjective)
Light 87/352 (247) 152 090–256 011 124 071–216 046
Dark 22/124 (177)
Residence
Urban 46/166 (277) 207 075–570 016 050 015–163 025
Suburban 59/279 (212) 145 053–392 047 066 021–202 047
Rural and semirural 3/28 (107)
OR, odds ratio; CI, confidence interval.
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Mamelodi day hospital in Pretoria. The reasons that these
patients cited for using skin lighteners included the pursuit of
a fairer complexion (i.e. equating lightness with beauty;
320%), skin problems (319%), peer usage (193%), adver-
tising influence (100%); family example (05%); and imitat-
ing a hero/heroine (08%). In contrast, the main reason put
forward in the present study was for the treatment of skin
problems (670%) followed by skin lightening (33%).
In a recent 7-year retrospective survey of 6664 African
patients seen in a predominantly black urban dermatology
practice in Durban, South Africa, we found a dramatic
decline in ochronosis from 100% in 1978 to 005% in
2013,27 suggesting the success of stricter South African gov-
ernment regulations introduced since 1990, especially per-
taining to the sale and use of products containing
hydroquinone. In their study, Hardwick et al. reported a
690% prevalence of ochronosis amongst users of skin light-
eners. In addition, they found that the major demographic
associations with ochronosis were a lower level of education
and a high proportion of women,10 which is consistent
with our own findings (Table 3).
Contrary to popular belief among the Indian community
that only African women use skin lighteners, the results show
that women of both African (381%) and Indian ancestries
(271%) follow this practice in South Africa. A study on the
practices of women living in Jordan reported a higher preva-
lence (607%) of skin lightening amongst Arab women.14
Few women reported using sunscreen, with an especially
low rate among African women (118%), which is of more
concern considering the long-term effects of sunburn and skin
cancers on skin lightened areas.8 This finding indicates lack of
knowledge and awareness about the dangers of ultraviolet
rays, and highlights the unaffordability of sunscreens. Consid-
ering how common the practice of skin lightening is globally,
there have been very few reported cases of skin cancers associ-
ated with this practice. Furthermore, to our knowledge, there
are no scientific data that support the notion that use of sunsc-
reens in the setting of chronic skin lightening prevents skin
cancer. Most women who did not use sunscreens were unem-
ployed.26
The use of skin lighteners in this study was associated with
ethnic background, age, education and place of residence
(Table 4). Generally, women aged 20–50 years were more
likely to use skin lighteners, which could be explained by the
high prevalence of acne and dyschromia encountered among
this age group. Unlike other countries,7,8,12,28 the population
in this study tended to use the creams on their face only
(925%) rather than on their whole body. Our study
population declared that skin lighteners were easy to access
and affordable ($1–5) from informal markets. The majority of
women stated that they received advice about skin lighteners
from friends and preferred to purchase products from small
convenience stores rather than from health experts like phar-
macists or doctors who would be more likely to educate them
Table 4 Factors associated with the use of skin lightening products
n/N (%)
Univariate Multivariate
OR 95% CI P-value OR 95% CI P-value
Ethnicity
African 111/289 (384) 171 119–244 < 001 211 129–346 < 001
Indian 73/273 (267)
Age (years)
< 30 51/174 (293) 056 036–088 < 001 049 027–090 002
31–50 68/237 (287) 054 036–083 < 001 053 032–086 001
> 50 68/160 (425)
Employment status
Employed 53/185 (286) 077 052–112 01725 091 059–139 066
Unemployed 132/384 (344)
Marital status
Married 83/275 (302) 079 056–113 020 086 056–133 051
Not married 104/295 (353)
Education
< Grade 10 91/231 (394) 412 194–872 < 001 384 167–886 < 001
Grade 10–12 87/274 (318) 295 140–622 < 001 305 140–663 < 001
Graduate 9/64 (141)
Skin colour (subjective)
Light 121/397 (305) 070 048–102 007 087 058–131 050
Dark 66/172 (384)
Residence
Urban 47/182 (258) 051 027–096 004 076 035–167 049
Suburban 118/335 (352) 079 044–142 043 097 050–186 092
Rural and semirural 18/50 (360)
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about deleterious side-effects. It was of considerable concern
to learn that many women could purchase moderate and
potent steroid creams from street vendors and cosmetic shops
despite the fact that, by law, these preparations require a med-
ical prescription. This common circumvention of the law sug-
gests the inadequacy of current government monitoring
policies.21
Over the last two decades, the most common active ingre-
dients found in skin lighteners have shifted from hydroqui-
none to corticosteroids and mercury,20 indicating that this
may be an opportune time to enforce stricter controls on the
purchase and sale of unregulated skin lighteners as stipulated
in the paper by Dlova and Ajose.29 Their paper articulates
the action plan of the African Dermatologist’s interest group
that convened at the ‘Ethnic Skin and Hair’ congress held in
Kenya (November 2012). The comparatively lower use of
skin lighteners in South Africa than in some other African
countries suggests that governmental regulations on skin
lighteners instituted in 1990 and afterwards have been par-
tially successful.
The present study has some limitations. Firstly, for a variety
of reasons, ranging from embarrassment over true motivations
for using skin lighteners to possible knowledge of the illegal-
ity of some of the products used, some women may have pro-
vided inaccurate or false information in response to the survey
questions. Secondly, the fact that the survey was not a popula-
tion study but conducted among hospital attendees may have
skewed our findings, perhaps resulting in an overestimation of
the prevalence of skin lightener use in the general population.
Nonetheless, we feel that our study provides a general picture
of the extent of the problem and where the emphasis should
be placed and directed on public health interventions and con-
sumer education.
This study shows that skin lightening is common amongst
African and Indian women in South Africa, with African
women being 17 times more likely to engage in this practice.
These findings underscore the fact that any public health
campaign related to skin lighteners would need to address the
various reasons why women use them. The ease with which
the women surveyed had purchased banned and scheduled
substances suggests the need for the government to be more
vigilant in its enforcement of existing regulations regarding
skin lighteners.
Acknowledgments
We would like to thank Professor Richard Hift (Department of
Medicine, Nelson R. Mandela School of Medicine, Durban,
South Africa), for his contribution in preparing the proposal
for this study; Professor David Katerere (Tshwane University
of Technology, Pretoria, South Africa) and Professor Lynn M.
Thomas (Department of History, University of Washington,
Seattle, WA, U.S.A.) for their invaluable intellectual input and
review of the manuscript; and the support received from
colleagues at the Department of Dermatology, University of
KwaZulu-Natal, Durban, South Africa.
References
1 Ly F, Soko AS, Dione DA et al. Aesthetic problems associated with
the cosmetic use of bleaching products. Int J Dermatol 2007; 46
(Suppl. 1):15–17.
2 Mahe A, Ly F, Aymard G, Dangou JM. Skin diseases associated
with the cosmetic use of bleaching products in women from Da-
kar, Senegal. Br J Dermatol 2003; 148:493–500.
3 Adebajo S. An epidemiological survey of the use of cosmetic skin
lightening cosmetics among traders in Lagos, Nigeria. West Afr J
Med 2002; 21:51.
4 Blay YA. Skin bleaching and global white supremacy: by way of
introduction. J Pan Afr Stud 2011; 4:4–46.
5 Petit A, Cohen-Ludmann C, Clevenbergh P et al. Skin lightening
and its complications among African people living in Paris. J Am
Acad Dermatol 2006; 55:873–8.
6 Hunter ML. Buying racial capital: skin-bleaching and cosmetic sur-
gery in a globalized world. J Pan Afr Stud 2011; 4:142–62.
7 Dadzie O, Petit A. Skin bleaching: highlighting the misuse of cuta-
neous depigmenting agents. J Eur Acad Dermatol Venereol 2009;
23:741–50.
8 Olumide YM, Akinkugbe AO, Altraide D et al. Complications of
chronic use of skin lightening cosmetics. Int J Dermatol 2008;
47:344–53.
9 Li EP, Min HJ, Belk RW et al. Skin lightening and beauty in four
Asian cultures. Adv Consum Res 2008; 35:444–9.
10 Hardwick N, Gelder L, Merwe C, Merwe M. Exogenous ochrono-
sis: an epidemiological study. Br J Dermatol 1989; 120:229–38.
11 Mahe A, Ly F, Perret JL. Systemic complications of the cosmetic
use of skin-bleaching products. Int J Dermatol 2005; 44(Suppl.
1):37–8.
12 Mahe A, Perret JL, Ly F et al. The cosmetic use of skin-lightening
products during pregnancy in Dakar, Senegal: a common and
potentially hazardous practice. Trans R Soc Trop Med Hyg 2007;
101:183–7.
13 Wone I, Tal-Dia A, Diallo O et al. Prevalence of the use of skin
bleaching cosmetics in two areas in Dakar (Senegal). Dakar Med
2000; 45:154–7.
14 Hamed SH, Tayyem R, Nimer N, Al Khatib HS. Skin-lightening
practice among women living in Jordan: prevalence, determinants,
and user’s awareness. Int J Dermatol 2010; 49:414–20.
15 Malik S. The domination of fair skin: Skin whitening, Indian women
and public health. PhD thesis, San Francisco State University Depart-
ment of Health Education Culminating Experience, 2007.
16 Ntambwe M. Mirror mirror on the wall, who is the fairest of
them all. Available at: http://www.scienceinafrica.com/old/index.
php?q=2004/march/skinlightening.htm (last accessed 14 August
2014).
17 Thomas LM. Skin lighteners in South Africa: transnational entan-
glements and technologies of the self. In: Shades of Difference: Why
Skin Colour Matters. (Glenn EN, ed), Stanford, CA: Stanford Univer-
sity Press, 2009, 188–209.
18 Thomas LM. Skin lighteners, black consumers and Jewish entrepre-
neurs in South Africa. Hist Workshop J 2012; 73:259–83.
19 Findlay GH. Ochronosis following skin bleaching with hydroqui-
none. J Am Acad Dermatol 1982; 6:1092–3.
20 Dlova NC, Hendricks NE, Martincgh BS. Skin-lightening creams
used in Durban, South Africa. Int J Dermatol 2012; 51(Suppl. 1):
51–3.
21 Anon. Regulations governing the sale of cosmetics containing
hydroquinone, mercury and lead. S Afr Gov Gazette 1983; 219:7–9.
22 Taylor SC, Summers P. Defining Skin of color. In: Dermatology for
Skin of Color (Kelly PA, Taylor SC, eds), 1st edn. New York:
McGraw-Hill Medical, 2009; 8–15.
© 2015 The Authors
BJD © 2015 British Association of Dermatologists
British Journal of Dermatology (2014) 0 (Suppl. 0), pp1–8
Skin lightening practices in South African women, N.C. Dlova et al. 7
27
23 Halder R, Grimes P, McLaurin C et al. Incidence of common der-
matoses in a predominantly black dermatologic practice. Cutis
1983; 32:388–90.
24 Taylor SC. Epidemiology of skin diseases in ethnic populations.
Dermatol Clin 2003; 21:601–7.
25 Taylor SC, Burgess CM, Callender VD et al. Postinflammatory hy-
perpigmentation: evolving combination treatment strategies. Cutis
2006; 78(2 Suppl. 2):6.
26 Dlova NC, Nevondo FT, Mwangi EM et al. Chemical analysis and in
vitro UV-protection characteristics of clays traditionally used for
sun protection in South Africa. Photodermatol Photoimmunol Photomed
2013; 29:164–9.
27 Dlova NC, Mankahla A, Madala N et al. The spectrum of skin dis-
eases in a black population in Durban, KwaZulu-Natal, South
Africa. Int J Dermatol 2014; doi: 10.1111/ijd.12589, (in press).
28 Nnoruka E, Okoye O. Topical steroid abuse: its use as a depig-
menting agent. J Natl Med Assoc 2006; 98:934.
29 Dlova NC, Ajose F. Communication on the dangers and abuse of
skin lighteners in Africa. Int J Dermatol 2014; 53:e335–7.
© 2015 The Authors
BJD © 2015 British Association of Dermatologists
British Journal of Dermatology (2014) 0 (Suppl. 0), pp1–8




CHAPTE R 4 
Women’s perceptions of the benefits and risks of skin-
lightening c reams in two South African communities. 
Dlova N, Hamed SH, Tsoka-Gwegweni J, Grobler A, Hift R. Women's perceptions of the 
benefits and risks of skin-lightening creams in two South African communities. J Cosmet 




Journal of Cosmetic Dermatology, 13, 236--241
Women’s perceptions of the benefits and risks of skin-lightening
creams in two South African communities
Ncoza Dlova, MBChB, FCDerm,1 Saja H Hamed, PhD,2 Joyce Tsoka-Gwegweni, MSc, BA Hons, BSc
Hons, PhD, MPH,3 Anneke Grobler, BSc, MSc,4 & Richard Hift, Mmed, PhD5
1Division of Dermatology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
2Faculty of Pharmaceutical Sciences, Hashemite University, Zarqa, Jordan
3Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa
4Centre for the AIDS Programme of Research in South Africa, CAPRISA, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South
Africa
5School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
Summary Background Skin-lightening products are commonly used by black communities in
South Africa and worldwide. This practice has deep historical and cultural roots and
is associated with adverse cutaneous effects.
Methods A cross-sectional survey of 579 African and Indian women aged 18–70 years
was conducted in two large public hospitals in Durban, South Africa.
Results There were 292 Africans and 287 Indians included in the survey sample. Of
these 32.3% had used skin-lightening products (60% of Africans and 40% of
Indians). Most of those who had used skin lighteners (85 of Africans and 76% of
Indians) claimed awareness of the adverse effects of the products, although this did
not appear to inform knowledge of the product, how it was used, nor the decision to
use the product. Most users (90%) expressed satisfaction with results achieved but
32% reported adverse events.
Conclusion Skin-lightening products are used by a third of African and Indian women
in South Africa Cultural and historical perceptions equating a fairer skin with social
advantage are pervasive and strongly reinforced by the media. There is a poor
understanding of the risks associated with the use of these products. Public education
campaigns are required to teach consumers about these risks and the importance of
concomitant use of sunscreens with these products.
Keywords: skin lightening, skin bleaching, cosmetic habits, ethnic, African, Indian
Introduction
Although skin-lightening products are medically indi-
cated treatment for hyperpigmentation, they are widely
abused as self-medication because of the cultural
perception that lighter skin complexion is better than
dark skin.1
Since ancient times, women in parts of Europe, the
Mediterranean and Asia have used skin lighteners. In the
past century and more recently, advertising of skin-light-
ening products is widespread albeit in subtle ways.2–6
In South Africa where the hue of one’s skin deter-
mined social hierarchy and consequently economic
opportunity, skin-lightening products became popular,
not only among black African people, but also the Jew-
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ish and other racially marginalized groups.7 From the
1930s certain products were marketed extensively to
black people, developing into a lucrative market worth
US$7 m by the late 19800s.7
These products are now known to result in long-
term adverse effects, such as telangiectasia, skin atro-
phy, hypertrichosis, steroid-induced acne, striae, der-
matitis and opportunistic infections.8–11 Hydroquinone-
containing compounds are particularly associated with
allergic and inflammatory reactions and paradoxical
pigmentation, while topical steroids typically results in
inflammatory acne,5,8,9 dermatitis, photosensitivity and
hyperpigmentation that may be slow to resolve.12
Hydroquinone-containing cosmetics were resched-
uled to prescription only products in South Africa in
1991.7 Policies regulating the sale of any active or
potentially active depigmenting agents were reinforced.
South African law requires the distributor to advise
women to use a sunscreen when supplying a skin-
lightening product.13,14 Yet our experience has shown
that though one in every three black South African
women admits to using skin-lightening products, only
21% use sunscreen. The potential risks of this are
emphasized by a recent case report of squamous cell
carcinoma following prolonged use of hydroquinone
without a sunscreen.5
Despite the restrictions on the sale and use of skin-
lightening products, access to them is still widespread,
mainly through illegal channels, and their usage contin-
ues to constitute a major public health issue, the extent
of which still needs evaluation in South Africa.6,15
Understanding the determinants of this illicit usage will
inform the development of targeted interventions aimed
at changing perceptions, educating the community and
changing practice. We therefore set out to study percep-
tions of the benefits and risks associated with the use of
skin-lightening products among black African and
Indian women in Durban, South Africa.
Methods
A cross-sectional survey was conducted among
patients attending the general outpatient departments
of two regional hospitals in Durban, namely the R.K.
Khan and Prince Mshiyeni Memorial Hospitals, which
serve a large black African and Indian population.
Patients attending dermatological clinics were
excluded. The study was approved by the UKZN Bio-
medical Research Ethics Committee (BE 180/11). All
respondents provided written informed consent.
African and Indian women aged 18 years and older
were interviewed in either isiZulu (vernacular) or Eng-
lish, as preferred by the subject using a questionnaire
modified from Hamed et al.1 Participants were ques-
tioned on their knowledge and perceptions about skin-
lightening products and the benefits and risks of using
these products.
Data analysis
Microsoft Excel was used for data capturing, and
analysis was performed using MEDCALC Statistical
Software version 12.7.5 (MEDCALC Software bvba,
Ostend, Belgium). Categorical data were summarized in
contingency tables and analyzed for significance using
a chi-squared test or Fisher’s exact test as appropriate.




Data were obtained from 579 women, of whom 292
(50.4%) were African and 287 (49.6%) Indian (Fig. 1).
The African respondents were younger, had achieved a
higher educational standard and income and were
mainly rural and peri-urban dwellers (all significant:
P < 0.0001). The Indian respondents were older, less
educated and were mainly urban residents. When
asked whether they were satisfied with their skin color,
96% of the Indian respondents and 87% of Africans
responded positively (P = 0.0005). Satisfaction corre-
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older
Decade of Life
Figure 1 Age distribution of study participants. African respon-
dents are significantly younger than Indian respondents
(P < 0.0001).
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educated bands being significantly less satisfied at 74%
and 86% than those who had received secondary and
tertiary education at 93% and 95% (P = 0.008).There
was no correlation with age or income.
Skin-lightening product experience
A total of 131 (32.3%) respondents had used skin-
lightening products, viz. 38% of Africans and 27% of
Indians (P = 0.005). Prevalence of use was negatively
correlated with education with usage exceeding 50%
for those with little formal education and 14% in those
with tertiary qualifications (P = 0.0005) (Fig. 2).
Although a significant increase with age was shown,
this may represent cumulative experience as no dis-
tinction was made regarding recent use. There was no
significant association with income, residence or skin
tone. A third ((36%) of those who reported satisfaction
with their skin tone used skin lighteners compared to
79% (P < 0.0001) of those who were dissatisfied.
While this was low, it was a surprisingly high number
which needs further investigation.
When probed about what influenced their selection
of products, 71% responded that they were influenced
by the brand name, 43% by price whereas 12% by the
ingredients. There was no difference between African
and Indian respondents.
Knowledge and perceptions about benefits and risks of
using skin-lightening products
By assigning a score of 0, 1, and 2 to the categories
disagree or neutral, agree and strongly agree to seven
questions which probed the perceived social advantage
of a lighter skin (Table 1); we derived an informal
desirability index for the perceived benefits of lighter
skin, with potential scores ranging from 0 (disagree
that a lighter skin is advantageous on any count) to
14 (strongly believe that a lighter skin is advantageous
on all counts). The scores did not correlate with any of
the parameters except age (P = 0.01) (Fig. 3). More
than a third of women believed that a lighter skin tone













Figure 2 Proportion of women using skin lightening products
categorized by educational achievement. Prevalence of use















Figure 3 Desirability index. This is the sum of the responses, on
a scale of 0 (disagree or neutral), 1 (agree) and 2 (Strongly
agree), to 7 questions which test the proposition that a lighter
skin is perceived as desirable. A high score represents strong iden-















Figure 4 Positive responses to 7 questions (Strongly agree or
Agree) (Table 1) which test the proposition that a lighter skin is
perceived as desirable. Most propositions are held by a third or
more of the respondents.
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a higher socio-economic class, helped women get better
job opportunities, and increased a woman’s chances of
getting married as it is considered more beautiful by
men (Fig. 4).
Respondents were ignorant of the active ingredients
in their preparations of choice. Only 12 of 180 users of
skin-lightening products knew the name(s) of the active
ingredients: two mentioned hydroquinone, while the
others named niacinamide, corticosteroids; vitamin C;
and fruit extracts in various combinations. This would
be expected because the respondents were lay people.
Of the studied respondents, 89% agreed that skin-
lightening products can affect the skin adversely, with
a slightly higher positive response among Africans
than Indians (93% vs. 86%, P = 0.03). Awareness of
risk was not affected by age, education, income or resi-
dence. We were unable to find a correlation between
knowledge of adverse effects and avoidance of use.
Three quarters of those using skin-lightening prod-
ucts understood what a sunscreen is, with 69% agree-
ing that it was important to use a sunscreen when
using skin-lightening products. In both cases, Africans
were significantly less knowledgeable than Indians
(51% vs. 92% and, 60% vs. 74%, P < 0.0001). Sev-
enty-nine percentage were aware that sun exposure
can reverse the effects of skin-lightening products, but
only 11% of African and 32% of Indian respondents
(P < 0.0001) applied sunscreen on the face when
going outdoors. Only 40% of respondents had any idea
whether their skin-lightening product contained a sun-
screen or not: 22.9% thought it did, 18.1% that it did
not.
The respondents’ satisfaction with the results they
had obtained with their skin-lightening product was
overwhelmingly positive more so for Indian women
than African (P < 0.0001) (Fig. 5). Women from a
rural or semi-rural background were more likely to be
satisfied than urban women (P = 0.0004). In addition
those with lighter skin tone were more likely to be sat-
isfied than those with darker color (P < 0.0001). A sig-
nificant number reported that their skin had been
damaged by the skin-lightening product that is, 23% of
Africans and 11% of Indians (P = 0.0001). Yet, sur-
prisingly, 90% of women who reported skin damage
still expressed themselves as very satisfied with the
result.
Discussion
Our results show that the use of skin lighteners is
widespread among black communities in South Africa.
Making the broad assumption that our results broadly
represent prevalence of use nationally, this would
translate into considerably more than 4 million users
among the African and Indian adult female popula-
tion.
Skin lightening and bleaching practices have a long
provenance and attempt to achieve esthetic ideals
rooted in precolonial conceptions of beauty2,6,16 which
were reinforced by colonial laws which classified people
based on their complexion and race. This Johnson his-
torical pre-occupation with fair skin is both racist and
sexist and continues to be strongly expressed in popu-
lar media and reinforced by the contemporary beauty
industry.6,17 Advertising may contribute to the percep-
tion that fair skin is more desirable by showing fair-
skinned models as a symbol of what is attractive and
desirable.2,3,6,15 For instance, Hamed et al. in a study
conducted in Jordan showed that 77% of 318 women













Figure 5 Satisfaction with the results obtained with use of a
skin-lightening product. A high proportion of respondents viewed
their experience positively, more so with Indian women than
African (P < 0.0001).
Table 1 A panel of questions put to the respondents to assess
their perceptions of the social advantages of a lighter skin.
Responses were coded on a five-point scale: strongly agree, agree,
neutral, disagree, and strongly disagree
1. A lighter skin tone is more beautiful
2. A lighter skin tone provides women with higher self-esteem
3. A lighter skin tone gives women a younger look
4. A lighter skin tone implies that a woman belongs to a higher
social class
5. A lighter skin tone helps a woman get a better job
6. A lighter skin tone increases a woman’s chance of getting
married
7. Men consider women with lighter skin tone more beautiful
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to prefer lighter skin tone regardless of their level of
education.1
Our results indicate that similar cultural conceptions
in black community are pervasive among the South
African black communities. Indian women appear to
hold these views more strongly than African women,
findings consistent with those from other African and
Asian countries.1,2,6,15,18 Between 80% and 90% of
our respondents agreed that this preference is rein-
forced by the way beauty products are advertised.
These views are tenacious and are not affected by fac-
tors such as education or income, though there is a
decline in the intensity of these views with advancing
maturity.
It is concerning that such widespread use is accom-
panied by little understanding of the risks involved.
Though most of the women interviewed agreed that
skin lightening may have adverse consequences,
almost none could name the active ingredient in their
chosen product. In choosing a product they were
guided by price and brand name, and not by the iden-
tity of the active ingredients in the formulation. Nor
were they aware whether it contained a sunscreen.
Few used a sunscreen in combination with the skin-
lightening product, even though most understood that
sun exposure can reverse the effects of skin lightening.
Self-prescribed use of skin-lightening products is
widespread in many African countries,19–21 and Ntam-
bwe15 has suggested that consumer ignorance regard-
ing the potential harmful side effects of these creams
indicates the need for public education as one way of
reversing this.
Use of skin-lightening products was associated with
very high levels of satisfaction. Our finding that satisfac-
tion correlated inversely with darkness of the skin sug-
gests that there may be an element of unrealistic
expectations in the use of these products. Somewhat
inexplicably, though some women reported that skin
damage as a result of using skin lighteners, most of these
women still reported that they were satisfied with the
result they had obtained. It is possible, however, that
some users have not yet used their products for a
period longer enough for the long-term side effects to
emerge,8–11,22 as in the rebound phenomenon following
topical steroid use reported by Plewig et al.12 A conclu-
sion to be drawn from our findings, however, is that
adverse consequences to skin lightening are not a com-
mon experience among users; this may reflect referral
bias among patients presenting to dermatologists, where
large numbers may still reflect a small percentage of the
very large product-using population from which they are
drawn. It will certainly complicate attempts to reduce
the prevalence of use among our population, given that
both the perception and the experience of serious harm
resulting from their use are low.
In conclusion, we have shown that use of skin-light-
ening products among black South African women is
prevalent and is not associated with appropriate knowl-
edge of risks or of safe practice. Culturally-linked percep-
tions of the social value of fair skin are pervasive and
are perpetuated by the use of fair-skinned models to
market cosmetics to black consumers. There are
extraordinary difficulties to reduce the inappropriate
use of skin lighteners given how deeply rooted cultural
perceptions of the desirability of a light complexion
are in black women. Extensive public education23 cou-
pled to effective policing of informal markets will be
required.
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Introduction
Skin creams that have bleaching properties and that are
reputed to improve the complexion are much sought after
by black South African women. The legacy of apartheid
in South Africa has left more than what is overtly obvious
for black South Africans and indoctrinated misconcep-
tions that will take many years to change. ‘‘Black’’ for
the purposes of this paper refers to the African, coloured,
and Indian women in South Africa.
Pigmentary conformists are viewed as unattractive. A
lighter complexion is preferred by many. According to
Findlay,1 the skin that black people most wish to avoid is
a dull, drab, dusty, or scaly surface. Brightness is what
they are looking for. In addition, some of the patients use
skin-lightening creams as self-medication in an effort to
get rid of common dermatological conditions such as
acne, melasma, and postinflammatory hyperpigmentation.
The use of creams to lighten the skin remains a wide-
spread and common practice in many African countries2.
The most common agents used include mercury-contain-
ing compounds,3 hydroquinone (p-dihydroxybenzene)
(HQ) and its derivatives, resorcinol, and topical steroids
of various potency. Most frequently, more than one agent
is used at a time.
Numerous studies on different populations of African
men and women have demonstrated the occurrence of
harmful long-term side effects from the use of skin-
lightening cosmetics.2,4,5 Mercury compounds have been
banned in cosmetics in several countries owing to nephro-
toxicity and neurotoxicity. Reactions to phenolic deter-
gent germicides6 and monobenzylether of HQ3 have been
reported.
In 1975, Findlay7 reported ochronosis after prolonged
use of skin-lightening creams containing HQ, which
inhibits tyrosinase and prevents the conversion of tyrosine
to dihydroxyphenylalanine, a precursor of melanin. The
pigmentation, which is blue–black clinically, appears
ochre-colored microscopically, hence the term ochronosis.
In these patients, the facial skin overcomes this lightening
effect and becomes darker with continued use of cream,
particularly in sun-exposed areas. The darker areas,
which have a reticulated and ripple-like sooty appearance,
corresponds to those areas in which the cream is well
rubbed in. The clinical findings can be graded into mild
(coarsening and darkening of the skin), moderate (large
black papules with normal skin in between), and severe
(black, caviar-like papules) ochronosis8. Recommenda-
tions were made in 1983 by the South African Depart-
ment of Health and Welfare to limit the concentration of
HQ in over-the-counter (OTC) skin lighteners to no more
than 2%, and this is now enforced.
We have noticed several African women presenting to
us with steroid-induced acne and steroid addiction syn-
drome. An alarming number present with permanently
damaged skin due to the use of OTC preparations and
products sold by street vendors. We have also observed a
change in the pattern in the last 10–15 years, as we are
seeing more steroid-induced cutaneous side effects than
exogenous ochronosis.
Topical steroids cause an array of cutaneous side
effects such as telangiectasia, atrophy, hirsutism, steroid- 51
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induced acne, striae, and opportunistic infections2,4. The
initial clearing of the skin noticed after application of
topical steroids might give a false sense of security and
confidence, as it is later followed by a rebound worsening
of acne. Of particular concern is the challenge in the
treatment of steroid acne, which is a common sequelae of
steroid abuse. The response to treatment is slow and
patients may agonize for several months. During this per-
iod, they need proper advice and support during the with-
drawal phase.
The last paper on skin-lightening products on the mar-
ket in South Africa was published by Findlay and De Beer
31 years ago.10 Here in we report the findings from an
investigation of the contents of the top 10 best-selling
skin-lightening creams available on the market in Durban,
South Africa.
Methods
Ten commercial skin-lightening facial products, which are readily
found in supermarkets, cosmetic shops, as well as sold by
hawkers on city streets, in Durban, South Africa, were randomly
selected for analysis. Selection criteria were based on:
1. Word of mouth recommendations for skin-lightening creams.
2. Facial cosmetic creams claiming skin-lightening properties
(fades dark spots, marks or blemishes, complexion enhancer,
exfoliative properties, etc.).
3. Prescribed products.
The 10 study products are listed in Table 1. The average
cost is between R10 and R35 per unit, with content ranging
from 20 g to 50 g per unit.
The creams were extracted with methanol and the resulting
extracts were analyzed by means of high-performance liquid
chromatography with both ultraviolet and fluorescence
detection. An isocratic elution method was used to separate the
components of the extracts.
Mercury in the creams was determined by cold vapour atomic
absorption spectrometry. Before analysis for mercury the
creams were digested in a (5:1 vol/vol) mixture of nitric and
hydrochloric acids.
In all cases, the samples were analyzed in triplicate.
Results
Of the 10 top-selling skin-lightening creams nine (90%)
were found to contain banned or illegal compounds. Six
(60%) of them were manufactured in South Africa and
the rest were illegally imported from Taiwan (1–10%),
Italy (1–10%), and the UK (1–10%). Four products
(40%) contained mercury as an active ingredient, two
(20%) contained corticosteroids, two (20%) resorcinol,
and one (10%) a derivative of HQ. The majority of prod-
ucts contained banned substances.
Only three (30%) products contained the active ingre-
dients labeled on the packaging. Two (20%) were incor-
rectly labeled, as they were found to contain mercury
instead of the natural albumen and placenta, or phenol
and 8-hydroxyquinoline, that was declared on the pack-
aging (Table 1). None of the products had a warning on
the packaging alerting the consumer to stop using the
cream if side effects were experienced or advice to use
the product with a sunscreen, as is stipulated by law on
the sale of cosmetics and toiletries in South Africa.9
Discussion
HQ was not found in the top 10 skin-bleaching prod-
ucts sold on the market in Durban. Only one product
contained a HQ derivative. On the other hand, nearly
half of the products contained mercury as an active
ingredient, although there was no indication of this com-
pound on the packaging label. The export of mercury-
containing cosmetics was banned11 in the EU in 2003,
yet sample 6 (Rico complexion cream), which contains
mercury, was manufactured in the UK and imported to
South Africa.
Clobetasol propionate and betamethasone dipropionate
are potent topical steroids. They are prescription drugs
whose supply by unauthorized people is illegal in South
Africa, and yet they are easily purchased from street ven-
dors at a very low cost of R10 compared with the retail
cost at pharmacies, which ranges between R100 and
R150/unit.
Of major concern also is the fact that prescription drugs
such as corticosteroid creams are easily dispensed by some
unscrupulous pharmacies without an official prescription,
and are sold at some general practitioner rooms by recep-
tionists without the patient consulting the doctor. The risk
of side-effects with such potent steroids is increased by
their inappropriate and uncontrolled use, and moreover
their application to thin skin areas such as the face and
neck may result in skin atrophy and telangectasia. We have
no knowledge of the original source of the preparations or
whether they all originate from the same supplier.
Topical corticosteroids as well as mercury, resorcinol,
and HQ-containing creams are widely available in South
Africa, but there is no governing body that regulates or
controls their sale and availability. Concern about the
side-effects and easy availability of these products, has
already been voiced by dermatologists.1,2,7
Although our sample number was small and repre-
sented only some central Durban city outlets, data analy-
sis is ongoing and we are presently looking at the top 40
selling skin-lightening creams in the whole of South
Africa for the presence of banned skin-lightening com-
pounds and corticosteroids.
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Conclusion
Since the last study by Findlay and De Beer, 31 years
ago,10 old brand names have come and gone and new
appealing and provocative names continue to intrude and
flood the South African market.
Stronger regulations and restrictions need to be
imposed on cosmetic shops and supermarkets. In addi-
tion, continuous education of consumers about side-
effects of these creams is mandatory. The South African
Medicines Control Council and the South African
National Consumer body need to be informed to investi-
gate the unscrupulous distribution of these products.
Advertisements for skin-lightening creams should be
controlled and the use of fair-skinned models for advertis-
ing skin products aimed at the black consumer should be
banned.
On completion of the second larger battery of tests, we
wish to commit to a massive, aggressive public education
campaign based on the above findings and give better
protection to consumers in an area fraught with consumer
exploitation and selling of illegal skin lighteners.
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Table 1 List of 10 creams analysed together with the active skin-lightening agents declared on the packaging labels and




manufacture Company Declared active ingredients
Active ingredients
found to be present
1 Lemon Lite – vanishing cream South Africa Adcock Ingram – Mercury
2 Movate Cream Italy Esapharma Clobetasol propionate (0.05%) Clobetasol propionate
3 Persivate South Africa Aspen Betamethasone valerate Betamethasone
4 Shirley Taiwan Shirley Chemical
Corporation
Contains natural albumen and
placenta base that have an
effect on lightening facial skin
Mercury
5 Bee-Co cream – Unknown – Resorcinol
6 Rico complexion cream UK Rico Skin Care Ltd – Mercury
7 Eskamel – acne and pimple cream South Africa SmithKline Beecham Resorcinol (2%) Resorcinol
8 Ponds – vanishing cream South Africa The Elida Pond’s Institute – –
9 Cuticura South Africa Novartis Phenol, 8-hydroxyquinoline Mercury
10 Gentle Magic skincare cream South Africa Du Marc CC – HQ derivative
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Melanoma incidence among white South Africans is increasing. Among black South Africans, 
melanoma is associated with an advanced stage at presentation and significant mortality. 
Objectives 
To assess the perception of skin cancer risk, knowledge of skin cancer, and understanding of 
the importance and use of sunscreens among South Africans. 
Methods 
A cross-sectional survey conducted among general outpatients over 4 months at a large central 
hospital in Durban, South Africa. 
Results 
Only half of the white respondents reported regular use of sunscreen. The number was 
substantially lower among the African and Indian counterparts. Less than 20% of whites 
reported checking their skin for suspicious moles. Most Africans were not aware that they were 
at risk of skin cancer, and only 10% were aware of the risk of developing skin cancers on acral 
sites and nails. 
Conclusions 
There is a disturbing lack of knowledge about skin cancer and sun protection behaviours among 
all South Africans. Given the increase in melanoma incidence and racial disparities in survival 






Melanoma incidence is rising in South Africa. There is a marked racial disparity in melanoma 
survival. This study illustrates a serious knowledge and practice gap among South Africans 
regarding skin cancer risk, screening and sun-protective behaviours, with marked differences 
based on ethnicity, possibly resulting from a perception that these issues are not relevant in 
Africans. It emphasizes the need for effective, culturally sensitive education and screening 
efforts. 
INTRODUCTION 
Despite efforts to encourage preventative measures1, melanoma incidence has increased over 
the last three decades. With its subtropical climate and long coastline promoting an outdoor 
lifestyle, South Africa has not escaped this trend. The ambient erythema ultraviolet radiation 
(EUV) in Durban is 25-35 minimal erythema dose (MED) units per day during summer2, 
reflecting relatively high levels of UV exposure. The age-standardized melanoma incidence 
rate among the white population in Cape Town was reported as 24.4 per 100,000 in 19983, but 
was found to be 33.5 and 36.9 per 100,000 for women and men, respectively in 20084. By 
comparison, incidence rates of between 0.9 and 1.2 per 100,000 among African South Africans 
have been reported5,6. Nearly three quarters of melanomas in the white South African 
population have been reported to have Breslow thickness <1.5mm3. By comparison, African 
patients present with significantly higher Breslow depths7. The South African melanoma data 
parallels US SEER (Surveillance, Epidemiology, and End Results Program) data in terms of 
the race-correlated differences in both incidence and in depth at presentation1,8,9. 
Early detection of melanoma through screening examination is associated with a lower 
probability of metastases10,11. In the absence of published data for SA, we endeavoured to 
determine the perception of skin cancer risk, skin cancer appearance, and general knowledge 
about sunscreen among South Africa’s three dominant ethnic groups: indigenous African and 
Indian (Fitzpatrick skin types 4–6), and white ( Fitzpatrick types 1-4 ). 
MATERIALS AND METHODS 
A cross-sectional survey was conducted in the general outpatient department of Inkosi Albert 
Luthuli Central Hospital, a major tertiary referral centre in Durban, KwaZulu-Natal Province. 
Durban is located on the eastern seaboard of South Africa and the hospital serves an ethnically 
diverse population. Ethical approval was received from the University of KwaZulu-Natal 
Biomedical Research Ethics Committee (BE 180/11). South African citizens aged between 18 
and 90 years attending out-patient clinics between 1 September and 31 December 2012 were 
invited to participate, excluding those attending the dermatology clinic. A power analysis 
suggested that 300 subjects from each ethnic group were required. All subjects provided written 
informed consent. A structured questionnaire designed for this study was administered by a 
trained study assistant who was proficient in both English and isiZulu, the locally used African 
language. A pilot study, wherein the protocol-questionnaire was administered to 20 subjects 
for validation was conducted. Subjects were not subject to clinical examination. 
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The questionnaire sought information on the following: 
• Socio-demographic characteristics, skin sensitivity, skin cancer risk and sun-protective 
behaviour. 
• Knowledge regarding skin cancer appearance, use and effects of sunscreen. 
• Self-initiated skin examination experience and that performed by practitioners. 
Data analysis 
Data were entered into a Microsoft Excel spreadsheet (Microsoft Corporation, Redmond WA, 
USA) and analysed with MedCalc Statistical Software version 12.7.5 (MedCalc Software 
BVBA, Ostend, Belgium). Data were summarised in contingency tables and analysed for 
significance using a chi-squared test or Fisher’s exact test as appropriate. Ordinal data were 
compared between groups by Mann-Whitney or Kruskal-Wallis tests as appropriate. 
Correlations were performed using the Spearman rank-order test. 
RESULTS 
Demographics 
During the four months 1000 people were approached and 963 participants were interviewed, 
of which 38.7% were African, 32.0% Indian and 29.3% white. The three groups differed in 
terms of sex ratio, age distribution, educational level and employment status. Women 
constituted 61%, 49% and 49% of the African, Indian and white samples respectively 
(p=0.002). The age distribution is shown in Fig. 1. The white group had higher levels of 
education and employment and a higher proportion of retired workers than the other two groups 
(data not shown). All differences are highly significant, and these effects should be borne in 
mind when correlating the responses to the questionnaire with race. 
Data showed that 27%, 36% and 58% of respondents in the African, Indian and white groups 
respectively reported that their skin turns red (as opposed to darker) on prolonged sun-exposure 
(p<0.0001). This may represent a susceptibility to sunburn and therefore, by inference, to 
photodamage. The figure for the African population appears high, and may have been 
overstated by the respondents. 
Understanding of sunscreen practice 
The respondents’ understanding of the rationale for sunscreen use was generally poor (Table 
1). A majority of white respondents understood the link between sun-exposure and skin 
damage, the protective effects of sunscreens against photo aging, and the concept of the sun 
protection factor (SPF). Understanding was significantly poorer among the other two groups, 
and the African group in particular. Only 23% of Africans and 49% of Indians, were aware that 
regular use of sunscreen can prevent darkening of the skin. Similarly, only 20% and 33% of 
these groups, respectively, were aware of the role of sunscreen in photoaging. While 82% of 
whites were aware that sunscreen can prevent skin cancer, only 31% of Africans and 59% of 




Although many of the respondents were aware of the risk of skin cancer, two trends emerged 
(Table 2). Firstly, there was a generally poor understanding of the risk of skin cancer 
irrespective of race, knowledge that sunscreen is protective, and a very poor knowledge of the 
practical steps to be taken to mitigate that risk. Only about 10% felt that they would recognise 
a potentially cancerous lesion or knew that the palms, soles and nails were potential sites for 
melanoma. Even among whites, who are at highest risk, 70% were unaware of the proper use 
of sunscreen to prevent skin cancer, and 82% were uncertain about the appearance of a 
potentially malignant lesion. Secondly, there was a clear differentiation between population 
groups, with Indian respondents demonstrating a lower level of knowledge than whites, and 
African respondents having the least knowledge. Regarding whether Africans require more 
information about the use of sunscreens and skin cancer, 97-98% of Africans agreed, whereas 
the figures were significantly lower for the other groups (p<0.0001), indicating a lack of 
awareness that African people are also subject to sun damage and skin cancer.  
Knowledge index 
Summing the answers to questions about photoprotection, cancer awareness and cancer 
prevention (but excluding those relating to actual practice), we derived an informal ‘knowledge 
index’ with a maximum score of 11 (Figure 2). Whites scored significantly higher than the 
other two groups (p<0.000001). There is a modal peak around a score of 6-7, with a second 
peak at the extreme left (indicating a near-complete lack of knowledge): 10% of whites, 20% 
of Indians and 50% of the African respondents fell at this end of the scale, suggesting a serious 
information-deficit within the community. Knowledge of those aged over 40 is significantly 
greater than those below, and was strongly correlated with completion of secondary school 
education and female gender (all p<0.000001). 
Prevalence of sun-protective behaviour 
One third of Indian respondents regularly practised sun-bathing (Table 3). The figure in whites 
is probably an underestimate given the significantly higher mean age of our sample. 
Approximately 50% reported sunscreen use, the frequency varying from 80% among whites to 
24% in Africans. However, usage was found to be inconsistent, with only 30% applying it daily 
or frequently, however: this may represent an element of over-reporting. Regarding the 
application of sunscreen on most days, 15% of African, 24% of Indians and 53% of whites 
reported that they did this with a further 11%, 17% and 24% reporting occasional use (data not 
shown). This result is highly significant (p<0.0001). 
Only 12% had ever inspected their skin for suspicious lesions and 6% had had their skin 
examined by a doctor, this figure being consistent across the groups. The examination was 
generally performed by a dermatologist, suggesting that family practitioners and other health 
care professionals are neglecting this important aspect of the physical examination. This may 




By summing the answers about probing sun-protective behaviour, we derived an informal 
‘behaviour index’ with a maximum score of 6 (Figure 3). Although the white respondents 
scored significantly higher than the other groups (p<0.000001), approximately 10% across all 
groups scored above 3, largely due to the general failure noted to use sunscreens regularly, to 
inspect their own skins and to undergo regular medical skin examinations. As with the 
knowledge index, the behaviour score correlated significantly with age, education, 
employment and female gender (all p<0.000001). 
DISCUSSION 
Perceived skin cancer risk may correlate with risk-averse behaviours. Likewise, a lack of 
perceived risk may be a barrier to risk reduction12,13. The incidence of melanoma is strongly 
influenced by ethnicity. Most public education programs for melanoma are directed towards 
whites14. A consequence of this may be that ethnic groups with darker skin, including Africans 
and Indians, may not be reached by such programmes, despite being at risk of melanoma. One 
quarter of the Africans and a third of the Indians reported a susceptibility to sunburn, and 
therefore to photo damage. An understanding of the relationship between sun-exposure and 
risk of skin cancer is fundamental to prevention. 
Our results indicate a lack of understanding of skin cancer and of sunscreen use in our 
population. This information deficit was particularly noticeable among African, and Indian 
populations Further, only half of whites, and considerably fewer from the other groups, 
reported frequent use of sunscreen, indicating that many of at-risk individuals are not in the 
habit of using sunscreen.  
Sunscreen usage discrepancy may be explained in part by varying degrees of knowledge about 
its uses and benefit. While 86% of whites knew the definition of SPF, only half of the Indians 
(55%) and less than a third of African (30%) did. There was a general lack of understanding of 
the need for sunscreen in white people and of the differences in risk across ethnic groups, 
suggesting a lack of understanding of the link between light skin, propensity to sunburn, risk 
of melanoma and of the role of sun protection in ameliorating this risk. 
Although Africans are at lower risk of melanoma than lighter-skinned groups, the risk is not 
negligible and may be reduced by limiting sun-exposure or using sunscreens. It is alarming that 
fewer than half of the African respondents were aware of their risk of skin cancer, or that they 
should use sunscreen. Aside from melanoma, basal cell carcinoma (BCC) has been reported to 
represent 12% to 35% of skin cancers in African Americans, and 2% to 8% of skin cancers in 
Africans. Further, the majority of BCC’s in Africans and Indians occur in sun-exposed skin. 
Indicating that sun protection is paramount, regardless of pigment9. 
The benefits of sunscreen are not restricted to cancer prevention. Sunscreen may reduce 
wrinkling and photo damage, resulting in more even pigmentation. With age, darker skin types 
are more likely to demonstrate skin mottling and uneven skin pigmentation15,16. Only a quarter 
of Africans were aware that sunscreen could encourage a more even skin pigmentation (23%). 
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Prevalence rates of skin bleaching in sub-Saharan Africa have been reported between 26% and 
67%, despite an array of potential adverse side effects from the practice17. Paradoxically, 
Africans are more likely to use bleaching products to lighten skin tone, often with adverse 
consequences, than to use sunscreen to reduce the darkening effects of the sun in the first place. 
Indeed, the increased sunscreen usage and education about sun avoidance among Africans and 
Indians might substantially reduce the perceived need for skin bleaching products. 
Early detection of skin cancers, particularly melanoma, is vital. Public education programs are 
usually directed towards primary and secondary prevention measures. Seventy percent of 
melanomas in Africans have been reported to be on the lower limb, with 90% of those being 
below the ankle, and acral lentiginous melanoma being the most common subtype 18,19. While 
melanoma incidence among Africans is low, with a reported incidence between 0.9 and 1.2 per 
100, 0005, Africans suffer a significant proportion of the morbidity and mortality associated 
with melanomas. Survival rates from plantar melanoma in Africans are very low with only 
25% of 40 African patients with plantar melanoma surviving for, 5-years.7. In the USA African-
Americans are more likely to present with advanced disease and to have a worse prognosis than 
whites 14. Disturbingly, only 10% of Africans were aware that they could get skin cancer on 
the palms, soles and under the nails, fewer than 10% Africans felt that they could identify a 
suspicious mole or skin cancer, and fewer than 5% had ever done skin checks.  
Melanoma incidence rates in white women and men have shown a 1.5 fold and 1.3 fold 
increases, respectively, over a ten year period4. Recent estimates indicate an extraordinarily 
high incidence in this population6,20. It is therefore disturbing that only 18% reported ever 
checking their skin for suspicious lesions, and 82% were not confident that they could 
recognize suspicious moles or skin cancer. Almost all our respondents, regardless of ethnicity, 
indicated a need for more information about skin cancer (97%, data not shown), and our 
findings confirm an information deficit on the related issues of sun protection, sun damage and 
melanoma prevention and detection. Given the significant morbidity, mortality and costs 
associated with advanced stage melanoma, early detection and prevention are critical. 
Our study has revealed a lack of risk-averse behaviours, with our knowledge and behavioural 
indices being reasonably correlated (r=0.49, p<0.0001). Although we have shown significant 
correlations in both knowledge and behaviour with age, race, education, employment and 
gender; our three groups are not homogeneous and a significant degree of interaction is 
expected between all these factors. 
There is a need to convey the message that hands, feet and nails are vulnerable in the African 
population, and should be inspected regularly. Physicians and health care providers should take 
a lead in instituting early detection and screening measures, and in educating the public on the 
need for these. Fewer than 10% of respondents reported that their doctor had ever talked to 
them about skin cancer or shown them how to check their skin, and fewer than 10% had ever 
had a medical examination of the skin. The high incidence of melanoma in whites and the 
disproportionate mortality burden of melanoma in Africans mandate public health and 
screening initiatives. 
 Our study indicates a pervasive lack of knowledge of the risks of sun-exposure, the benefits 
of sun protection and the measures necessary to prevent and detect melanoma. Africans and 
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Indians need to be educated about the benefits of using sunscreen not only to prevent skin 
cancer but to obviate skin mottling and uneven skin tone which is a characteristic feature in 
this population. This in turn may lessen some of the dependency of our African population on 
skin-lightening preparations. We believe that there is a need for major improvements in public 
education, and for an increased emphasis on these measures by health care providers. The 
results indicate the need for targeted and culturally inclusive programmes to increase the rate 
of early detection, decrease melanoma incidence and improve skin health more generally.  
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Knowledge of sun protection. The values represent all positive responses (“yes”) to the 







 African (%) Indian (%) White (%) All (%) p 
Do you know that suntanned skin 
means damaged skin? (n=949) 
43 (12%) 89 (29%) 164 (59%) 296 (31%) <0.0001 
Do you know what SPF (sun 
protection factor) means? (n=948) 
110 (30%) 165 (55%) 239 (86%) 514 (54%) <0.0001 
Did you know that sunscreen can 
make your skin colour/tone more 
even? (n=939) 
89 (24%) 137 (46%) 157 (57%) 383 (41%) <0.0001 
Do you know that the use of a 
sunscreen can prevent further 
darkening of the skin? (n=947) 
85 (23%) 147 (49%) 64 (23%) 296 (31%) <0.0001 
Did you know that sunscreen can help 
prevent your skin from wrinkling? 
(n=949) 
73 (20%) 101 (33%) 162 (58%) 336 (35%) <0.0001 
Did you know that sunscreen can help 
prevent skin cancer? (n=947) 










 African (%) Indian (%) White (%) All (%) p 
Can black skin get skin cancer? 
(n=928) 
173 (49%) 225 (74%) 240 (88%) 638 (69%) 0.0001 
Do Blacks need to wear 
sunscreen? (n=942) 
166 (45%) 217 (73%) 213 (77%) 596 (63%) <0.0001 
Do you know what a suspicious 
mole or a skin cancer spot looks 
like? (n=940)  
24 (7%) 37 (12%) 51 (18%) 112 (12%) <0.0001 
Did you know that black people 
can get skin cancer on the palms, 
soles, fingernails and toenails? 
(n=937) 
37 (10%) 39 (13%) 21 (8%) 97 (10%) 0.13 
Do you know that whites have to 
wear a sunscreen everyday for 
365days from the age of 2 to 
prevent skin cancer? (n=953) 




Prevalence of risk-reducing behaviour among the respondents. The values represent all positive 






Indian (%) white (%) All (%) p 
Do you like to lie out in 
the sun? (n=941) 
29 (8%) 100 (33%) 30 (11%) 159 (17%) <0.0001 
Do you ever wear 
sunscreen? (n=951) 
87 (24%) 128 (42%) 222 (80%) 437 (46%) <0.0001 
Do you ever check your 
skin for suspicious mole 
or skin cancer spots? 
(n=937) 
17 (5%) 43 (15%) 51 (18%) 111 (12%) <0.0001 
Have you ever had a skin 
exam by a dermatologist 
to look for a skin cancer? 
(n= 952) 
14 (4%) 21 (7%) 22 (8%) 57 (6%) 0.077 
Have you ever had a skin 
exam by any doctor to 
look for skin cancer? 
(n=958) 
15 (4%) 23 (7%) 24 (9%) 62 (6%) 0.08 
57
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FIGURE LEGENDS  
Figure 1 
Age distribution of respondents, categorised by race. The African population is significantly 
younger than the white population, with the Indian group demonstrating an intermediate 
profile. 
Figure 2 
Knowledge index, based on responses to questions probing knowledge of sunscreen use, skin 
cancer and its detection and prevention. A scale of 0 (no appropriate response to any question) 
to 11 (appropriate response to all questions) is shown on the horizontal axis. The frequency of 
scores is shown on the vertical axis. There is a modal peak around a score of 6-7, with a second 
peak at the extreme left, indicating a near-complete lack of knowledge: 50% of the African 
respondents fell at this end. 
Figure 3 
Behaviour index, based on responses to questions probing sun-protective and cancer-detection 
behaviours. A scale of 0 (no appropriate behaviour reflected any response) to 6 (appropriate 
behaviour reflected in all responses) is shown on the horizontal axis. The frequency of 
responses is shown on the vertical axis. Though the white respondents scored significantly 
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Clays have been used in southern Africa as photoprotectants by the indigenous
people. Typically, two types of clay are used: one white in colour and the other
red. In this work, the two clays were identified and characterized, and their in
vitro SPF values measured. The clays afford a low SPF but offer broad-
spectrum protection. No cutaneous side effects from the use of these clays are
known. Further consideration should be given to the potential use of clays in
sunscreen preparations.
Photodermatol Photoimmunol Photomed 2013; 29: 164–169
In hot, sunny climates as experienced in Durban, South Africa, photoprotective
measures are required all year round to prevent erythema, irrespective of photoskin
type (1). Indigenous African women, particularly those from rural areas, use local
clay material for photoprotection and decorative purposes. These women follow a
subsistence lifestyle and are outdoors for many hours each day, gardening, fetching
wood and water, cooking and performing other chores. They also lack the means to
purchase commercial sunscreen products. Although these women typically present
with Fitzpatrick skin types 5 and 6, for which skin cancer is less common, photo-
protection is important to prevent hyperpigmentation disorders such as melasma.
Clay minerals are widely used in the pharmaceutical industry for a variety of
purposes in oral and topical applications, as excipients and in aesthetic medicine (2).
They have been used since ancient times (2), so it is not surprising that they form
part of the heritage in southern Africa. Recently, the ultraviolet (UV)-protective
capacity of clays was reported (3).
Two clays are typically used: one white in appearance and the other red. The white
clay is known locally as umcaku (isiZulu/isiXhosa) and the red as ibomvu (isiZulu/
isiXhosa). The women mix the clay (100 g) with water (125 cm3) and glycerine
(20 cm3) to produce a paste that is applied to the face. The clays are used individually
with some women preferring one over the other. The distinct appearance of patients
wearing these clays is shown in Fig. 1. As very little is known of the composition and
UV efficacy of these clays, it was of interest to undertake a study thereof.
Photodermatology, Photoimmunology & Photomedicine





White and red clay samples were obtained from the local
riverbank next to Inanda district in Durban. Informal
traders, who are predominantly black women, buy 5-kg
clay balls from the river traders and sell them at the local
Durban market.
The clays were characterized by means of X-ray fluores-
cence, X-ray powder diffraction, Fourier transform infra-
red spectroscopy, transmission electron microscopy and
thermogravimetric analysis. Particle-size analysis was per-
formed on a Malvern Mastersizer 2000 instrument
(Malvern Instruments Ltd., Malvern, Worcestershire, UK)
that employs laser light scattering.
In order to estimate the UV-protective efficacy of the
clays in their natural state, they were subjected to the in
vitro SPF testing procedure, as developed by Diffey and
Robson (4), on an Optometrics SPF 290 Analyser (Opto-
metrics Corporation, Ayer, MA, USA). For this test, the
clays were applied to Transpore tape at an application
density of 2 mg/cm2.
RESULTS
X-ray fluorescence was used to determine the chemical
composition of the clays. The results are presented as
weight percentages of the oxides in Fig. 2a. The major
constituents of the clays were oxides of silicon and alu-
minium. In the case of the red clay, iron oxide was also
present, which is consistent with the hue of the clay. A
small percentage of titanium dioxide was also present in
both clays. The main impurities were K2O, MgO, Na2O,
P2O5, Cr2O3 and MnO. The loss on ignition was 10.58 and
24.46 wt% for the white and red clay, respectively. The
mass loss is mainly due to the removal of structural water
and organic substances.
The energy-dispersive X-ray spectrometry analysis
spectra also confirm the presence of the major oxides (see
Fig. 2b).
The phases of the oxides present were investigated by
means of powder X-ray diffraction (Fig. 2c). The white
clay consisted predominantly of kaolinite and quartz (as
evidenced by the peaks at 3.52, 4.37 and 4.17 Å for kao-
linite and 3.31 and 4.28 Å for quartz). The red clay
instead contained kaolinite, quartz and haematite (peaks
at 2.72, 2.55 and 1.81 Å). The presence of these phases
was confirmed by Fourier transform infrared spectros-
copy (Fig. 2d). Further confirmation that the major com-
ponent of these clays was kaolinite was obtained from
thermogravimetric analysis (Fig. 2e). The exotherm at
507°C in the case of the white clay and 481°C in that
of the red clay correspond to loss of structural hydro-
xyl groups due to the transformation of kaolinite
[Al2Si2O5(OH)4] to metakaolinite (Al2Si2O7). The mass
loss below 100°C is due to dehydration (removal of mois-
ture). The mass losses between dehydration and dehy-
droxylation are due to the presence of the iron oxides,
particularly for the red clay. Kaolin deposits have been
reported in Inanda (the source of the clays) and the
nearby Ndwedwe region (5).
The microstructure of the two clays, as observed by
transmission electron microscopy and scanning electron
Fig. 1. Patients wearing the white and red clays.
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microscopy, can be seen in Figs 2f and 2g, respectively. The
white clay appears as platy particles that have the typical
kaolinite pseudo-hexagonal shape. The red clay is less
regular in morphology.
The white clay sample showed a broad, dispersed
particle-size distribution, whereas the red clay showed a
bimodal distribution (Fig. 2h). In the case of the white
clay, 50% of the particles (by volume) had a diameter
smaller than 12.463 mm. For the red clay, the value was
14.630 mm. Using the classification of clay  2 mm,
silt = 2–63 mm and sand = 63–2000 mm, the fractions in
the white clay were 9.9%, 58.9 % and 31.2%, respectively.
For the red clay, the corresponding figures were 11.5%,
68.4% and 20.1%, respectively. That the white clay had a
greater fraction of ‘sand’ is in keeping with a larger SiO2/
Al2O3 ratio (theoretical value for kaolinite is 1.16), indica-
tive of a high-quartz content. The fact that the clay
particles are mostly in the micron range accounts for the
visible appearance of these clays when applied to the skin.
Modern sunscreen formulations that contain metal oxides
do so in a micronized form in which the particles have
diameters in the nanometer range and appear almost invis-
ible but have good UV blocking ability.
The white clay displayed an estimated SPF of 3.6, a UVA/
UVB ratio of 0.9 and a critical wavelength of 388 nm. The
red clay had an estimated SPF of 4, a UVA/UVB ratio of 1
and a critical wavelength of 389 nm. Both clays can there-
fore be classified as broad-spectrum protectants as their
critical wavelengths are greater than 370 nm. The fact that
the red clay has a higher proportion of smaller particle sizes
improves its light scattering and absorbing ability. Particle
dispersion is one aspect that sunscreen formulators keep
foremost in mind in order to achieve good sun protection.
Because the clays discussed here are formulated in the
home by simple mixing with household reagents, namely,
water and glycerine, particle aggregation is probably a lim-
iting factor in achieving an improved SPF.
DISCUSSION
This work has shown that the clays typically used in rural
parts of South Africa for UV protection consist chiefly of
a
SiO2 Al2O3 Fe2O3 MnO MgO Na2O K2O TiO2 P2O5 Cr2O3 Total LOI 
White clay 63.42 32.85 0.49 0 0.2 0.02 1.13 1.5249 0.02 0.0855 99.72 10.58 






















White clay Red clay
Fig. 2. Data recorded for the characterization of the ultraviolet-protective clays: (a) chemical composition of the clays obtained
from X-ray fluorescence, (b) energy-dispersive X-ray spectra, (c) X-ray powder diffractograms, (d) attenuated total reflectance
Fourier transform infrared spectra, (e) thermogravimetric analysis curves, (f) transmission electron micrographs, (g) scanning
electron micrographs and (h) particle-size distribution curves.
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the mineral kaolinite. Traditionally, clay soils rich in this
mineral are widely used in southern Africa for a variety of
medicinal purposes because they exhibit low toxicity.
However, it needs to be pointed out that in some regions
clays are contaminated with arsenic; therefore, the toxicity
of the clays needs to be assessed before widespread usage.
These traditional non-commercial sun protective meas-
ures bear some similarity to commercial physical sun-
blocks. They are both composed of metal/metalloid
oxides. (In the case of commercial physical sunblocks, the
typical active agents are either titanium dioxide or zinc
oxide.) They are both messy to use and can cause staining.
To improve their aesthetic appeal commercial sunblocks
are available in designer colours and in South Africa these
are widely used and popularized by surfers and cricketers.
The traditional clays discussed here have their own inher-
ent colouring.
Although the SPF of both clays is low, they do provide
some degree of UVA protection. This is an important con-
sideration as UVA constitutes the greater amount of inci-
dent solar UV radiation and has been implicated in skin
cancer. Another aspect of sunscreen usage is application
density. Typical commercial sunscreens are tested with an
application density of 2 mg/cm2, but it is well known that
typical usage patterns are less than half this amount. Here,
however, this is unlikely to be the case because of the 100 g
of clay mixed they use 5 g to cover the face, which is
greater than the amount advocated for sunscreens.
These clays provide a cost-effective, easily available and
culturally appropriate product for rural South African
women. Although our study did not consider the safety
profile of these clays, the indigenous women who have
used these clays for decades have not reported any cuta-
neous side effects apart from a residual orange hue on the
skin. Given the difficulty in finding suitable photostable
and non-toxic organic sunscreen absorbers, greater con-
sideration should be given to the potential of clays as addi-
tives for sun-protection creams.
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a b s t r a c t
Ethnopharmacological relevance: The stem bark of Garcinia livingstonei is used traditionally as a skin
lightening agent.
Aim of the study: To isolate and identify compounds responsible for the observed skin lightening activity
of Garcinia livingstonei and to evaluate their cytotoxicity.
Materials and methods: Constituents of the stem bark and fruits of Garcinia livingstonei were isolated
using chromatographic techniques and structures were determined using 1D and 2D NMR and MS
analysis. MeWo cells were used to evaluate the cytotoxicity and impact on melanin levels of extracts and
compounds isolated, in vitro.
Results: Twelve known compounds, morelloflavone (1), morelloflavone-7″-sulphate (2), guttiferone A
(3), sargaol (4), isojacareubin (5), 6-deoxyisojacareubin (6) and in addition to the common triterpenoids,
betulin, betulin aldehyde, lupeol, lupenone, euphol and stigmasterol were isolated in this investigation.
Morelloflavone, morelloflavone-7″-sulphate and sargaol, were found to be considerably less cytotoxic
and more effective as skin lightening agents than hydroquinone.
Conclusions: A range of compounds was isolated from the stem bark and fruit of Garcinia livingstonei.
Although the bark extract contained the cytotoxic guttiferone A, it was found to be less toxic than
hydroquinone, and morelloflavone, the 7″-sulphate derivative and sargaol show potential for develop-
ment as depigmentation/skin lightening agents.
& 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Garcinia livingstonei T. Anderson (syn. Genetta angolensis
Vesque) (Clusiaceae) is found throughout tropical Africa, where
it occurs as a distinctive small to medium sized (2–10 m) ever-
green tree in low altitude riverine fringes and open woodlands
(Palgrave and Palgrave, 2002). It is known variously in South Africa
as the African or Lowveld Mangosteen, and umPhimbi, isiHlumanye
or uGobandlovu (isiZulu) (Pooley, 1993; Hutchings et al., 1996). The
wood is used as a general purpose timber, while the flesh of the
pinkish orange fruit is edible, with a refreshing acid-sweet taste,
and can also be fermented to prepare a pleasant alcoholic
beverage (Palgrave and Palgrave, 2002).
The powdered root is used as an aphrodisiac in the treatment of
impotence (Arnold and Gulumian, 1984), for abdominal pains
during pregnancy (Samuelsson et al., 1992), and as an aid in
childbirth (Yu, 1982), while steam from a decoction of the dried
leaves is used to treat watering eyes (Arnold and Gulumian, 1984).
Coughs, fevers and parasitic diseases are treated with infusions of
the fruits and stems (Iwu, 1993).
Previous investigations of this species have resulted in the
isolation of a variety of bioactive oxygenated aromatic compounds.
A series of novel prenylated xanthones was isolated from Garcinia
livingstonei which showed fungiostatic activity against Cladospor-
ium cucumerinum comparable to that of miconazole, and inhibited
SW 480 human colon carcinoma cell growth at levels similar to
that of 5-fluorouracil (Sordat-Diserens et al., 1992a). Sordat-
Diserens et al., (1992b) isolated the xanthone dimer garcilivin A,
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/jep
Journal of Ethnopharmacology
0378-8741/$ - see front matter & 2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.jep.2013.07.023
n Corresponding author at: Natural Products Research Group, Department of
Chemistry, Faculty of Engineering and Physical Sciences, University of Surrey,
Guildford, Surrey GU2 7XH, United Kingdom. Tel.: +441483686827.
E-mail address: d.mulholland@surrey.ac.uk (D. Mulholland).
Journal of Ethnopharmacology 149 (2013) 570–575
73
Author's personal copy
which has since been shown to display trypanosomal activity against
Trypanosoma brucei brucei (Mbwambo et al., 2006). Bioassay-guided
fractionation of the fruit has yielded the HIV-inhibitory tetrapreny-
lated benzophenone guttiferone A (3) (Gustafson et al., 1992), and the
biflavanoid ent-naringeninyl-(I-3α,II-8)-4′-O-methylnaringeninwhich
is moderately active against a Ghanaian CQS strain of Plasmodium
falciparum (Mbwambo et al., 2006).
Several tree species are used traditionally on the eastern
seaboard of South Africa for the treatment of skin diseases and
cosmetic purposes, such as for skin lightening, often under the
Xhosa and Zulu name umemezi (Earle, 1976; Khan, 1996; Cocks and
Dold, 2004; Momtaz et al., 2008). Although a highly valued
ethnomedicinal species (Hutchings et al., 1996), dermatological
uses for Garcinia livingstonei have not earlier been documented
either locally, or elsewhere in its extensive tropical African range.
Only recently has its application in skin treatment been reported
through a personal communication to one of us (NCD) in her
capacity as a dermatologist. Clinical observations (Dlova, unpub-
lished results) have revealed that a water slurry of the powdered
stem bark is an effective facial sunscreen and/or skin lightener. A
literature search indicated that other Garcinia species such as
Garcinia indica Choisy (Jain and DeFilipps, 1991) are used to treat
skin diseases, with two taxa, the African Garcinia kola Heckel and
the Asian Garcinia subelliptica Merr. reported to yield tyrosinase
inhibitors, from leaves and fruit respectively (Masuda et al., 2005;
Okunji et al., 2007).
As no previous studies have focused on this aspect of the use of
Garcinia livingstonei, the current work was carried out with the
aim of isolating compounds for screening for possible application
in skin-lightening preparations.
Disorders of hyperpigmentation are seen in all skin types;
however, they are encountered more frequently in skin of color
(Kanthraj, 2010). While no single therapy has been shown to be
superior or to be of benefit to all patients, sometimes combination
therapy is recommended to maximize the management of
complex cases (Sheth and Pandya, 2011). The main goal of
treatment is to decrease the hyperpigmentation with minimal
side effects. A range of topical agents are available to treat
hyperpigmentation and act at different levels of the melanogen-
esis pathway (Kanthraj, 2010; Sheth and Pandya, 2011). The most
common synthetic pharmacologic agents used are hydroquinone,
corticosteroids, and mercurials (Olumide et al., 2008). The long-
term use of these products may cause undesirable cutaneous or
systemic side effects (Findlay et al., 1975; Findlay and de Beer,
1980; Olumide et al., 2008).
p-Hydroquinone (1,4-dihydroxybenzene) was one of the ear-
liest products used for the treatment of hyperpigmentation and
remains the standard against which other treatments for hyper-
pigmentation are measured. (Draelos, 2007; Sheth and Pandya,
2011). However, its use has been associated with various side
effects, which include irritant contact dermatitis and exogenous
ochronosis (Findlay and de Beer, 1980; Hardwick et al., 1989;
Olumide et al., 2008). In 1975, Findlay and co-workers reported
ochronosis amongst black South African women after prolonged
use of skin lightening creams containing p-hydroquinone, which
inhibits tyrosinase and prevents the conversion of tyrosine to
dihydroxyphenylalanine, a precursor of melanin. Tyrosinase is,
accordingly, a potential target in the search for a medically
acceptable skin lightening agent from natural sources. This subject
has been the focus of a recent review (Smit et al., 2009).
Given the problems related to hydroquinone use, there exists a
need for the identification of novel agents that can be used as skin
lightening products, either for cosmetic or clinical use. In this work
we examine the properties of compounds isolated from Garcinia
livingstonei, measuring both their ability to both alter melanin
levels in human melanoma cells, and their relative cytotoxicity.
2. Experimental section
2.1. Plant material
Stembark of Garcinia livingstonei T. Anderson was collected in
Zululand, KwaZulu-Natal Province, South Africa, in June 2002, and
fruits were collected on the Howard College Campus of the
University of KwaZulu-Natal in January 2004. Plant material was
identified by Professor Neil Crouch and vouchers for bark (N.
Crouch 942) and fruit (N. Crouch 1137) lodged at the KwaZulu-Natal
Herbarium (NH) in Durban.
2.2. Isolation of compounds
The stem bark was air-dried at room temperature and milled,
while the fresh fruits were first peeled and the nut-like kernels
separated from the surrounding fruit flesh. The dry powdered
stem bark (0.65 kg) was successively extracted with dichloro-
methane, ethyl acetate and methanol for 24 h each, using a Soxhlet
apparatus, and the solvents concentrated in vacuo to yield 14.6,
18.7 and 62.2 g of extract, respectively. 1H NMR and tlc analysis
showed that the ethyl acetate and methanol extracts of the stem
bark were very similar, and they were combined. Fresh seed
kernels (1.2 kg), obtained as described above, were successively
extracted in similar fashion with hexane, dichloromethane, ethyl
acetate and methanol, yielding 38.9, 2.2, 6.4 and 50.0 g of extract,
respectively. The fresh fruit peel (1 kg wet mass) was soaked in
methanol overnight, filtered, and the filtrate concentrated in vacuo
to give a suspension, which was extracted with ethyl acetate and
concentrated in vacuo, yielding 18.8 g of extract.
Repeated separation by gravity column normal phase (Merck
9385 Si gel) and size exclusion (Sephadex LH-20) chromatography,
and semi-preparative scale tlc (Merck 05554 aluminium-backed
tlc plates) was undertaken using hexane:dichloromethane:ethyl
acetate:acetone:methanol solvent mixtures. The dichloromethane
extract of the stem bark yielded betulin, (2.5 g), betulin aldehyde
(5 mg), lupeol (5 mg), lupenone (5 mg), euphol (50 mg) and
stigmasterol (120 mg). The combined ethyl acetate/methanol
extract of the stem bark yielded morelloflavone (1) (20 mg) and
morelloflavone-7″-sulphate (2) (20 mg). Guttiferone A (3) (5 mg)
was isolated from the fruit peel extract. The hexane extract of the
fruit kernels yielded sargaol (4) (50 mg) and isojacareubin (5)
(5 mg) and 6-deoxyisojacareubin (6) (5 mg) were isolated from the
dichloromethane extract (Fig. 1).
2.3. Identification of compounds isolated
NMR anaylsis was performed on a Bruker 400 MHz NMR
spectrophotometer and spectra were determined in CDCl3 or
CD3OD. HRMS were recorded on a Finnigan MAT 95 XP high
resolution Double Focussing MS at the University of Surrey.
Structures of compounds isolated were confirmed by comparison
of NMR and MS data against literature values as referenced in
Section 3.
2.4. In-vitro screening of compounds isolated
A human granular fibroblast cell line derived from malignant
melanoma was used in all in vitro assays (MeWo; ECACC No:
93082609) and was purchased from ECACC (Porton Down, UK).
Cells were grown in EMEM supplemented with 2 mM glutamine,
1% non-essential amino acids, 10% foetal bovine serum and 100 U/
ml penicillin, 100 μg/ml streptomycin. All cell culture medium and
supplements were purchased from Invitrogen (Paisley, UK). MeWo
cells were seeded into 96-well plates (Nunc International, Leices-
tershire, UK) at a concentration of 10,000 cells/well and incubated
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at 37 1C for 48 h in a humidified container for attachment. Chemi-
cals/crude extracts or vehicle (0.1% DMSO) was then added to the
wells at the indicated concentrations and cells incubated for a
further 48 h. Following exposure, medium was collected and cyto-
toxicity determined by LDH-leakage using the cytotoxicity detection
kit (Roche, Lewes, Sussex, UK), as per the manufacturer′s instruc-
tions. For evaluation of melanin content, cells were washed with
PBS, lysed with 1 N NaOH and centrifuged to remove cellular debris.
The melanin content of the supernatant was then determined by
optical density at 405 nm (Takiwaki et al., 2004).
3. Results and discussion
Twelve known compounds, morelloflavone (1) (Li et al., 2002),
morelloflavone-7″-sulphate (2) (Li et al., 2002), guttiferone A (3)
(Gustafson et al., 1992), sargaol (2-geranyl-6-hydroxy-2,8-dimethyl-
chromene) (4) (Numuta et al., 1992; Voutquenne et al., 1999),
isojacareubin (5) (Helesbeux et al., 2004), 6-deoxyisojacareubin (6)
(Ishiguro et al., 1993) and the common triterpenoids, betulin, betulin
aldehyde, lupeol, lupenone, euphol and stigmasterol were isolated in
this investigation The structures of the isolated compounds were
established using NMR spectroscopy and mass spectrometry and by
comparison against literature data as referenced above.
In addition to its HIV-inhibitory activity (Gustafson et al., 1992),
guttiferone A (3) has also been shown to be a potent inhibitor of
cholinesterase (Lenta et al., 2007) and glutathione transferase
enzymes (Muleya et al., 2008), as well as exhibiting antioxidant
(Ngouela et al., 2006), leishmanicidal (Lenta et al., 2007), anti-
plasmodial (Ngouela et al., 2006), trypanocidal (Abe et al., 2004),
and cytotoxic (Williams et al., 2003) effects. The activity of
morelloflavone (1) as an anti-inflammatory (Gil et al., 1997;
Castardo et al., 2008) and antioxidant (Sanz et al., 1994;
Deachathai et al., 2005; Hutadilok-Towatana et al., 2007) are
well-documented; it has also been found to be a potent tyrosinase
inhibitor (Masuda et al., 2005), anti-HIV-1 (Lin et al., 1997), and
anti-bacterial (Verdi et al., 2004) agent, and to have antimalarial
(Ngouamegne et al., 2008) and analgesic (Luzzi et al., 1997)
properties. Isojacareubin (5) is known for its activity as an antic-
oagulant (Wu et al., 1998), and 6-deoxyisojacareubin (6) for its
antifungal (Morel et al., 2002) and antibacterial (Kuete et al., 2007)
properties, while sargaol (4) shows marked activity as an anti-
oxidant (Nahas et al., 2007).
Morelloflavone (1), morelloflavone-7″-sulphate (2), guttiferone A
(3), and sargaol (4) together with the ethyl acetate and methanol
extracts of Garcinia livingstonei stem bark (crude extracts 39b and
39c, respectively), and the fruit peel extract, were selected for further
in vitro analysis. MeWo cells, a human malignant melanoma cell line,
were selected to investigate the action of these compounds and
Fig. 1. Structures of compounds isolated from Garcinia livingstonei.
Fig. 2. The classical pro-oxidant hydroquinone decreases melanin content but is highly toxic to MeWo cells. MeWo melanoma cells were exposed to 25–200 mM
hydroquinone or vehicle for 48 h. Following exposure, cell death was then measured by LDH assay, normalized to vehicle and TX100-treated cells, and melanin content by
absorbance at 405 nM. Each data point represents n¼37SEM, and is representative of at least three independent experiments.
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extracts in vitro, both in terms of impact on melanin levels and
overall cytotoxicity. The melanin content of the melanocytes was
determined after dosing these cells with known concentrations of
the test extracts/compounds, whereas the cytotoxicity assay was
based on the measurement of lactate dehydrogenase (LDH) released
from the cytosol of damaged cells into the culture medium: Full
details of the procedures used are given in Section 2.
Prior to examining the derived compounds and extracts, the
response of MeWo cells to the classical pro-oxidant and skin-
lightening agent hydroquinone was examined. As can be seen from
Fig. 2, hydroquinone was able to elicit a dose-dependent decrease in
melanin content of the cells, with an EC50¼8771.3 mM. This effect
on melanin content was accompanied by dose-dependent cytotoxi-
city, with an IC50¼4575.4 mM.
Following characterization of the response of MeWo cells to
hydroquinone, we next examined the effect of the 25 mM for pure
chemicals and 100 mg/mL for crude extracts on both melanin
content and cytotoxicity (Fig. 3). The fruit peel extract was
extremely cytotoxic, leading to complete cell death within 48 h
and compromising the LDH readings. In addition, the crude
extracts 39b and 39c were both darkly coloured and their melanin
readings were thus also compromised; these results will not be
discussed further. As previously observed by Williams and collea-
gues, guttiferone A was shown to be cytotoxic, with 25 mM causing
approximately 80% cell death, a value that is consistent with the
reported IC50 value of approximately 1 mM (Williams et al. 2003).
This was the most cytotoxic pure chemical examined, with 25 mM
exposures of morrelloflavone, morelloflavone-7″-sulphate and
sargaol only causing between 10 and 20% cell death (Fig. 3A).
In addition, all compounds were able to decrease the melanin
content of the cells (Fig. 3B), although to differing extents. Again,
guttiferone A produced the largest decrease, but this interesting
activity was offset by the large cytotoxic effect observed at the
same dose. Morelloflavone, morelloflavone-7″-sulphate and sar-
gaol all caused significant decreases in melanin content (approxi-
mately 60% of control; Fig. 3), while causing less than 20% cell
death at 25 mM. Accordingly, these compounds were selected for a
more complete concentration–response examination. Fig. 4 shows
concentration–response curves for each compound (1 to 100 mM),
with both cytotoxicity (LDH) and melanin content measured.
Morelloflavone, morelloflavone-7″-sulphate and sargaol all elicited
a dose-dependent effect on cytotoxicity and melanin content
(Fig. 4A–C, respectively). All three compounds elicited a concentra-
tion-dependent decrease in melanin content and cytotoxicity in
MeWo cells, with morelloflavone-7″-sulphate having the most
promising profile. Fig. 4b shows a clear separation of the curves
for cytotoxicity (IC50¼41.872.5 mM) and melanin content
(EC50¼8.671.3 mM), suggesting that this compound has the most
Fig. 4. Response of MeWo cells to morelloflavone, morelloflavone-7-sulphate and
Sargaol from Garcinia livingstonei. MeWo melanoma cells were exposed to
1–100 mM of morelloflavone (A), morelloflavone-7-sulphate (B), sargaol (C) or
vehicle for 48 h. Following exposure, cell death was then measured by LDH assay,
normalized to vehicle and TX100-treated cells, and melanin content by absorbance
at 405 nM. Each data point represents n¼37SEM, and is representative of at least
three independent experiments.
Fig. 3. Response of MeWo cells to 25 μM (pure compounds) and 100 mg/mL (extracts) from Garcinia livingstonei. MeWo melanoma cells were exposed to 25 mM pure
compounds, 100 mg/mL mixed extracts or vehicle for 48 h. Following exposure, cell death was then measured by LDH assay, normalized to vehicle and TX100-treated cells,
and melanin content by absorbance at 405 nM. HQ¼hydroquinone, Mel¼morelloflavone 6, Mel-7-SO4¼morelloflavone-7″-sulphate 7, Sargao¼sargaol 10, Gutti
A¼guttiferone A 4, Ext 39b and Ext 39c¼ethyl acetate and methanol extracts of Garcinia livingstonei stem bark, respectively, Fruit peel¼fruit peel (methanolic) ethyl
acetate extract. Data are representative of at three independent experiments.
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favourable balance of maximal pharmacological effect with
minimal toxicological liability. It should be noted, however, that
of the three compounds tested morelloflavone-7″-sulphate also
elicits the smallest absolute change in melanin content, being 74%
of control, compared to 13% for sargaol; the current dose range
was insufficient to determine a robust maximal effect for morello-
flavone, but it is expected to be in excess of 60%.
4. Conclusion
Morelloflavone (1), morelloflavone-7″-sulphate (2), guttiferone
A (3), and sargaol (4) are all more effective in reducing melanin
content of MeWo human melanoma cells than hydroquinone. In
addition, morelloflavone, morelloflavone-7″-sulphate, and sargaol
are less cytotoxic. Although morelloflavone, isolated from Japanese
material of Garcinia subelliptica has previously been shown to
possess potent tyrosinase inhibitory activity (Masuda et al., 2005),
the current investigation revealed that morelloflavone-7″-sulphate
7 possessed the best separation between reduction in melanin and
induction of cell death.
In conclusion, preliminary results show that morelloflavone,
morelloflavone-7″-sulphate and sargaol are highly effective mela-
nin production inhibitors. When tested in the human melanoma
cell line MeWo, they inhibit melanogenesis to a greater extent
than hydroquinone, whilst causing less cytotoxicity. As such, these
compounds represent good candidates for further development of
novel skin lightening agents to be used in the cosmetic and clinical
arenas.
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Autosomal dominant inheritance of central
centrifugal cicatricial alopecia in black South Africans
Ncoza C. Dlova, MBChB, FCDerm,a Francois H. Jordaan, MBChB, MMED,b Ofer Sarig, PhD,c
and Eli Sprecher, MD, PhDc,d
Durban and Cape Town, South Africa; and Tel Aviv, Israel
Background: Central centrifugal cicatricial alopecia (CCCA) is the commonest type of primary scarring
alopecia in women of African descent. Little is currently known about the disease genetics.
Objective: We sought to investigate patterns of inheritance in CCCA and ascertain the contribution of
nongenetic factors such as hair-grooming habits to the pathogenesis of the disease.
Methods: Affected individuals with at least 1 available family member were recruited from 2005 through
2012 inclusive for pedigree analysis. CCCA was diagnosed on clinical and histopathological grounds.
Results: Fourteen index African families with 31 immediate family members participated in the initial
screening. The female to male ratio was 29:2 with an average age of 50.4 years. All patients displayed
histologic features typical for CCCA. Pedigree analysis suggested an autosomal dominant mode of
inheritance. Hair-grooming habits were found to markedly influence disease expression.
Limitations: Small number of patients is a limitation.
Conclusion: CCCA can be inherited in an autosomal dominant fashion, with partial penetrance and
a strong modifying effect of hairstyling and gender. ( J Am Acad Dermatol 2014;70:679-82.)
Key words: African; black; familial; follicular degeneration syndrome; genetic; hair loss; lymphocytic
primary scarring alopecia; scarring alopecia; South Africa.
P
rimary scarring alopecia is a form of hair
loss in which hair follicles are destroyed
and replaced by fibrous tissue.1 Central
centrifugal cicatricial alopecia (CCCA) is the most
common type of primary scarring alopecia in
African American women,2-5 and characteristically
manifests with irreversible hair loss involving
either the vertex or mid scalp that tends to
progress symmetrically in a centrifugal pattern.6
Histologic features include perifollicular lympho-
cytic infiltrate and fibroplasia,7 which may be
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associated with perivascular lymphocytic infiltrate
and premature disintegration of the inner root
sheath.6,8
The majority of CCCA studies have been conduct-
ed with African American participants. A survey by
the North American Hair Research Society was
carried out in Cleveland, OH, and showed
that 28% of 326 African
American females had cli-
nical evidence of CCCA.9
Although the prevalence
of CCCA in black South
Africans is unknown, a
cross-sectional study con-
ducted among 874 African
adults recruited from 2
church groups, 1 community
organization, and 2 male
hostels in Cape Town, South
Africa, found that 1.9% of this
population had CCCA, all of
whom were women.10 In a
recent 7-year retrospective
survey of 6664 African
patients seen in a predo-
minantly black urban derma-
tology practice in Durban,
South Africa, hair disorders in general and CCCA
more specifically accounted for 5.2% and 0.4% of all
skin conditions seen, respectively.11
The cause of CCCA remains elusive, with
interaction between a genetic predisposition and
hair-grooming techniques in women of African
descent having been suggested.6,12 Although consid-
erable effort has been invested in characterizing
incriminated hairstyling techniques, much less is
known regarding the genetics of the disease.
Supporting a predominant role for inherited factors
in the pathogenesis of CCCA, independent of
hair-grooming habits, is a recent report on 2 families
with natural hair and with clinical and histologic
evidence of CCCA.13
The pathomechanisms underlying hair follicle
scarring in primary scarring alopecia, and more
specifically in CCCA, are not well understood.
Everts et al14 have shown altered retinoid
metabolism in human and mouse models with
primary cicatricial alopecia, particularly CCCA.
Karnik et al,15 in a recent study of lichen planopilaris,
proposed that abnormal function of the peroxi-
some proliferatoreactivated receptor gamma could
possibly trigger inflammation, with resultant
abnormal lipid metabolism within the sebaceous
gland, resulting in a toxic accumulation of lipids
with ensuing inflammatory response. Whether this
mechanism applies to CCCA as well remains to be
determined.
In this article, we report 14 index families
with 31 immediate family members in Durban,
South Africa, all of whom had a clinical and histo-
logic diagnosis of CCCA and provide evidence for
autosomal dominant inheritance of this condition.
METHODS
Patients
Ethical approval for the
study was obtained from the
Nelson R. Mandela School
of Medicine Institutional
Review Board (BE 180/11).
All patients who presented
with CCCA from 2005
through 2012 inclusive were
recruited from both the
private- and public-sector
hospitals in Durban, South
Africa. To be included in the
study, patients had to fulfill
published clinical criteria
for CCCA diagnosis.2,7,16 A
general skin and hair exami-
nation by an experienced
dermatologist familiar with ethnic hair was
undertaken to exclude skin and scalp infection,
traction alopecia, or acne.
We used a central hair loss grading (CHLG) score
as previously described.17 A CHLG of 0 was taken as
normal hair thickness without discernible alopecia; a
CHLG of 1 was given in the presence of slight
alopecia and early CCCA without obvious effect on
hair density; a CHLG of 2 was indicative of subtle
clinical alopecia; and a CHLG of 3 to 5 corresponded
to clinically obvious mild, moderate, and severe
CCCA. In addition, patients needed to have a
minimum of 1 affected family member available
for examination of the scalp and who agreed to
be subjected to a confirmatory scalp biopsy, to
be included in the study. Immediate family
members included the index patient’s parents,
siblings, and offspring. Written informed consent
was obtained from all participants or their legal
guardians. A detailed history of personal and
family history of diabetes mellitus (DM), along
with hair grooming and drug consumption, was
obtained.
Histopathology
Supportive evidence for CCCA was obtained
through dermoscopic examination18 and histo-
pathological studies. Two dermoscope-guided 4-mm
CAPSULE SUMMARY
d Central centrifugal cicatricial alopecia is a
lymphocytic cicatricial alopecia occurring
commonly in women of African descent.
d Central centrifugal cicatricial alopecia is
familial, and is inherited in a dominant
fashion. It is triggered by certain
hairstyles. Although it also occurs in
black males, gender-related hair-
grooming habits may explain the
preponderance of female patients.
d Early detection and counseling of family
members regarding hair-grooming
approaches may arrest progression of
alopecia.
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punch scalp biopsies were performed for each
individual with a clinical diagnosis of CCCA.
Scalp biopsy specimens were fixed in 10%
buffered formalin and thereafter embedded in
paraffin. Both horizontal and vertical sections
were stained with hematoxylin-eosin for routine
histopathological examination. All samples were
reviewed by 1 dermatopathologist. The diagnosis
of CCCA was established according to criteria
previously published.2,7,16 A numeric scoring system
was devised to evaluate biopsy specimens for a
diagnosis compatible with CCCA.
According to this system, 3pointswere awarded for
the presence of lichenoid lymphocytic folliculitis
(lymphocytes surrounding follicles with exocytosis
into follicular epithelium), 2 points for perifollicular
lymphocytes (lymphocytes in the immediate vicinity
of follicles but separated from the follicular epithe-
lium), 1 point for perifollicular fibrosis (concentric
fibrosis of variable thickness surrounding follicles),
and 1 point for the presence of compound follicles
(fused infundibula of follicles indicating disturbed
follicular dynamics). A diagnosis of CCCA was
considered likely with a score of 3 or more.
RESULTS
Clinical features
All patients were of African descent. There were
14 index African families with a total of 31
participating immediate family members, and the
female to male ratio was 29:2. The average age was
50.4 years (range: 11-94) with 45% between age 30
and 50 years, whereas the average age of onset was
41 years (range: 11-75), with 48% being between age
30 and 50 years. All but 1 female had traction
alopecia (28; 96.5%). This individual, aged 11 years,
kept natural hairstyle only.
None of the participants had skin infections or a
positive drug history; acne and DM were diagnosed
in 1 participant each.
As defined by the inclusion criteria, all patients
had 1 or 2 members of their family with a clinically
and histologically confirmed diagnosis of CCCA. In 2
families, 2 generations were affected, whereas in
another family, cousins were also affected. Only in 1
(2%) family were males given the diagnosis of CCCA,
ie, father and son. All the affected families showed an
autosomal dominant pattern of inheritance (Fig 1;
available at http://www.jaad.org).
There appeared to be a strong correlation
between the severity of CCCA as interpreted by the
CHLG score, and the frequency and preference of
hair-grooming methods. Fifteen (48%) participants
who had CHLG greater than 2 practiced frequent
braiding and weaving for hair grooming, of whom
9 (29%) gave a history of braiding or weaving
chemically processed hair (relaxed or permed). Of
those with CHLG 0 to 1, 11 (35%) had natural virgin
hair, had never used any chemicals or traction on
their hair, and maintained short hairstyles. These
were either very young (\15 years) or very old
([75 years) female participants who had escaped
the latest hair-grooming trends, or males who had
kept natural short haircuts, as culturally accepted.
With regards to symptomatology, 11 (35%) patients
presented with thinning and breakage of the vertex
hair as the main symptom, as observed by other
authors,4 9 (29%) were asymptomatic and the
remaining 11 (35, 5%) patients presented with either
painful papules, tender scalp, dandruff, or pruritus.
Histopathology
A total of 31 scalp biopsy specimens were
submitted. Twenty biopsy specimens of late lesions
were submitted for vertical sectioning and 19 for
horizontal sectioning. Eleven biopsy specimens of
early lesions were submitted for vertical sectioning
and 10 for horizontal sectioning. Combining vertical
and horizontal sections increased the diagnostic
yield and the diagnosis of CCCA was made on all
31 specimens. Hair shaft granulomas caused by
disruption of follicular epithelium were evident in
2 biopsy specimens, as were atrophy of follicular
epithelium, concentric perifollicular fibrosis, and
lymphocytes.
DISCUSSION
We have described 14 index African families with
a total of 31 immediate family members who
displayed characteristic clinical and histologic
features of CCCA.2 To our knowledge, a similar
cohort of patients has not been described in the
literature. Each of the 14 index patients had at least
1 immediate family member who had CCCA. Family
members were recruited and examined, and
subjected to a confirmatory dermoscope-guided
biopsy.18 The pedigrees of the 14 families are highly
suggestive of an autosomal dominant mode of
inheritance (Fig 1; available at http://www.jaad.
org), with partial penetrance and a strong
modifying effect of hairstyling and gender. In the
majority of patients, a strong family history of CCCA
from the maternal side was observed. The case of
paternal transmission rules out X-linked inheritance
provided CCCA is genetically homogeneous. We
believe that gender-related hair-grooming habits
may explain the preponderance of female patients
in our cohort. Indeed, most African males in South
Africa keep their hair natural and very short, making
it difficult to pick up the subtle areas of alopecia.
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In fact, in the only family with male patients studied,
the index patient had been using chemical hair
relaxers and we have documented chemical
hair grooming as an aggravating environmental
factor. The absence of DM and skin infections in
the majority of our patients casts doubt on any
association of DM and skin infections in patients
with CCCA, as was reported by Kyei et al.19
Similarly, we could not find any association
between CCCA and acne as previously reported.19
In contrast, we detected a positive correlation
between use of traction-inducing hairstyles such as
braids/weaving, and the severity of CCCA, more so
in patients who applied traction on chemically
processed hair.6,15,19 Traction alopecia was found in
most female patients (96.1%), as described by other
authors suggesting that traction alopecia inCCCAmay
serve as an environmental trigger in patients with an
inherited propensity to develop CCCA. However, the
fact that 6 (19.4%) patients had natural hair, yet
had clinical and histologic confirmation of CCCA,
lends further support to the notion that endogenous
factors play a pivotal role in the disease pathogenesis
of some primary cicatricial alopecias.20,21
In conclusion, results of this study are strongly
suggestive that CCCA can be inherited in a dominant
fashion, and confirm the important contribution of
hairstyling to the disease manifestations.22 Certainly
a population study to screen for early symptoms and
signs of CCCA in younger African girls and women
would be desirable, particularly those with affected
family members.
Natural hairstyles should be encouraged in
patients with CCCA and their relatives to obviate
the rapid progression and severity of the hair
loss, which may result in major psychological
effects (unpublished data, October 2013). Public
and hairstylist educational campaigns will hasten
early recognition and diagnosis.
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Fig 1. Pedigrees depicting autosomal dominant inheritance of central centrifugal cicatricial
alopecia in all 14 affected families.
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Background
Central centrifugal cicatricial alopecia (CCCA) is the most
common type of primary scarring alopecia in African
American women.1 Cicatricial alopecia is characterised by
both the destruction and replacement of the hair follicle by
fibrous tissue However CCCA is a distinct form of scarring
alopecia characterised by hair loss which starts at the ver-
tex and gradually progresses in a centrifugal pattern. It
was, first described in 1968 by Lopresti et al.2 who origi-
nally coined it ‘‘hot comb alopecia’’ based on the hypothe-
sis that heat from hot combing was responsible for the
alopecia. The term follicular degeneration syndrome was
later proposed by Sperling and Sau in 1992, as they found
no etiological relationship between use of a hot comb and
the scarring alopecia.3 Then Headington4 proposed scar-
ring alopecia in African Americans, and Sperling denomi-
nated it central centrifugal scarring alopecia.5 Finally, the
term central centrifugal cicatricial alopecia was adopted by
the North American Hair Research Society6 in 2001.
Women of African ancestry have a higher predilection
for CCCA, with a female/male ratio of 3:1.7 Clinically,
this condition usually presents in middle-aged women and
is characterized by typical primary involvement of either
the vertex or crown with symmetric spread in a centrifu-
gal pattern. Symptoms may vary from asymptomatic to
painful papules, pustules, tender scalp, or mild pruritus.
The distribution of hair loss closely resembles that of
androgenic alopecia or female pattern hair loss (FPHL)
however a lack of follicular openings in CCCA signifies
the presence of scarring. in females.8
The most frequent histological features of CCCA are
lymphocytic folliculitis, premature degeneration of the
inner root sheath, perifollicular granulomatous inflamma-
tion, destruction of folliculo sebaceous units with reten-
tion of arrector pili muscle, and associated scarring and
fibrosis replacing some of the hair follicles are the most
frequent histological features of CCCA.8 Other primary
scarring alopecia that can cause central cicatricial alope-
cia, such as lichen planopilaris, discoid lupus erythemato-
sus, and folliculitis decalvans may pose difficulty in trying
to distinguish from full blown end-stage CCCA.1
Various treatment modalitie for CCCAs have been used
with varying success. They include moderate to potent
topical steroids, intralesional steroids, oral antibiotics
such as tetracyclines, hydroxychloroquine, and immuno-
suppressive agents such as mycophenolate mofetil, and
ciclosporin.8 In addition, avoidance of hair grooming has
been recommended for affected patients.8
In this report we describe two African families with
CCCA, each with a family member with a clinical and
histological diagnosis of CCCA without any evidence of
mechanical or chemical damage to the hair.
Family 1
A 45-year-old African woman presented with a 1-year
history of hair loss involving the crown (Fig. 1e). She 17
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admitted to having occasional pustules and painful pap-
ules or tender areas of the scalp concentrated mainly on
the crown. Hair grooming involved occasional chemical
relaxing of hair once every 4 months in the last 3 years
and mainly natural twisting of the hair. The affected
patient’s family, which included her 92-year-old mother
and three other female siblings aged 65 years, 63 years,
and 55 years, respectively were called for scalp
examination and a thorough hair grooming history was
taken. A 4 mm scalp punch biopsy was taken for histo-
logical examination.
All four family members were found to have features of
CCCA both clinically and histologically. (Fig. 1a–d) The
92 year-old mother who had natural virgin hair, which
had never been subjected to any chemical or mechanical
trauma had clinical and histological features of CCCA
(Fig. 1a). Their grooming methods included mainly infre-
quent chemical relaxing once every 3–4 months and occa-
sional braids. All the family members were not aware of
the occurence of hair loss.
Family 2
A 35-year-old African woman presented with gross scar-
ring alopecia involving the crown for 5 years (Fig. 2a).
She noticed her hair was getting thinner and sparse over
the crown but did not seek medical advice until later. She
admitted to frequent use of chemical relaxers as well as
sewn-in hair weaves and sometimes braids with extended
hair for grooming her hair. She applied chemical relaxers
on her hair every month and had hair braids with
extended hair on relaxed hair. In between these hairstyles
the patient would have sewn - in or glued-in hair weaves.
Her family members, who included her 65-year-old
mother and 11-year–old daughter, were called for exami-
nation and a thorough hair grooming history was taken.
A 4 mm scalp punch biopsy was taken for histological
examination. Unfortunately, her mother was not available
for examination.
Her 11-year–old daughter had clinical and histologi-
cal features of CCCA (Fig. 2b,c). She had natural virgin
hair and had never used any form of chemical or
mechanical trauma to the hair. Her daughter was
not aware of hair loss, until examination by the derma-
tologist.
In all seven patients from families 1 and 2, skin his-
tology showed perifollicular and perivascular lymphoid
cell infiltrate with eccentric thinning of the follicular epi-
thelium with concentric lamellar fibroplasia compatible




Figure 1 Family 1. (a) 92-year-old mother, with clinical and histological features of central centrifugal cicatricial alopecia
(CCCA), no history of chemical or mechanical grooming of hair. (b) CCCA in a 65-year-old (first) daughter, very mild, kept
natural hair most of the time, with occasional use of relaxers four times a year. (c) 63-year-old (second) daughter with CCCA,
loose braids on natural hair most of the time. (d) 55-year-old (third) daughter with CCCA, grooming method is braids on natu-
ral hair most of the time. (e) 45-year-old (fourth) daughter with CCCA, grooming method is chemical relaxers every 2–
3 months with occasional loose braiding of the hair.
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Discussion
The etiology of CCCA is the subject of much speculation
but remains elusive. Gathers and Lim have found that
sewn and glued hair weave, as well as cornrow or braided
hairstyles seem to be positively associated with CCCA.8
Nnoruka, however, attribute CCCA to the duration of
hair grooming practices such as chemical relaxers.9 Kyei
et al. in their survey of 326 African American women
found an association between hairstyles causing traction
alopecia and the occurence of CCCA. They also con-
cluded that bacterial infection may play a role in the
development of CCCA.10 The treatment of CCCA
remains challenging as well as loose braiding of the hair,
guided only by case reports and expert opinion, in the
absence of prospective or case-controlled studies.
Our documented cases seem to demonstrate that CCCA
does occur in natural virgin hair which suggests a possible
familial link. The affected family members who wore
tight braids and had hair weaves on already chemically
relaxed hair seemed to exhibit a more severe disease than
those who only used chemical relaxers infrequently.
We therefore postulate that there might be a genetic
defect of the internal root sheath in some Africans or Afri-
can Americans as a primary pathologic event, which may
be familial. This defect may manifest in adolescence, and
predominantly among females, because of a higher fre-
quency of hair grooming practices. Clinical disease mani-
fests early; however, thick curly hair obscures the lesions,
which become evident later with disease progression. The
elderly members of affected families tend to demonstrate
less severe disease than younger generations. This sparing
is thought to be in line with less frequent use of potentially
damaging combinations of hair grooming practices. The
Figure 3 Histology: · 40 transverse section with features of
central centrifugal cicatricial alopecia – eccentric thinning of




Figure 2 Family 2. (a) 35-year-old mother with central cen-
trifugal cicatricial alopecia (CCCA), hair grooming involved
a combination of chemical relaxers, tight braidswith
extended hair, and sewn - in hair weaves. (b) 11-year-old
daughter with clinical and histological features of CCCA,
natural virgin hair with no history of any chemical or
mechanical trauma. (c) Close up of the scalp showing small
areas of scarring alopecia devoid of follicular pores con-
firmed on histology as CCCA in the 11-year-old girl with
natural virgin hair
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combination of chemical relaxers and traction which I refer
to as a the ‘‘deadly duo’’ appears to result in early severe,
progressive hair loss. Early examination and diagnosis of
affected family members may help halt the rapid progres-
sion of this devastating, progressive scarring disease. Fur-
thermore, afflicted patients may benefit from early
counselling and advice on proper gentle hair-grooming
practices.
Conclusion
To our knowledge, this is the first case series document-
ing a familial association in CCCA.
Further family studies or case-controlled studies are
needed to confirm this observation, which suggests CCCA
may have a familial genetic predisposition, which can be
aggravated or triggered by external factors such as cumu-
lative effects of chemical and mechanical trauma. If
confirmed in larger studies, the term ‘‘familial central
centrifugal cicatricial alopecia’’ may be appropriate.
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DEAR EDITOR, Frontal fibrosing alopecia (FFA) is an uncommon
clinical variant of lichen planopilaris (LPP), presenting with
band-like scarring alopecia (SA) involving the hairline, first
described by Kossard in 1994.1 Lately, familial cases of FFA
have been reported in both white and black patients,2,3 sug-
gesting among other factors the possibility of genetic inheri-
tance. There is a paucity of information on the epidemiology
of FFA in black patients, with only one report by Miteva et al.4
in Miami, wherein they reported on 11 (78%) of 141 African
American patients having FFA, 10 female and one male. No
published reports were found regarding cases from Africa. The
intention of this 5-year retrospective review is to provide
insight on the demographic and clinical profile of black
patients with FFA in South Africa.
We reviewed single-centre case notes and clinical pictures of
patients presenting with a histopathologically confirmed diag-
nosis of FFA between 2006 and 2012, inclusive. In total 44
patients were seen; 20 had FFA only and 24 had associated
lichen planus pigmentosus.5 This study will focus on the 20
patients with FFA only, 19 (95%) female and one (5%) male,
whose clinical data are summarized in Table 1. The age of onset
ranged from 27 to 66 years, with a mean of 42 years. Most
were African (19, 95%), with one (5%) female Indian patient.
Fourteen of the 19 women (74%) were premenopausal.
Only one patient (5%) had a positive family history, citing
her mother and first cousin as being affected.2 FFA involved the
frontotemporal region in all 20 cases, while two of the patients
had associated patchy LPP. Traction alopecia (TA) presented in
the majority of African female patients (n = 17), of whom 14
complained of hairline loss. Seven patients in total (35%) had
pruritus, one of whom also had painful, tender pustules.
Histology confirmed LPP in all of the patients except one,
who declined biopsy. Histology showed typical features of
LPP, consisting of follicular loss with perifollicular fibrosis
and lichenoid inflammation around hair follicles.1,6 Only two
patients (10%) had both eyebrow and limb hair loss, while
eight (40%) had eyebrow loss and none had facial papules.
All 18 female African patients (90%) admitted to using
chemicals or had traction-inducing hairstyles. The lonely hair
sign (Figs 1, 2) described by Tosti et al.7 was detected in 70%
of the African patients with FFA. Loss of follicular ostia as a
hallmark sign of scarring alopecia8 may be misleading, as five
patients (25%) had prominent follicular ostia despite histologi-
cal confirmation of a scarring process (Figs 1, 2). Cutaneous or
mucosal lesions of lichen planus were not observed. Treatment
included hydroxychloroquine 200 mg twice daily for 6–-
12 months, clobetasol dipropionate, tacrolimus 01% and
minoxidil 2%.9,10 Traction-inducing hairstyles and frequent
use of chemical relaxers were discouraged. Wigs instead of
weaving were recommended for those with extensive disease.
The cases of FFA reported in the literature have been mainly
in postmenopausal white women.1 While Miteva et al.4 reported
the occurrence of FFA in 11 postmenopausal black patients, our
patients were predominantly premenopausal (74%). Both this
series and that of Miteva et al. confirm that FFA is not exclu-
sively a disease of postmenopausal white women, but affects
the black population as well. Our report is similar to that of
Miteva et al. in that almost all of our patients had used traction
and/or chemicals for grooming and had evidence of TA, creat-
ing difficulties in diagnosis. The lonely hair sign7 and loss of
eyebrows are useful clinical signs in the early diagnosis of FFA.
The age range of onset was much lower than in other stud-
ies,1,11 explicable by the early use of traction-inducing hair-
styles, which probably aggravate the progression of FFA.
Africans tend to be less hairy than their Indian and white
counterparts, resulting in less noticeable body hair loss. This
may explain why only one African patient showed limb hair
loss, along with the Indian patient. At 2-year follow-up we
were able to abort the progression of alopecia in five of the
20 patients with early disease who started on chloroquine and
topical treatments. This is in line with the report of Chiang
et al.9, wherein they reported the efficacy of hydroxychloroqu-
ine in patients with low LPP activity score. One patient fol-
lowed up for 5 years defaulted treatment and presented with
generalized hair loss resembling alopecia universalis. This sup-
ports the observation made by Chew et al.6 in which the pro-
cess of scarring alopecia is somewhat generalized rather than
confined to the hairline and eyebrows.
We have documented the largest series of FFA in black
patients to date, and the first report in Africa. Despite the limi-
tations of a retrospective review, we have shown that FFA can
be easily confused with TA, as these two conditions often
coexist in Africans, supporting the assertions of Miteva et al.4
and Tosti et al.7 While other studies have shown absence of
follicular ostia as a hallmark of SA, we have shown that this is
not necessarily so, and can be misleading. Therapeutic options
are limited, and the goal of treatment is making early diagno-
sis, thus aborting active disease progression to minimize SA.
Long-term prospective cohort studies are needed to elucidate
BJD
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and predict treatment response, as well as to determine the
aetiology and natural progression of FFA.
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Gene–gene interactions between HLA-C,
ERAP1, TNFAIP3 and TRAF3IP2 and the risk of
psoriasis in the Chinese Han population
DOI: 10.1111/bjd.12442
DEAR EDITOR, Psoriasis is a common immune-mediated skin dis-
order characterized by epidermal hyperproliferation, vascular
remodelling and inflammation.1 It has a strong genetic com-
ponent, and gene–gene and gene–environment interactions
also contribute to the pathogenesis of psoriasis. Recently,
almost 40 susceptibility genes have been identified for psoria-
sis through genome-wide association studies (GWASs) in
diverse populations.2–9 Several genes exhibited important roles
in the development of psoriasis, including HLA-C, ERAP1,
TNFAIP3 and TRAF3IP2, through the nuclear factor-jB pathway
or interleukin-17 signalling. Moreover, the interactions
between HLA-C and ERAP1; TNFAIP3 and HLA-C; and HLA-C and
TRAF3IP2 in a western ethnic population were revealed, greatly
deepening the understanding of the genetic architecture in
Fig 1. Frontal fibrosing alopecia, frontotemporal and with patchy
distribution, prominent follicular ostia and lonely hair sign.
Fig 2. Frontal fibrosing alopecia showing prominent follicular ostia
and lonely hair sign.






Frontal fibrosing alopecia and lichen planus pigmentosus - 
is there a link? 
Dlova NC. Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link? Br J 




us to consider a causal link between the infiltration of the fil-
ler and the appearance of xanthelasma, much more likely than
a casual association between the spontaneous start of xanthel-
asma and the filler injection. We suppose that the hyaluronic
acid, injected to reduce the wrinkles of the lower eyelids, may
have produced an inflammatory reaction with oedema result-
ing in an increase of vascular permeability. It is important to
remember that, normally, LDL has a low percentage of capil-
lary leakage but local trauma increases this rate.10 The extrava-
sated LDL may have formed complexes with the injected
hyaluronic acid, which were internalized by histiocytes. Fur-
thermore, hyaluronic acid favours the oxidation of LDL,
increasing the formation of foam cells.
Our cases suggest that special attention should be paid
while performing infiltration of hyaluronic acid in the perior-
bital region.
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Frontal fibrosing alopecia and lichen planus
pigmentosus: is there a link?
DOI: 10.1111/j.1365-2133.2012.11146.x
MADAM, Frontal fibrosing alopecia (FFA) is a primary lympho-
cytic cicatricial alopecia with a distinctive pattern involving the
hairline, eyebrows and other hair-bearing areas, first described
by Kossard1 as a progressive recession of the frontal hairline
in postmenopausal white women. Miteva et al.2 have reported
for the first time the occurrence of FFA in African Americans.
Lichen planus pigmentosus (LPPigm), on the other hand, is
an uncommon macular variant of lichen planus occurring as
diffuse or reticulated macules on sun-exposed areas and in
flexures. LPPigm resembles erythema dyschromicum perstans
or ashy dermatosis on histology.3 Ashy dermatosis is charac-
terized by the progressive occurrence of ash-coloured macules
with erythematous margins commonly distributed over the
trunk and proximal extremities.4
The coexistence of FFA and idiopathic lichen planus has
been reported,5 but not LPPigm and FFA. We report here for
the first time 24 cases of LPPigm preceding FFA in Durban,
South Africa (Fig. 1a).
A retrospective review of 44 patients diagnosed with FFA
(2006–2012) revealed that 24 patients had pigmentation on
sun-exposed areas (LPPigm) while 20 had FFA only. This
study will focus on the 24 patients with FFA and LPPigm.
The clinical diagnosis was corroborated by histology in all
24 patients (Table 1). Most patients were African (22; 91%),
while two (9%) were Indian. There were 23 women (95%)
and one African man (5%). The age at onset ranged from 25
to 56 years (mean 40). Most of the women were premeno-
pausal (14 ⁄22; 64%), while 8 ⁄22 (36%) were postmeno-
pausal. All patients had frontotemporal hair loss but only two
exhibited facial papules on the forehead and cheeks, the
histology of which confirmed sebaceous hyperplasia, with
vellus hair involvement. The mean lag interval from LPPigm
to FFA was 14 months (range 6–36). Eyebrow and limb hair
loss affected 38% and 25% of the patients, respectively. Trac-
tion alopecia (TA) featured in most of the African women but
in neither of the Indian women nor in the African man. None
of the patients had a positive drug or family history. Human
immunodeficiency virus (HIV) infection coexisted in one
(4%); the rest had a noncontributory medical history.
LPPigm was first described in India by Bhutani et al.3 as a
rare variant of lichen planus characterized by hyperkeratosis,
atrophy of epidermis as well as vacuolar degeneration of the
basal layer (Fig. 1b). It has been reported in various ethnic
groups, e.g. Latino, Korean, Japanese and Middle Eastern
 2012 The Authors
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populations, but never in Africans. Although Faulkner et al.5
reported FFA in association with idiopathic lichen planus in a
premenopausal white woman in 2002, the coexistence of
LPPigm and FFA has never been reported.
Interestingly, most patients were oblivious to the hair loss
which was preceded by LPPigm by about 14 months, and
dismissed it as TA, a not so uncommon finding in African
women.6 Two of the patients presented with skin-coloured
facial papules. Donati et al.7 and Tan and Messenger8 have
described vellus hair involvement in some of their cases. Most
of our patients were African women and were premenopausal,
with an age at presentation ranging from 25 to 56 years. This
is lower than the age range of 53–72 years reported by Miteva
et al.2 It is possible that the mechanical trauma that is associ-
ated with hair grooming hairstyles could explain the early age
at which manifestation of FFA in African patients occurs. The
African man had a slower rate of frontal recession compared
with his female counterparts, and this could be explained by
absence of traction-inducing hairstyles.
It appears that LPPigm could be the herald sign for FFA. FFA
can be easily dismissed as TA, particularly in black patients,
missing the association described here. Therefore proper clinical
examination using the diagnostic features distinguishing
between FFA and TA described by Miteva et al.,2 and a biopsy of
the scalp margin, should be undertaken on all African patients
presenting with LPPigm. On histological confirmation of FFA,
patients should be commenced on appropriate treatment.9
Further advice and counselling, on gentle hair grooming
hairstyles with avoidance of tight braids or frequent chemical
treatment, should be provided. Topical retinoids, skin-lighten-
ing creams as well as strict sun protection were recommended
for LPPigm as well as chloroquine 200 mg twice daily for
1 year for FFA. The psychological impact of the pigmentation
on affected patients cannot be underestimated, particularly
with the advent of HIV and its associated generalized pigmen-
tation for which patients can be easily mislabelled.
The well-defined, sequential clinical progression from
LPPigm to FFA, and its histological confirmation, suggest that
LPPigm and FFA are but separate bands of the same spectrum
of disease. The aetiology of FFA remains elusive; however,
genetic and environmental factors have been implicated.10
There are insufficient data in the literature on the natural
history of both diseases; however, it is known that FFA and
LPPigm do stabilize after some time. As to when and how far
they will stabilize remains unknown. Further to confirm the
predictive status of LPPigm as the harbinger of FFA, further
long-term prospective cohort studies need to be undertaken to
elucidate this association.
Acknowledgments
I am grateful to Prof. Antonella Tosti for her critical review of
the manuscript, Dr Mick Forder and Dr Esra Masinga for pro-
viding the histology picture, and Dr Andiswa Skenjane, Dr
Nokubonga Khoza and Dr Siza Mazibuko (Dermatology
Department, Nelson R. Mandela School of Medicine) for per-
forming some of the biopsies and referring some of the
patients.
N .C . DLOVADermatology Department, Nelson R. Mandela
School of Medicine, University of KwaZulu-Natal,
Private Bag X 7, Congella 4013, Durban, South Africa
E-mail: dlovan@ukzn.ac.za
(a) (b)
Fig 1. (a) Clinical appearance of lichen planus pigmentosus (LPPigm) on the face, ears and V of the neck, with evidence of frontal fibrosing
alopecia to mid-scalp, and bilateral eyebrow loss. The patient was not on treatment, and predominantly wore tight braids. She noticed hair loss
1 year after onset of pigmentation. (b) Photomicrograph showing pigmentary incontinence with some mild basal vacuolar degeneration consistent
with LPPigm (haematoxylin and eosin; original magnification · 100).
 2012 The Authors






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 2012 The Authors




1 Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring
alopecia in a pattern distribution. Arch Dermatol 1994; 130:
770–4.
2 Miteva M, Whiting D, Harries M et al. Frontal fibrosing alopecia in
black patients. Br J Dermatol 2012; 167:208–10.
3 Bhutani L, Bedi T, Pandhi R, Nayak N. Lichen planus pigmentosus.
Dermatology 1974; 149:43–50.
4 Zaynoun S, Rubeiz N, Kibbi AG. Ashy dermatoses – a critical
review of the literature and a proposed simplified clinical classifica-
tion. Int J Dermatol 2008; 47:542–4.
5 Faulkner CF, Wilson NJ, Jones SK. Frontal fibrosing alopecia associ-
ated with cutaneous lichen planus in a premenopausal woman.
Australas J Dermatol 2002; 43:65–7.
6 Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing and the
prevalence of scalp disease in African adults. Br J Dermatol 2007;
157:981–8.
7 Donati A, Molina L, Doche I et al. Facial papules in frontal fibrosing
alopecia: evidence of vellus follicle involvement. Arch Dermatol
2011; 147:1424–7.
8 Tan KT, Messenger AG. Frontal fibrosing alopecia: clinical presenta-
tions and prognosis. Br J Dermatol 2009; 160:75–9.
9 Chiang C, Sah D, Cho BK et al. Hydroxychloroquine and lichen
planopilaris: efficacy and introduction of Lichen Planopilaris
Activity Index scoring system. J Am Acad Dermatol 2010; 62:387–
92.
10 Saurat JH, Kaya G, Saxer-Sekulic N et al. The cutaneous lesions of
dioxin exposure: lessons from the poisoning of Victor Yushchenko.
Toxicol Sci 2012; 125:310–17.
Funding sources: none.
Conflicts of interest: none declared.
Lack of ‘appropriately assessed’ patient-
reported outcomes in randomized controlled
trials assessing the effectiveness of interven-
tions for rosacea
DOI: 10.1111/j.1365-2133.2012.11148.x
MADAM, Rosacea is a chronic skin disease, and psychological
problems are fairly common in people affected by rosacea.
The persistent red pimply rash on the face can be a source of
embarrassment, anxiety and low self-esteem. It may instil a
lack of confidence and even lead to depression or body dys-
morphic disorder. Rosacea can also have a significant negative
impact on health-related quality of life (HRQoL).We have
documented the patient-reported outcomes (PROs) used in
clinical trials identified in the Cochrane Review on the effec-
tiveness of interventions for rosacea, published in the Cochra-
ne Library March 2011, and we reported their measurement
properties previously.1 Here we discuss the results.
We independently evaluated the PROs in 58 included
studies using the ‘Checklist for describing and assessing
patient-reported outcomes in Clinical Trials’, as described in
the Cochrane Handbook for Systematic Reviews of Interventions.2 We
extracted from the primary report details of the number of
items or domains, the type of rating scales used, the timing
of the assessments and whether symptoms were presented as
scores at baseline or at follow-up or both, as well as any
measurement property that we identified. We abstracted esti-
mates of effect on PROs and applied GRADE (Grades of Rec-
ommendation Assessment, Development and Evaluation)
methodology to create evidence profiles, summarizing results
and confidence in effect estimates (all data available on
request).3
Two of the 58 studies reported assessments of change in
HRQoL as an outcome of the interventions. Other PROs were
reported in 29 of 58 studies and included not only assess-
ments of changes in severity but also, in 10 of them, the
degree of patient satisfaction associated with these changes
(Fig. 1). None of the PRO assessment tools met the recom-
mended criteria based on the quality ‘checklist’. In six of the
studies the self-assessments were made by way of question-
naires of unsupported validity. Most of the instruments used
in the remaining studies were based on Likert-type scales,
and three of the studies utilized visual analogue scales (see
Fig. 2). Moreover, the majority of the studies focused princi-
pally on the numbers of papules and pustules, which,
although they may provide a quantifiable, objective and
more readily understood outcome, are generally considered
to be clinician-centred rather than patient-preferred. Two
studies evaluating quality of life used validated tools that are
internationally recognized: a disease-specific instrument, Ocu-
lar Surface Disease Index, was used in one study,4 and the
generic Dermatology Life Quality Index was applied in the
other.5
The overall quality of the evidence based on the GRADE
profile was generally considered low to moderate. However,
based on patients’ assessments there is evidence that topical
metronidazole (four studies) and azelaic acid (three studies)
improve papulopustular rosacea, and topical ciclosporin
improves the quality of life of participants with ocular rosacea
(one study). Most of the randomized controlled trials (RCTs)
assessing the effects of tetracycline were old and less well
designed, and of those studies that were eligible for inclusion
most failed to show any effect on participant-assessed rosacea
severity. Several recent, well-designed RCTs have investigated
the effects of subantimicrobial anti-inflammatory dose doxycy-
cline (40 mg) for the treatment of rosacea, but these did not
address the patients’ views.1 Evidence provided by one RCT
indicated that pulsed dye laser and intense pulsed light therapy
can reduce erythema and telangiectasia on the face.1 Clearance
of the redness and telangiectasia is highly desirable, as these
symptoms can be a source of personal embarrassment and
may lead to low self-esteem. Therefore, further studies of
laser- and light-based therapies should be considered a prior-
ity. Three treatments were rated as ineffective by the partici-
pants in the trials: (i) pimecrolimus, (ii) a cream containing
 2012 The Authors
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In human lymphoid malignancies, galectin-7 was reported
to be expressed and to be a critical tumour-modulating gene. It
may significantly affect lymphoma progression in the clinical
setting.6 Using an approach based on genomic analysis of an
aggressive lymphoma variant and its nonaggressive parental
cells, the most prominent change was the strong upregulation
of galectin-7.7 Galectin-7, a member of the galectin family,
designated as the product of the p53-induced gene 1 (PIG1,
now known as LGALS7), is a regulator of apoptosis and contrib-
utes to different events associated with the differentiation and
development of pluristratified epithelia. Galectin-7 is thought
to function in stratified epithelial tissue in response to environ-
mental injuries, such as wound healing or UV radiation.8 UV
radiation exposure has been shown to induce skin keratinocytes
to express rapidly galectin-7 mRNA and protein, and galectin-7
has been reported to take part in UV-induced apoptosis.8,9
Microarray analysis revealed that galectin-7-transfected cells
expressed approximately nine times more HMG-CoA synthase
(HMGCS1) mRNA than untreated cells.10 HMGCS1 is a key rate-
limiting enzyme, preceding HMG-CoA reductase, in the path-
way for endogenous cholesterol synthesis. Recently, we discov-
ered that galectin-7 interacts with HMGCS1 while inducing its
expression (Norihiro Fujimoto, Hideki Mieno, Ryoko Hoso-
kawa, Eita Fujimoto, Shingo Tajima. unpublished data).
We present here two women with normolipaemic PX coin-
ciding with tumour-stage MF treated with PUVA. MF, a cuta-
neous T-cell lymphoma, is considered to express galectin-7
even without PUVA treatment. Galectin-7 expression in MF
lesions plays at least a partial role in generating PXs via induc-
ing and holding HMGCS1. In our cases, UV irradiation
(PUVA) might have accelerated galectin-7 expression and
rendered the lesions ready to generate PXs. Overexpression of
galectin-7 contributed to induction of epidermal apoptosis,
cholesterol synthesis and subsequent lipid incontinence. This
theory is supported by the result that lipid-laden macrophages
in the upper dermis as well as epidermis were positively
stained with antibodies against AE1 ⁄AE3 and galectin-7
(Fig. 2c, d). This explains well the possible aetiological process
of DPXs in MF treated with PUVA.
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Familial frontal fibrosing alopecia
DOI: 10.1111/j.1365-2133.2012.11101.x
MADAM, Frontal fibrosing alopecia (FFA) is a cicatricial alopecia
that was first described by Kossard in 1994.1 It primarily af-
fects caucasian postmenopausal women with progressive reces-
sion of the frontotemporal hairline. In recent years the disease
has been increasingly reported in Europe,2–4 the U.S.A.5 and
Japan.6 Most authors consider FFA a variant of lichen planopi-
laris because of its similar pathological features. Three reports
of familial cases of FFA have been published in the litera-
ture;7–9 however, recent articles with large case series of FFA
do not discuss the possibility that the disease may occur in
families.2–5 We report four new familial cases of FFA includ-
ing two families with involvement of three members.
In all our 10 patients diagnosis was confirmed by pathol-
ogical examination. Biopsies were taken from the frontal hair-
line in areas showing perifollicular erythema and ⁄or scaling.
Dermoscopy was utilized to select the biopsy site in seven
patients. A biopsy from the forearms was also taken in the
two hispanic sisters. Horizontal sections of 4-mm scalp biop-
sies showed reduced follicular density, a lichenoid lympho-
cytic infiltrate involving the outer root sheaths of the upper
follicles, mild perifollicular fibrosis and follicular drop out.
Clinical data from our four families as well as from the pre-
viously published families with FFA are summarized in
Table 1. In three of our four families FFA occurred in siblings
as in the three other families reported in the literature.
 2012 The Authors
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Affected members of our families either lived together (family
1) or close by in the same town. In all our families the
diagnosis of FFA was first made on one female patient who
then diagnosed and referred her relatives. In two of our fami-
lies FFA affected individuals who either because of their age
or because of their sex differ from the typical demographics
of FFA. In fact, family 3 consisted of two sisters who devel-
oped the disease in their twenties. Both gave a history of nor-
mal menses and blood tests showed a normal hormonal
profile. To our knowledge these are the youngest patients with
FFA reported in the literature. The youngest premenopausal
women reported in the large case series of FFA were aged
31,5 342,4 and 40 years.2 In family 2 FFA affected a brother
and a sister, which is peculiar as the condition is extremely
rare in men. The family reported by Roche et al.8 also involved
male and female siblings. The prevalence of men in familial
cases of FFA (12Æ5%) is then significantly higher than in the
series of FFA reported in the literature (3%5 and 0%2–4).
We had two families with three affected members, includ-
ing a black family from South Africa, from where the disease
has never been reported. As most black women have traction
alopecia due to their hairstyle practice, the diagnosis of FFA in
the black population is more difficult. A concomitant FFA may
be overlooked as both conditions affect the frontotemporal
hairline.10
The epidemiology of FFA strongly suggests a role of envi-
ronmental factors in its development. In fact, FFA is a rela-
tively new condition that is becoming increasily common
worldwide. The occurrence of the disease in families can sim-
ply indicate exposure to common environmental triggers.
However, genetic predisposition may also play a role as it is
well documented that inherited genetic traits codetermine the
susceptibility of an individual to toxic chemicals.11 Dioxin-like
chemicals are environmental pollutants that are ingested with
fatty foods of animal origin. These toxins persist in the envi-
ronment and are very slowly eliminated from the human
body.12 The possibility that dioxin-like substances can trigger
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Expanding the therapeutic repertoire of
infantile haemangiomas: cohort-blinded study
of oral nadolol compared with propranolol
DOI: 10.1111/j.1365-2133.2012.11131.x
MADAM, Infantile haemangiomas (IHs) are benign vascular
endothelial neoplasms, with potential for significant complica-
tions and cosmetic disfigurement. Propranolol, a nonselective
beta-blocker, was reported to be beneficial in the treatment of
IHs either alone or in combination with corticosteroids.1
Long-term safety data and appropriate dosage are currently
being investigated. As the beta-adrenergic system is involved
in novelty detection and memory modulation,2 the potential
long-term deleterious brain effects of prolonged propranolol
use in infancy are not known. Nadolol is a synthetic, nonselec-
tive beta-blocker that is comparatively more beneficial due to a
better safety profile,3,4 its inability to cross the blood–brain
barrier5 and a longer half-life, requiring less frequent dosing
and less rebound.6,7 The objectives of our study were to
explore the efficacy and safety of nadolol in patients with IH,
and the feasibility of conducting a randomized controlled trial.
Patients and methods
This assessor-blinded, cohort study using oral nadolol was
conducted at the Hospital for Sick Children, Toronto, ON,
Canada from 2009 to 2011, and was approved by the institu-
tion’s research ethics board, Health Canada, and registered
(NCT01010308). The inclusion criteria for the intervention
arm were infants 1 month to 1 year of age, with head and
neck IH causing function loss, and ⁄or potential disfigurement.
The control group was randomly selected from patients treated
with oral propranolol for at least 6 months between 2008 and
2010, and were matched for age and location. Patients with
proven or suspected PHACES syndrome (posterior fossa abnor-
malities, haemangioma, arterial cerebral abnormalities, cardiac
anomalies ⁄coarctation of the aorta, eye anomalies, sternal
anomalies) and medical contraindications to propranolol were
excluded.
The intervention was nadolol suspension 10 mg mL)1,
administered orally, starting at 0Æ5 mg kg)1 per day divided
twice daily with weekly increments of 0Æ5 mg kg)1 up to a
maximum of 4 mg kg)1 per day according to the response.
Propranolol oral suspension (1 mg mL)1) was administered
incrementally to a maximum of 2–3 mg kg)1 per day divided
three times daily. The duration of the study was 24 weeks.
Baseline procedures included history and physical examina-
tion, electrocardiogram, vital signs, growth parameters and
standardized digital photography. Ten follow-up visits also
included an adverse event review and parental assessment of
improvement. An assessor who was blinded to the interven-
tion and duration of treatment evaluated the improvement in
the size or extent of IH by comparing photographs at each
visit against baseline using a 100-mm visual analogue scale
(VAS) with three anchors: ()), 100% worsening of the hae-
mangioma; 0, no change and (+), 100% shrinkage of the
haemangiomas, where 5 mm represented 10% change.8,9 The
primary outcome measure was the percentage improvement in
the size or extent of the haemangioma at 24 weeks. Secondary
analyses were correlation between assessor and parental assess-
ments, and frequency and severity of adverse events.
Statistical methods
Descriptive statistics were used to summarize the data. Fisher
exact tests (for categorical data) and Wilcoxon signed-rank
tests (for continuous data) were used to compare the baseline
characteristics. A mixed model analysis of variance was used
for the primary outcome. A Pearson correlation [with 95% CI
(confidence interval)] between investigator and parental VAS
was calculated. Statistical tests were conducted at level 0Æ05.
All analyses were performed using SAS v9.2 (2008, SAS Insti-
tute Inc., Cary, NC, U.S.A.).
Results
Ten patients, 30% girls, were recruited in the nadolol group and
nine patients (67% girls) in the propranolol group. There were
no baseline differences (Table 1) between the groups. Five
patients in the nadolol group had an amblyogenic periorbital
IH.
The mean dose was 2Æ19 ± 1Æ1 mg kg)1 in the nadolol
group and 1Æ89 ± 0Æ29 mg kg)1 in the propranolol group.
Patients receiving nadolol had a mean percentage IH shrinkage
of 51 ± 18Æ45% at the 4-week visit, 83 ± 13Æ86% at the 12-
week visit and 97 ± 3Æ05% at the end of the study
(24 weeks). A good, but less favourable response was noted
in the propranolol group, 28 ± 10Æ44%, 56 ± 16Æ55% and
86 ± 14Æ82% at 4, 12 and 24 weeks, respectively (P < 0Æ001,
 2012 The Authors
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Case report
A 35-year-old African man developed an asymptomatic
progressive recession of the frontal hairline over 1 year.
Clinical examination revealed frontotemporal recession
with loss of follicular orifices and partial loss of both eye-
brows (Fig. 1a,b). Routine examination of the remaining
scalp was normal. Further close inspection of the hair
margin with a dermatoscope showed perifollicular plug-
ging and very subtle erythema masked by pigmentation
(Fig. 1c). The rest of the body, including the hair, nails
and mucosa, was unaffected. The subjects general medical
and drug history were insignificant. His family history
showed no evidence of similar or any other scarring alo-
pecia. The patient had always maintained natural virgin
hair and had no history of using chemicals or mechanical
manipulation for hair grooming purposes. Thyroid screen,
antinuclear factor, complete blood count and hepatitis
screen were normal.
Two 4-mm transverse and horizontal histopathological
sections of the affected margin of the scalp revealed fea-
tures typical of lichenplanopilaris,1–3 including reduced
follicular density, a lichenoid lymphocytic infiltrate
involving the outer root sheaths of the upper follicles,
mild perifollicular fibrosis and follicular dropout (Fig. 2).
A diagnosis of frontal fibrosing alopecia (FFA) was
confirmed and the patient was commenced on hydroxy-
chloroquine 200 mg twice per day for 6 months, topical
steroid (clobetasol diproprionate), 0.1% tacrolimus and
2% minoxidil. The patient was followed up for 1 year
and showed a good response to treatment evidenced by
the slow progression of the disorder.
Discussion
Frontal fibrosing alopecia has been classified as a variant
of lichenplanopilaris (LPP) based on some reports docu-
menting an association with classical multifocal LPP over
the vertex of the scalp and other sites, in addition to the
typical histological findings.1 Although LPP is uncommon,
Ochoa et al. 4 have reported annual incidence rates of
1.15–7.59% in hair referral centers in the USA.
Typically, FFA presents with a frontoparietal pattern of
hair loss and is usually associated with the loss of eye-
brows.2 It may also be associated with hair loss on other
peripheral body hair sites, which was recently confirmed
histopathologically.3,5 The condition may be accompanied
by pruritus, as well as evidence of perifollicular erythema,
scaling and diminished follicular orifices.1 Although our
patient did not have evidence of hair loss from peripheral
body sites at the time of examination, he did show clini-
cal evidence of bilateral eyebrow hair loss; however, he
declined eyebrow biopsy. Chew et al.3 performed biopsies
on eyebrows and the upper limbs of affected patients to
show that LPP with scarring alopecia is a generalized pro-
cess rather than one that is localized to the frontal scalp.
ª 2012 The International Society of Dermatology International Journal of Dermatology 2012
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Although our patient revealed intact peripheral body hair
at the time of examination, it is possible that further
evolution of the disease and ongoing follow-up will
enable us to confirm Chew et al.s findings.3
The etiology of this primary cicatricial alopecia remains
uncertain and its treatment is therefore challenging.
Suggested treatments comprise topical corticosteroids,
tacrolimus, chloroquine, finasteride and dutasteride.6–8
Frontal fibrosing alopecia predominantly occurs in post-
menopausal women, but there are a few reports of its
emergence in premenopausal women6 and its sporadic
occurrence in White men is well known.1,9 In 2012,
Miteva et al.10 reported the first male of African-American
descent with FFA amongst 10 Black female patients with
FFA in a retrospective chart review study conducted in
the USA and UK.
To our knowledge, the present patient is the second
Black male and the first male of African descent from
Africa with FFA to be reported in the English-language
literature. The presentation, and clinical and histopatho-
logical findings in this case were similar to those in other
male cases reported in the literature.1,9,11 The present
case, together with the series reported by Miteva et al.,10
indicates that FFA occurs in patients of African, African-
American and Afro-Caribbean descent and is not confined
to White and Asian populations, and that practitioners
should be alert to this condition in Black males, who,
unlike Black females, may not be subject to traction alo-
pecia. Frontal fibrosing alopecia has not been reported in
the African continent previously. Hence, this case illus-
trates that the condition exists in Africa, where frontal
hair recession is often attributed to traction alopecia.
Figure 2 Histopathology shows vacuolar interface changes
with scattered lymphocytes and perifollicular fibrosis in
keeping with lichenplanopilaris. (Hematoxylin and eosin




Figure 1 (a) Scarring alopecia presents with lighter skin and
the loss of eyebrow hair. (b) Frontoparietal hairline recession
is apparent. (c) Close examination shows perifollicular
plugging and dusky erythema
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Alopecia has been shown to have a significant impact on quality of life, particularly in women. 
There are however no data for African populations. 
Objectives 
To pilot an original questionnaire and a model-based methodology to measure the Quality of 
Life (QoL) and its determinants on a sample of black South African women of African ancestry 
affected by alopecia. 
Methods 
50 participants aged 21-79 were chosen at random from patients presenting to dermatologists 
with alopecia. We used an original questionnaire1 consisting of 24 questions grouped into three 
categories assessing the impact of subjective symptoms, objective signs and relational impact, 
each measured on a 4-level Likert scale.  These were then combined using component based 
structural equation model2,3 to return a Quality of Life Index (QLI) and to rank the factors 
contributing to this. 
Results 
On a scale ranging from 0 (high QoL) to 100 (severely decreased QoL), we found a mean QLI 
score of 67.7. The negative impact of alopecia on QoL was higher in younger patients than 
older patients. The factors with the highest impact (as assessed by path coefficient, a measure 
of weighting) were those relating to the subjective experience of alopecia and self-image 
(56.3%), followed by those relevant to relationships and interaction with other people (34.8%). 
The presence of objective symptoms and signs such as pruritus were of minor importance 
(8.9%). 
Conclusions 
Although not a life-threatening condition, alopecia may seriously impair QoL of African black 
women, particularly by inducing anxiety and reducing self-esteem. Health care practitioners 






Primary alopecia of the scalp is usually classified into scarring and non-scarring, and requires 
a good history, reliable clinical records, adequate biopsy and histopathological interpretation 
to make a definitive diagnosis4,5. It has been established that the most common type of hair loss 
in both sexes is androgenetic alopecia, and racial differences in the prevalence or pattern have 
been observed6.  
Ascertaining the influence and impact of skin diseases on patients’ quality of life (QoL), using 
quality of life indicators, is important, and is now well established in dermatology1,7-11. Hair 
plays such a vital role in aesthetics that few skin conditions carry as much emotional burden as 
alopecia, especially in women6,12, some of whose emotions seem disproportionate to the degree 
of alopecia, indicating poor self-esteem and low QoL6,13-16. Such feelings can be easily 
aggravated by non-compassionate health care practitioners who may underestimate the impact 
of hair loss on such patients. However, there is little published information on the psychological 
effects of patients with hair loss in African countries, possibly in part because of a focus on the 
burden of infectious diseases, a priority in the developing countries17, rather than aesthetics. 
Schmidt et al. looked at the correlation between QoL and coping strategies in 50 female patients 
diagnosed with diffuse or androgenetic alopecia using Hairdex, an instrument developed to 
measure QoL in patients with hair loss18. Their findings indicated that patients with obvious 
hair loss reported a more negative impact on various Hairdex aspects (functioning, emotions, 
self-confidence and stigmatization) than those who had slightly visible hair loss. Their small 
group of studied patients showed striking signs of psychological disturbance despite having 
little obvious hair loss.  
Van der Donk et al. studied 58 women with androgenetic alopecia15 and found their daily 
behaviour to be influenced by alopecia in 88% of participants, with 75% indicating a loss of 
self-esteem. Other authors have emphasized the inherent intricacies and challenges of dealing 
with an unpredictable and yet visible and progressive disorder19. Although there are extensive 
reports on the psychosocial consequences of hair loss, most studies have used a medical instead 
of a holistic psychological approach19. Factors that determine the psychological impact of 
alopecia include those which are disease-related (visibility of hair loss), psychological (beliefs 
about illness), behavioural (coping) and demographic (gender)12,15,19,20.  
Although investigators have studied QoL in patients with acne21, psoriasis22 and general skin 
disorders the effect of alopecia on an African population has not been studied 6. This is an 
omission, given the increasing prevalence of hair disorders among black women; such 
disorders are currently rated as the fifth commonest skin disorder amongst African 
Americans23,24 and black South Africans25. 
The aim of this pilot study is to investigate the effectiveness of a newly developed questionnaire 
and algorithm for determining QoL in African women with alopecia, and secondarily to 
provide preliminary estimates of the impact of alopecia in this population. 
122
5 
MATERIALS AND METHODS 
Patients 
This cross-sectional study was conducted over a six month period, from 5th January to 31st July 
2013 inclusive. Ethical approval was obtained from the Nelson R. Mandela School of Medicine 
Institutional Review Board (BE 180/11). African women patients who presented with alopecia 
were recruited randomly from the dermatology clinic at King Edward VIII Hospital and a 
private practice in Durban, South Africa. This hospital is a major public tertiary referral 
hospital for KwaZulu-Natal Province located on the eastern seaboard of South Africa, and sees 
predominantly patients of African and Indian extraction.  
We administered to all patients the questionnaire for the Alopecia Quality of Life Indicators 
(A-QLI) developed by Fabbrocini et al.1(Table 1). The first part of this questionnaire gathers 
demographic and general clinical data (age, race, duration of disease, clinical diagnosis, 
percentage of scalp affected). The second comprises multi-choice questions in a 4-point scale 
(very much, a lot, a little, not at all) about subjective symptoms, objective signs and 
relationship issues (patient’s feeling, using bandanas or other devices to hide scalp area, the 
influence of alopecia on friendships, relationships, sexual activities, social relations etc.). 
The questionnaire was administered by trained interviewers. We recruited 50 South African 
women of African ethnicity between 21 and 79 years of age, with a mean age of 45.18 years. 
Statistical methods 
The QoL assessment was determined using a component-based hierarchical Structural 
Equation Model, in which the calculated QLI is a function of three latent variables (the inner 
model), independent dimensions which would contribute collectively to the subject’s sense of 
well-being. We identified three latent variables: subjective symptoms, objective symptoms and 
relationships. Each latent variable was inferred from a number of manifest variables, 
comprising the answers returned on the questions; 9 for subjective symptoms, 3 for objective 
symptoms and 7 for relationships. A further 5 questions were found to provide no relevant 
information and were excluded from the analysis (questions 10, 11, 22, 23, 24). The 
relationship between each latent variable and its manifest variables constitutes the outer model. 
We used a Partial Alternating Least Squares Optimal Scaling-Path Modelling (PALSOS-PM) 
algorithm2,3,26 that calculates an overall score, and displays the weighted contribution of each 
latent variable to the overall score. Scores are expressed on a scale 0-100, where 0 represents 
the highest QoL and 100 the lowest. 
RESULTS  
All participants completed the questionnaire and were entered into the analysis. The 
unidimensionality of each latent variable in the model was confirmed by Cronbach’s alpha and 
Dillon-Goldstain indexes which exceeded 0.7. The quality of the model was reflected by a 




The model is summarised in Figure 1. The respective QoL score for the three latent variables 
subjective symptoms, objective symptoms and relationships were 72.4, 74.8 and 57.5 
respectively. Their relative weighting was determined by their partial correlation coefficients 
(r2) and returned values for the path coefficients of 0.485, 0.193 0.381 respectively. These 
relationships are summarised in Figure 1. The QLI is then calculated by the following equation: 
QLI = 0.485× Score subjective symptoms +0.193× Score objective symptoms+0.381×Score relationship. 
The calculated mean QLI for our subjects is 67.7. A QLI exceeding 50 is regarded as reflecting 
significant impairment of QoL and was shown in 74% of our patients. 
Though both subjective symptoms and objective symptoms have high scores at 72 to 75, the 
major drivers of impaired quality of life are subjective symptoms and relationships, with partial 
coefficients (r2) values of 56.3 and 34.8; the the contribution of objective symptoms by contrast 
is low in comparison at 8.9.  
The relative impact of the three latent variables is summarised in Figure 2. Here the y-axis 
represents the path coefficient, a measure of the relative weighting of the variable to the overall 
score, while the x-axis represents the QLI score for each variable. Variables falling in the right 
upper quadrant are highly significant in that they have both a high QLI and a high weighting. 
Variables falling in the left lower quadrant are of less significance in that they have a lower 
QLI and lower impact. The other two quadrants represent high QLI/low weighting and low 
QLI/high weighting respectively. Subjective symptoms is shown to be the most critical factor. 
For each latent variable, the relative impact of the component manifest variables are shown in 
Figures 3-5. The most critical variables are again those in the upper right quadrant which 
represent a high QLI and high weighting. For the latent variable subjective symptoms, the 
highest-ranking concerns are: fear that children may develop alopecia, regret at personal 
appearance, inability to forget the presence of the problem, fear that it might spread and worries 
about cost implications. The highest-ranking concerns in terms of the latent variable 
relationships are embarrassment in social interaction, having to explain one’s appearance to 
other people, fear of presenting an unpleasant appearance to other people, and fear of appearing 
unkempt. Concerns about contagiousness and deterioration in work or study performance are 
not significant factors. The manifest variables contributing to  objective symptoms: scalp 
visibility; itch and physical hair loss on hair grooming are not major factors in their own right. 
We identified age as an important factor influencing QoL. A radar plot summarising overall 
QLI, as well as the mean score for each of the latent variables, is shown in Figure 6. The mean 
values for the age groups 21-40, 41-16 and 60+ are plotted. Patients appear to become more 
accepting of their condition with increasing age. 
DISCUSSION 
Alopecia is highly prevalent. In a recent retrospective survey of 6,664 African patients seen in 
a predominantly black urban dermatology practice in Durban, hair disorders in general and 
CCCA in particular, accounted for 5.2% and 0.4% of all skin conditions seen respectively, and 
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constituted the fifth commonest skin disorder among black South Africans25. Studies have 
reported traction alopecia and central centrifugal cicatricial alopecia (CCCA) as the most 
common types seen in women of African ancestry23. In the present study lichen planus 
pigmentosus (LPP) and its variants constituted the most prevalent type of alopecia. The frontal 
fibrosing alopecia pattern was the most common. It is often recognised early as it affects the 
hairline unlike other hair disorders such as the patchy manifestations of LPP or CCCA, which 
are usually not noticed until they affect hair density. 64% of our patients reported a history of 
alopecia for more than one year, and only 12% of the participants had sought medical assistance 
within the first six months of onset. The delay in consultation could conceivably be due to a 
lack of understanding of alopecia by the patient, and particularly a failure to understand that 
there is a potential for irreversible scarring. 
Given the major role that hair plays in the identity and self-image of women, it is not surprising 
that our study has shown a significant impairment in QoL in our patients. This is consistent 
with other reports6,12,19. Some of our patients were pre-occupied by the condition to the point 
of obsession. They worried about the cause, which they often do not know, their fear being 
compounded by societal misperceptions, such as an association between alopecia and 
HIV/AIDS. This was a cause of serious worry to 52% of the patients. 
This is a preliminary study intended to pilot a model for determination of QLI, and is limited 
by sample size and selection bias. Our statistical model and the calculation of QLI in the 
identification of the determinants of QoL appears to hold promise and will be further refined 
and validated. Future prospective longitudinal studies and studies using a cross-sectional 
design will provide more definitive data on the impact of alopecia in African patients on QoL, 
and how the perceptions of those with the disease evolve over time. Finlay has recently stressed 
the importance of rigorous standards in reporting QoL studies in dermatology (and indeed in 
medicine generally), and has suggested that a set of minimum standards should be agreed11. It 
is therefore necessary that such follow-up studies conform to these standards. 
Our study does however provide strong evidence that alopecia has a significant deleterious 
impact on QoL in this population, and has provided some indication of the principal factors 
affecting this as perceived by the patients. We therefore believe it essential that physicians 
address the psychosocial aspects of alopecia as part of the management of their patients. There 
may be significant psychological comorbidity in terms of anxiety and depression12, and a multi-
faceted approach involving psychologists, social workers and support groups is likely to be of 
benefit. 
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Summary of manifest variables, participant responses and calculated loading, with standard 
error of the mean (SEM) and interquartile range (IQR). Responses are classified as follows: A: 
Distresses me very much; B: A lot; C: A little; D: Not at all. 
 
 Participant responses    






Latent variable: Subjective symptoms        
I am uncomfortable using a wig. 56% 16% 14% 14% 0.760 0.078 0.64-0.91 
I need to hide my condition with hats and 
bandanas 44% 16% 06% 34% 0.838 0.049 0.74-0.93 
It costs me a lot of money to look after 
my hair. 42% 24% 20% %14 0.937 0.019 0.91-0.98 
I am saddened by the appearance of my 
hair /eyebrows/eyelashes 5% 24% 08% 16% 0.971 0.009 0.95-0.99 
I worry about having this hair problem 
for the rest of my life. 66% 16% 12% 06% 0.955 0.014 0.94-0.98 
I cannot forget that i have this hair 
problem 52% 22 14% 10% 0.969 0.007 0.96-0.98 
I worry that it might spread.  50% 26 08 16 0.969 0.011 0.945-0.986 
I do not like to be seen without a wig in 





  0.598 0.145 0.281-0.825 
I am afraid my children may have 
alopecia 54% 14% 08% 24% 0.975 0.007 0.962-0.987 
Latent variable: Objective symptoms        
My scalp is visible 38% 30% 24% 08% 0.970 0.012 0.941-0.988 
I lose tufts of hair when I comb or 
shampoo 22% 22% 40% 16% 0.883 0.033 0.819-0.940 
I feel itchy on my scalp. 26% 14% 30% 30% 0.952 0.018 0.914-0.980 
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 Participant responses    






Latent variable: Relationships        
I feel that people find it unpleasant to 
look at me? 32% 14% 30% 22% 0.967 0.009 0.95-0.98 
I feel that other people notice my 
hair/eyebrows/eyelashes 26% 38% 22% 14% 0.938 0.0144 0.92-0.97 
I am afraid that people think my hair is 
not well cared for. 24% 30% 26% 20% 0.964 0.010 0.94-0.98 
I am embarassed when going out to a 
party or function  40% 16% 16% 28% 0.971 0.009 0.95-0.99 
have to explain to others what is wrong 
with my hair 34% 32% 14% 20% 0.952 0.014 0.93-0.98 
I feel that others are afraid of catching 
disease from me 12% 8% 22% 58 0.861 0.055 0.74-0.941 
My work and studies have deteriorated 








Summary of the structural equation model, indicating impact and relative weighting of the three 
latent variables Subjective symptoms, Objective symptoms and Relationships, and of 19 
manifest variables on these. l represents loading, p.c. the path coefficiient, R2 the R squared 
coefficient and c.i. the confidence interval. 
Figure 2 
The impact of the three latent variables on QoL, as measured by the QLI. Variables falling in 
the right upper quadrant have the highest impact in that they have both a high QL score and a 
high weighting. 
Figure 3 
Subjective symptoms: The impact of the relevant manifest variables on QOL, as measured by 
the QLI. Variables falling in the right upper quadrant have the highest impact in that they have 
both a high QL score and a high weighting. 
Figure 4 
Objective symptoms: The impact of the relevant manifest variables on QOL, as measured by 
the QLI. Variables falling in the right upper quadrant have the highest impact in that they have 
both a high QL score and a high weighting. 
Figure 5 
Relationships: The impact of the relevant manifest variables on QOL, as measured by the QLI. 
Variables falling in the right upper quadrant have the highest impact in that they have both a 
high QL score and a high weighting. 
Figure 6 














































SUMMARY OF THE STUDIES 
This dissertation comprises 14 studies, which together, add significantly to the knowledge 
base of South African ethnodermatology. Globally people with ethnic skin types outnumber 
their white counterparts by at least 3 to 1 [50]; in South Africa the ratio is approximately 9:1. 
Historically dermatological research has focused predominantly on the skin disorders of 
white people, to the detriment of an understanding of ethnic skin. The studies summarised in 
this dissertation successfully sought to increase our understanding of skin disorders in South 
African ethnic population groups. 
The initial study sought to describe the spectrum of skin conditions among Africans attending 
private healthcare facilities in KwaZulu–Natal (Chapter 2). The results provide a baseline for 
further studies, as well as establishing a rational basis for the selection of interventions, both 
medical and non-medical, which are required to improve skin health in our population. 
Given the propensity of ethnic skin to dyschromia [23], and long-standing concerns about the 
widespread exposure of our population to potentially harmful skin-lightening preparations 
[51], we studied women’s perceptions of the benefits and risks of skin lighteners (Chapter 3). 
The study found that despite implementation of legislation, prohibiting the sale of mercury, 
hydroquinone and corticosteroid-containing products, more than a third of South African 
women admitted to using skin lightening products purely for non-medical indications. 
Cultural and historical perceptions among both African and Indian women that fairer skin is 
preferable to darker skin tone and this is reinforced by media. 
We then identified the active compounds in the skin lightening products commonly used by 
our patients (Chapter 5). According to the SA government’s regulations on sale of skin 
lighteners, it is mandatory for manufacturers to include a sunscreen in the final skin 
lightening product, a policy driven by and strongly endorsed by the dermatology fraternity. 
Given its situation at latitude 29°S, mean UV exposure is sufficient to produce a high risk of 
both photodamage and skin cancer. Public awareness of this risk and of the measures 
necessary to mitigate it is therefore critical. We conducted a survey to determine the extent of 
knowledge of and compliance with these measures (Chapter 6). A majority of the African 
respondents lacked knowledge about skin cancer and appropriate preventative measures. 
Surprisingly only half of their white counterparts were found to adhere to sun-protective 
measures despite full knowledge of the dangers associated with sun exposure. 
We further undertook two laboratory studies intended to explore the scientific basis for two 
aspects of indigenous knowledge. Firstly we analysed red and white clays, which are 
commonly used for sun protection (Chapter 7). We identified the mineral constituents and 
showed that these do indeed have sunscreen properties, amounting to a low SPF-equivalent, 
though with the advantage of an extended spectrum spanning both UVA and UVB 
wavelengths. Given the naturally sun-resistant characteristics of pigmented skin, this low-
efficacy but effectively costless, freely-available sunscreen is likely to provide adequate sun 
protection during periods of sun exposure. Even though the mask like appearance of the clay 
may not be aesthetically pleasing to the average middle class women this did not deter its use 
amongst the rural low income group women, who needed it the most.  
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Secondly we analysed a local plant extract, derived from Garcinia livingstonei, which is 
traditionally used as a skin-lightening compound. The plant extracts were found to be less 
toxic than hydroquinone furthermore they show potential for further research and 
development into safer skin lightening agents (Chapter 8). 
The final section of our study (Chapters 9-14) was directed at specific aspects of two scarring 
hair disorders to which African patients are particularly predisposed, namely central 
centrifugal cicatricial alopecia (CCCA) and frontal fibrosing alopecia (FFA) and how these 
impact on the quality of life (Chapter 15). We found that CCCA can be inherited as an 
autosomal dominant genetic disorder which can be aggravated by various hair grooming 
practices. In addition we found that FFA can be associated with lichen planus pigmentosus, 
the latter presenting as a herald sign for FFA. 
DISCUSSION 
The spectrum of skin diseases in a black population in KwaZulu-Natal, 
South Africa (Chapter 2) 
The spectrum of disease in the KZN cohort is similar to that of previous studies conducted in 
Gauteng province; however the order of occurrence of dermatoses has changed to reflect 
changing socioeconomic conditions in SA. There is a difference in the ranking of dermatoses 
in ethnic skin between developed and developing countries. Acne and eczema are reported as 
the leading causes of dermatoses in countries such as USA and UK whilst countries such as 
Ghana and Nigeria, Tanzania, Malawi, Uganda and Ethiopia report infections as the leading 
cause [52]. In our study, not unexpectedly, South Africa occupies an intermediate position in 
that acne and eczema head the list but skin infections feature among the top five dermatoses. 
The order of disease occurrence is also reflective of socio-political changes over time, for 
example pellagra, which was a leading cause of dermatosis between the years 1957 and 1975, 
was virtually non-existent in 2013. This reflects an improvement in standard of living and 
nutrition, as well as the redistribution of health care priorities towards primary health care, 
accelerated by the demise of apartheid. Though a rise in incidence of pellagra has been 
reported in relation to HIV infection [53], the disease is not nearly as prevalent as it was 50 
years ago.  
This study is one of few to have documented the spectrum of dermatoses in the broader South 
African population, is relevant in that the relative prevalence of the various dermatoses is 
continually evolving, and is the first study to describe the spectrum and prevalence of skin 
conditions in KwaZulu-Natal, the second most populous province in South Africa. It will 
inform effective planning of healthcare service delivery, healthcare provider education and 
social and educational interventions and community for both this province and South Africa 
as a whole. The study is limited in that it assessed patients in a private practice who for socio-
economic reasons may not be relevant of the African population as a whole. However, we 
have now performed a complementary study in the dermatology clinic of King Edward VIII 
hospital (currently in preparation for publication), a large public referral hospital in Durban. 
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The two studies together should provide an accurate appraisal of the importance of the 
various skin diseases in our population. 
Skin lightening compounds in KwaZulu-Natal (Chapters 3-5) 
Although skin lightening products are medically indicated in the treatment of 
hyperpigmentation, they are widely abused as self-medication because of a widespread 
cultural perception that a lighter skin complexion is preferable to a dark complexion [54]. We 
have identified both intentional use of skin lightening preparations and inadvertent exposure 
of the whole face in an effort to treat dyschromia as one of the commonest conditions seen in 
our patients. This prompted us to investigate skin lightening practices, women’s perception of 
the benefits and risks of using skin lightening creams as well as an analysis of the active 
compounds of the commonly used skin lightening creams in Durban (Chapters 3-5).  
The importance of dermatoses resulting from the abuse of skin lighteners was first reported 
by Findlay in 1975 [31], with further epidemiological data provided by Schultz in 1982 [44], 
when dyschromia was still reported as one of the commonest skin conditions, despite 
government legislation banning the use of hazardous products such as hydroquinone, 
mercury, resorcinol and phenol. 
One of the factors contributing to dyschromia is the inappropriate use of topical steroids in an 
effort to treat acne. Our survey showed that 23.5% of women used these products to treat 
acne without full knowledge of the adverse effects on the skin. A similar number of women 
(26.2%) were found to use these creams in a deliberate effort to lighten the skin. This 
highlights a major concern: the strong culturally-driven perception that lighter skin is more 
attractive than darker skin. Furthermore, we found that this perception is not restricted to our 
African population, and that as many as 40% of women of Indian extraction in our province 
also deliberately engage in this practice for similar reasons. 
We then investigated the active chemical compounds in the top-ten-selling over-the-counter 
skin lightening creams. The last study investigating skin lightening products was undertaken 
by Findlay et al. 33yrs ago [32]. We found that hydroquinone, formerly in common use, is no 
longer an ingredient of the most popular brands. Mercury however was detected in half the 
products. We also observed serious deficiencies in the labelling of products, which frequently 
failed to list the active compounds and their concentrations. Easy access to these products by 
the population, as well as a lack of package labelling by industry, will continue to give rise to 
dermatoses related to skin bleaching. We therefore recognise an imperative for more vigilant 
regulation of both industrial and retail practice as well as public health campaigns to educate 
consumers about the adverse effects of skin lightening products.  
To obviate the adverse effects of skin lightening, it is recommended that they should be used 
together with a broad-spectrum sunscreen [55]. Since the last study by Findlay, further 
recommendations were made regarding complementary use of sunscreens when using skin 
lighteners and have been incorporated into the South African regulatory framework [56-58]. 
Yet our study showed that although one in every three African South African women admits 
to using skin lightening products, only 21% use sunscreen. The potential risks of this are 
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emphasised by a case report of squamous cell carcinoma following prolonged use of 
hydroquinone without a sunscreen [55], and an increased prevalence of skin cancer among 
African-Americans and Africans has indeed been documented [13].  
Cancer awareness and sunscreen use (Chapter 6) 
In anticipation of this, we set out to determine the level of awareness of skin cancer, of 
sunscreen use and the frequency of risk appropriate and risk-inappropriate behaviour among 
our population (Chapter 6). We found that a high proportion of African participants lacked 
knowledge about skin cancer and measures for its prevention. A widespread misconception 
that Blacks do not get skin cancer has contributed to the high levels of ignorance regarding 
skin cancer in this population [59]. This is compounded by a of skin cancer prevalence 
studies among Africans, resulting in a lack of scientific evidence to dispel this belief. 
Whereas the white subgroup, who are known to be a higher risk for skin cancer, possessed a 
better knowledge of skin cancer, they were poor in their implementation of preventative 
measures. Only 12% claimed to practise self-examination for skin cancer and just 6% 
reported having consulted a doctor for skin examination.  
Ethnopharmacology and indigenous knowledge systems: Use of traditional 
medicinals for sun-protection and skin-lightening (Chapters 7-8) 
More than a quarter of African women reported using traditional sunscreen in the form of red 
clay (ibomvu) and white clay (umcaku) to prevent hyperpigmentation and sunburn. This was 
almost exclusively reported by African women, and only one Indian woman reported using 
clay as sunscreen. We studied these clays to determine whether there is a scientific rationale 
for their use. Clay minerals are widely used in the pharmaceutical industry for a variety of 
purposes in oral and topical applications, as excipients and in aesthetic medicine [60]. We 
studied two clays from riverside banks, red and white. These were found to contain oxides 
and silicates of aluminium (kaolinite) with additional iron oxide (haematite) confined to red 
clay. Although the clays afford only a modest SPF (3.6-4) against ultraviolet B, they also 
protected against longer UVA wavelengths, which are themselves not harmless, being 
implicated in skin cancer and hyperpigmentation disorders such as melasma, apparently 
without any adverse effect. Given the sun-protective effect afforded by the endogenous 
melanin of our African subjects, this modest additional protection would appear to be 
sufficient for its purpose, thus vindicating its use in traditional communities. 
A number of our subjects reported using the plants ummemezi and umqonga as traditional 
medicinals for skin lightening. The use of plants in traditional medicine is a widespread 
phenomenon, with an estimated 75 000 tonnes of material consumed annually in South Africa 
and 72% of the black South African population making use of traditional health care systems, 
often in parallel with conventional allopathic medicine [61, 62]. We believe that this is the 
first time that traditional plants and minerals have been investigated solely for dermatological 
indications, and is the first study to validate the inhibitory effect of organic extracts and 
compounds isolated from the stem bark and fruit of Garcinia Livingstonei on melanin. The 
investigation showed that Morelloflavone 7 sulphate and Sargaol extracts exact their 
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antimelanogenic effects by inhibiting tyrosinase. This suggests that these compounds are 
indeed biologically active; potentially product development opportunities should be explored: 
this, and indeed bioprospecting more generally, may yield compounds of both therapeutic and 
commercial value, with the further potential to empower indigenous communities through 
benefit sharing. 
Ethnic hair disorders (Chapters 9-15) 
Our study placed hair disorders among the five most prevalent dermatoses in KwaZulu-Natal, 
with alopecia being the most common of these. Though the field is both complex and 
extensive, we set out to describe the two common causes of scarring alopecia, CCCA and 
FFA and their impact on quality of life. 
Central centrifugal cicatricial alopecia (CCCA) (Chapters 9-10) 
CCCA is the most common type of primary scarring alopecia in women of African descent 
[63]. The exact prevalence of CCCA is still unclear, however figures varying from 2.7% to 
5.7% have been documented, as well as its association with increasing age [64]. It is one of 
the five commonest conditions with which African Americans present to dermatologists [63]. 
While a genetic basis has been for the condition has been suggested, little is currently known 
about the disease genetics. We have shown evidence for a heritable component, initially in 
two families, followed by a series of 30 patients who showed a positive family history of this 
condition; pedigree analysis suggested an autosomal dominant mode of inheritance. 
However, we have shown that hair grooming habits markedly influence disease expression. 
To our knowledge this is the first study in the literature to show a genetic association with 
CCCA. The permanent, extensive hair loss that results in many patients makes CCCA, from 
the point of view of the patient, a very serious disorder and a full understanding of its 
aetiology, and therefore, potentially, of appropriate prevention and management, imperative. 
Our findings may serve as a useful foundation for further studies in this area. 
Frontal fibrosing alopecia (FFA) (Chapters 11-14) 
Previous studies on FFA are predominately based on studies in white and Asian patients; 
FFA is uncommon in patients of African descent [65]. Our study of FFA constitutes the first 
series of black patients in Africa. We have further reported the occurrence of FFA in an 
African male. Possibly the lack of recognition of FFA in African patients is due to the 
overlapping clinical presentations of FFA and traction alopecia, which is extraordinarily 
common in this population[65]. 
We have shown that, most African women with FFA are premenopausal, which is in contrast 
to the experience in white women [66]. We were also unable to confirm a loss of follicular 
ostia [66], as a sign of scarring; further study will be required to resolve this discrepancy. 
Furthermore we confirmed the observation by Khumalo et al. (2007) that traction-inducing 
hairstyles may aggravate the severity of FFA, particularly when traction alopecia is further 
aggravated by joining of weaves and braids to chemically treated hair. 
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Our data raises two interesting possibilities. Firstly, our report of three families with FFA 
may suggest a genetic aetiology for this challenging hair condition. Secondly, we have 
identified the co-occurrence of FFA with cutaneous lichen planus pigmentosus (LPPigm) as 
well as a possible familial association in patients of African ancestry. To our knowledge this 
is the first such report, though a combination of genetic and environmental factors have been 
postulated [67]. The well-defined, sequential, histologically confirmed clinical progression 
from LPPigm to FFA, raise the possibility that LPPigm and FFA share the same aetiology. 
Quality of life in African patients with alopecia Chapter 15) 
Finally we performed a pilot study to ascertain the influence and impact of skin diseases on 
patients’ quality of life (QoL), using QoL indicators as described in previous publications 
[68-71]. Hair plays a vital role in aesthetics, and few skin conditions cause as much 
emotional distress as alopecia, especially in women, where several studies have shown an 
association with poor self-esteem and impaired quality of life [72-77]. Such distress can be 
easily aggravated by non-compassionate health care practitioners who may underestimate the 
impact of hair loss on such patients. Information on the psychological effects of hair loss on 
African patients is lacking. This may be in part a consequence of interest primarily focusing 
on diseases perceived as more common and of a higher priority, such as those of infectious 
origin [52]. The method employed in our pilot study appears valid, and has shown that 
alopecia in African women, as has been shown in other groups, has a significant, deleterious 
impact on quality of life, and suggests a need for focused interventions on the part of health 
care practitioners to mitigate this. Well-designed, larger cross-sectional and longitudinal 
studies are necessary to extend this work. In a recent editorial, Finlay summarises the 
evolution of QoL indices and their underlying methodology, and emphasizes the need for 
rigorous reporting of these using a set of criteria as yet to be agreed [78]. Such follow-up 
studies will conform to these standards. 
STUDY LIMITATIONS 
The studies contained in this thesis have a number of potential biases. The spectrum of 
disease was calculated from a sample of patients attending a single private clinic; with 
consequent potential selection bias. We have however now completed a complimentary study 
in a large public sector hospital; a study currently being prepared for publication. With the 
proviso that both studies were limited to single facilities, it is unlikely that they will be a 
major deviation from the actual experience within the province. Diagnoses reported in this 
study were in most instances those recorded in the patients’ hospital records, and have not 
been independently reviewed and validated; there is the potential for some of these to be 
inaccurate, and some relevant clinical data may have been missing from the patient records. 
All questionnaire-based surveys have their limitations, such as recall bias and the editing of 
replies for fear of judgement and feelings of embarrassment. The latter is a particular problem 
when questionnaires are administered face-to-face; on the other hand this format does allow 
the administrator to explain questions with the potential to be understood to the subject, 
allowing a more accurate response. 
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We were only able to obtain useful data on 10 skin-lightening products, and our findings may 
not be fully representative of the full spectrum of products in the market. This work 
continues, and we are currently analysing 40 more products in South Africa in order to 
establish a better understanding of the extent of the problem. 
GENERAL CONCLUSIONS 
Hay et al. have stated that skin conditions are the 4th leading contributor to the world’s non-
fatal disease burden and argued that their prevention and treatment deserves urgent attention 
[3]. In South Africa little is known about the spectrum and prevalence of skin diseases. The 
South African Medical Research Council has reported that skin diseases caused premature 
mortality in 790 cases of 12 million deaths in the year 2000 (Bradshaw et al. 2003). This is 
not a true reflection of the prevalence of skin diseases, since the above figures only reflect 
mortality. It is well known that skin disease affects quality of life and has economic and 
social impacts on patients [68, 69, 71, 79].  
The work included in this dissertation represents the first study to assess the spectrum of skin 
disease seen in an ethnic population in KwaZulu-Natal. It is unlikely that results would differ 
significantly elsewhere in South Africa, and this work is therefore relevant and useful; it has 
already demonstrated clearly the changing profile of dermatoses in the African population 
over the past few decades. We have shown that acne, eczema, dyschromia, infections and hair 
disorders are, in order, the most prevalent dermatoses in KwaZulu-Natal. Steroid acne caused 
by inappropriate use of steroid creams to treat various skin conditions and for skin bleaching 
is a cause for concern. As anticipated, very few patients presented with skin cancers, 
confirming the very low prevalence of cancer in patients from dark-skinned ethnic 
populations, such as those of African ancestry.  
There is a need to sensitize health care providers to ethnodermatology, to provide additional 
training and resources, and to include this important subject within undergraduate medical 
programme. This information should be used to inform effective planning and screening for 
skin diseases and offer pertinent recommendations for the needs of the country as a whole. 
We have shown that the highly prevalent use of skin-lightening products among African and 
Indian South African women is not accompanied by appropriate knowledge of their risks and 
of the precautions which should be taken to reduce adverse effects. There are extraordinary 
difficulties in reducing the inappropriate use of skin lighteners as a result of deeply rooted, 
albeit misplaced, cultural perceptions about the desirability of a light complexion in black 
women. Culturally-linked perceptions of the social value of fair skin are pervasive, and are 
perpetuated by the use of fair-skinned models to market cosmetics to black consumers and 
the over-representation of light-complexioned black women on film and television. Extensive 
public education, coupled with effective policing of both the formal and informal markets 
where these products are bought is imperative. That these products are also used widely by 
Indian women in KwaZulu-Natal had not hitherto been suspected. Clearly this is a group 




Through laboratory investigations of commonly used traditional plants, we have isolated a 
range of compounds from the stem bark and fruit of Garcinia livingstonei some of which 
proved less toxic and more potent than the standard universally used hydroquinone. This 
opens up potential for future research to develop safe innovative treatments for dyschromias, 
based on natural resources from indigenous plants. Similarly we have shown that clay 
products, long used for sun protection in African society, provide a useful degree of UVA 
protection. These clays play an important role for rural South African women in resource 
poor areas because they are cheap; easily accessible and culturally acceptable. Commercial 
sunscreens essentially unaffordable for many potential users in the developing world, and the 
potential for the development of a cheap, effective preparation utilising this abundant mineral 
resource deserves consideration. 
We are particularly concerned by the serious gap in both knowledge and behaviour regarding 
skin cancer we identified among our population. This failure to understand the risk of skin 
cancer was most marked among our African population, and probably results from the 
perception that these issues are not relevant in blacks, thus emphasising the need for 
effective, culturally sensitive education and screening efforts. It is however worrying that the 
white population, though better informed, exhibits an essentially complacent attitude toward 
sun protection despite the very high lifetime risk of skin cancer to which they are subject.  
Hair plays a vital role in aesthetics. We have shown that alopecia significantly impairs QoL 
by lowering self-esteem among black women in South Africa, and it is important that health 
care medical practitioners are aware of its psychological impact. CCCA is more common in 
women of African descent and has been linked to excessive use of hair-straightening relaxers. 
We have shown a possible genetic link to the etiology of CCCA, have provided the first 
published descriptions of FFA in Africans and have identified a probable association between 
FFA and LPPigm; this opens up the possibility that early detection may be possible, and 
allow the prevention of irreversible scarring alopecia. At the practical level, proper 
delineation of the contribution of a range of hair grooming styles to disease development and 
progression will assist us in establishing effective preventative and treatment strategies. 
The genetic associations we have shown for CCCA and FFA require further study. We are 
presently looking at 20 families with CCCA and 15 families with FFA to analyze the gene 
expression patterns in CCCA and FFA through study of RNA samples obtained via 4mm 
scalp punch biopsies of affected subjects and age, race, and gender-matched controls. We are 
also in the process of identifying the genetic basis of CCCA as well as establishing a bank of 
DNA samples from patients with CCCA for the purpose of future research.  
IMPLEMENTATION OF RESEARCH FINDINGS 
Clinical practice 
All dermatologists operating under the guidance of the Division of Dermatology are now 
with a list of products which contain banned skin lightening creams and are required to work 
through this list with any patient they see who has been using skin lighteners. We have also 
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hired a counsellor who will assist with proper counselling of patients and explain their 
conditions in their mother tongue. 
Regulation 
I have initiated a discussion with the Dermatology Society of South Africa (DSSA) and the 
analytical chemists with whom I have been collaborating to have all commonly-used skin 
lightening products analysed. Those which are legitimate will then be issued with a stamp of 
approval endorsed by DSSA. This will indicate to consumers which products are safe for use. 
I am recommending measures to ensure that pharmacists are closely monitored so that they 
do not issue steroid and hydroquinone-containing creams without a valid prescription. (This 
was found to be a very common practice.) Similarly doctors in general practice need to be 
counselled against dispensing steroid creams from their rooms without seeing the patients, 
and issuing unlabelled creams, and then monitored for compliance. 
Current and planned research projects 
Skin cancer 
Albinism 
In co-operation with the Albinism Society, we are planning a database of all patients with 
albinism in the province of KZN. A priority is the study of the clinical types and evolution of 
skin cancers in these patients. We are also contemplating on conducting further research on 
albinism using the database which we are working on. 
Ethnopharmacology 
There is a need for further research on traditionally used medicines, and a thorough 
assessment of the potential for commercialisation of the extracted compounds. 
Hair 
CCCA 
We are presently collaborating with Prof Amy McMichael at the University of North 
Carolina, and Prof Eli Sprecher in Tel Aviv, to analyze the gene expression patterns in CCCA 
through study of RNA samples obtained via 4mm scalp punch biopsies of 12 affected 
subjects and 12 matched controls. In addition, we will establish a bank of DNA samples from 
patients with CCCA for the purpose of future research. 
FFA 
We are working with Prof John McGrath, St Thomas Hospital. London, to analyse the gene 
expression patterns in families with FFA. 
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Spectrum of skin disease in the public sector 
This is a follow up study on the study conducted in the private sector and is in preparation for 
publication. This will give a balanced overview of the spectrum of skin conditions seen in 
KwaZulu-Natal. 
Education 
We are modifying our undergraduate curriculum to reflect relevant findings. I am first author 
of a chapter Common skin diseases and treatment in Africa in Taylor and Kelly’s 
Dermatology for skin of color, currently in press which covers skin conditions relevant to 
Africa and is directed towards the promotion of practice that is appropriate to the health of 
ethnic skin, to African culture and the African environment [80]. We are also producing a 
textbook comprising lecture notes for use in southern Africa and have received sponsorship 
for this. We have a programme of offering Dermatology workshops to provide continuing 
education to medical practitioners, emphasizing the importance of common ethnic skin 
conditions which were previously not adequately covered in the undergraduate curriculum. 
Dermatological surgery has not previously formed part of our postgraduate curriculum for 
trainee dermatologists leading to deficiencies in the training of registrars for the management 
of the skin cancers seen in our albino African and white patients. We have therefore 
established a dermatological surgery training programme in collaboration with the 
dermatological surgery faculty at Harvard Medical School, which will initially run over a 
period of 5 years. This is the first programme in Africa, and we are hoping to export this 
expertise to dermatologists drawn from the rest of South Africa and indeed the rest of Africa. 
Patient education and support 
We have completed 25 patient-education pamphlets or posters and 10 video presentations 
dealing with common skin conditions to be made available to dermatology outpatient clinics, 
which the KwaZulu-Natal Department of Health has undertaken to make available at all its 




The albino population is at greatest risk, presenting with advanced skin cancer, owing to poor 
access to health facilities, ignorance and poor socioeconomic factors. We are investigating 
ways of developing and teaching community workers who will in turn conduct educational 
workshops on skin care and skin cancer awareness for albinos in the rural areas. We will be 
working closely with social workers and psychologists. The Albinism folder which we have 
developed is aimed at assisting the community workers. We will be raising funds to assist 
with supply and or donation of sunscreens and protective sun hats to all rural patients who 
cannot afford to purchase these. 
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Skin cancer in the white population 
 We are implementing outreach programmes to educate the public about skin cancer and use 
of sunscreens. We already run a “beach spot examination programme” at holiday times which 
will be strengthened. We are planning a series of talks to schools targeting children with a 
view to educating them about the dangers of sun tanning and artificial tanning booths. 
Care of the skin and use of skin lighteners 
We have written a chapter on the care of the skin and hair for a children’s textbook intended 
to raise interest in science, technology, engineering and mathematics among primary school 
children in South African schools. One aspect of this is a perceived need to empower girls to 
rise above inappropriate societal expectations, such as those surrounding the supposed 
desirability of a light complexion. Our contribution reinforces the important message that the 
best skin is the one that you are born with. We have also approached the producer of the 
popular TV soap opera Generations, widely viewed every weekday by a significant part of 
the African population, with the suggestion that material raising awareness of the dangers of 
skin lighteners be incorporated into the script. This suggestion was well-received. We have 
also written articles for popular magazines and participated in podcasts, TV and radio 
interviews to increase the awareness of the implications of our research findings among the 
public. 
GENERAL CONCLUSIONS: ETHNODERMATOLOGY 
The above studies show a growing need for the field of ethnodermatology, particularly in 
Africa. As previously mentioned general dermatology research has focused primarily on 
white skins neglecting a large proportion of a growing population. There has been a 
significant inclusion of black people within the middle class sector and this invariably calls 
for an increase in the knowledge and understanding of black skin. Indigenous knowledge 
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